# EDGAR Filing Document

**Accession Number:** 0002093375
**File Stem:** 0002093375-26-000002
**Filing Date:** 2026-3
**Character Count:** 582538
**Document Hash:** ceee154f341134fec90cf36ffec53746
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002093375-26-000002.hdr.sgml**: 20260320

**ACCESSION NUMBER**: 0002093375-26-000002

**CONFORMED SUBMISSION TYPE**: S-1

**PUBLIC DOCUMENT COUNT**: 39

**FILED AS OF DATE**: 20260320

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DentonX Inc
- **CENTRAL INDEX KEY:** 0002093375

**ORGANIZATION NAME:**
- **EIN:** 394170349
- **STATE OF INCORPORATION:** WY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-1
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-294481
- **FILM NUMBER:** 26777880

**BUSINESS ADDRESS:**
- **STREET 1:** 1999 HARRISON STREET
- **STREET 2:** SUITE 1800
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94612
- **BUSINESS PHONE:** 9252202187

**MAIL ADDRESS:**
- **STREET 1:** 1999 HARRISON STREET
- **STREET 2:** SUITE 1800
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94612

**As filed with the U.S. Securities and Exchange Commission on March 20, 2026**

**Registration No. 333-________________**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM S-1**

**REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933**

![Picture 877356019](dtnxs1_1.jpg)

**DENTONX INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Wyoming** | **7374** | **39-4170349** |
| (State or Other Jurisdiction<br> of Incorporation) | (Primary Standard Industrial<br> Classification Code) | (IRS Employer<br> Identification No.) |

---

**1999 Harrison Street, Suite 1800**

**Oakland, CA 94612**

**925-220-2187**

(Address, including zip code, and telephone number, including area code, of registrant's principal executive office)

Approximate date of commencement of proposed sale to the public: **As soon as practicable after this Registration Statement becomes effective.**

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act of 1933, please check the following box and list the Securities Act registration Statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act of 1933, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act of 1933, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

------

i

------

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY OUR EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A), MAY DETERMINE.

------

ii

------

**PRELIMINARY PROSPECTUS**

**THE INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. WE MAY NOT SELL THESE SECURITIES UNTIL THE REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND IT IS NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED. THERE IS NO MINIMUM PURCHASE REQUIREMENT FOR THE OFFERING TO PROCEED.**

**SUBJECT TO COMPLETION, DATED MARCH 20, 2026**

![Picture 1284146484](dtnxs1_1.jpg)

**DENTONX INC**

**3,000,000 SHARES OF COMMON STOCK**

**$0.0001 PAR VALUE PER SHARE**

Prior to this Offering, no public market has existed for the common stock of DentonX Inc. Upon completion of this Offering, we will attempt to have the shares quoted on the OTCQB or OTCID operated by OTC Markets Group, Inc. There is no assurance that the Shares will ever be quoted on the OTCQB or OTCID. Although we believe that in the future we will meet the eligibility requirements in order to be quoted on the OTCQB or OTCID, we cannot quantify the likelihood that this will be the case. To be quoted on the OTCQB or OTCID, a market maker must apply to make a market in our common stock. As of the date of this Prospectus, we have not made any arrangement with any market makers to quote our shares. Additionally, there is the possibility a market maker may not apply to make a market in our common stock.

In this public offering we, "DentonX Inc" are offering 3,000,000 shares of our common stock. The offering is being made on a self- underwritten, "best efforts" basis. There is no minimum number of shares required to be purchased by each investor. The shares offered by the Company will be sold on our behalf by our sole executive officer, Mr. Lionel Pinuer, who is deemed to be an underwriter of this offering. The Company may engage and offer the shares through one or more broker-dealers. A commission of seven percent (7%) will be offered in cash from proceeds of the offering to any engaged broker-dealer. As of the date hereof, there are no broker-dealers engaged. There is uncertainty that we will be able to sell any of the 3,000,000 shares being offered herein by the Company. Mr. Pinuer will not receive any commissions or proceeds for selling the shares on our behalf. All of the shares being registered for sale by the Company will be sold at a fixed price of $5.00 per share for the duration of the Offering. Assuming all of the 3,000,000 shares being offered by the Company are sold, the Company will receive $13,830,000 in net proceeds. Assuming 2,250,000 shares (75%) being offered by the Company are sold, the Company will receive $10,342,500 in net proceeds. Assuming 1,500,000 shares (50%) being offered by the Company are sold, the Company will receive $6,855,000 in net proceeds. Assuming 750,000 shares (25%) being offered by the Company are sold, the Company will receive $3,367,500 in net proceeds. There is no minimum amount we are required to raise from the shares being offered by the Company and any funds received will be immediately available to us. There is no guarantee that we will sell any of the securities being offered in this offering. Additionally, there is no guarantee that this Offering will successfully raise enough funds to institute our business plan. Additionally, there is no guarantee that a public market will ever develop and you may be unable to sell your shares.

The Company is a technology infrastructure company seeking to develop a non-bank lending platform that consolidates the fragmented mortgage and financial services industry. The Company intends to integrate scalable technology infrastructure with lending operations to provide flexible, data-driven credit solutions to underserved borrowers, including self-employed individuals, real estate investors, small and medium-sized enterprises (SMEs), and diverse communities often excluded by traditional qualified mortgage (QM) standards. The Company's model contemplates generating dual revenue streams from platform fees and lending activities, supported by proprietary acquisition and automation frameworks that enable workflow efficiency and ecosystem intelligence-creating a scalable network that learns from transactions, expands capacity, and delivers compounded value across participants in non-QM and SME lending. The Company does not originate loans, extend credit, underwrite financial products,

------

iii

------

broker securities, or provide consumer financial services. All regulated financial activities are conducted exclusively by independent licensed entities, that utilize the Company platform for internal operational and infrastructure purposes.

As of the date of this filing, Mr. Pinuer, our Chief Executive Officer and Chief Financial Officer owns 200,000 shares of our common stock representing 1.06% of our issued and outstanding shares of common stock. Mr. Luis Carlos Ung, our sole director, President and Secretary owns 2,000,000 shares of common stock of which 500,000 are held directly and 1,500,000 indirectly, representing 10.64% of our issued and outstanding common stock and two shareholders, AG Partners I Inc. and OutstandingX LLC, own 6,600,000 and 6,080,000 shares of common stock, respectively, representing in the aggregate 67.49% of our issued and outstanding common stock. AG Partners I Inc. and OutstandingX LLC collectively will continue to control our Company if no shares are sold in this offering. If all 3,000,000 shares are sold, AG Partners I Inc. and OutstandingX LLC collectively will hold 58.19% of the outstanding common stock.

This primary offering will terminate upon the earliest of (i) such time as all of the common stock has been sold pursuant to the registration statement or (ii) 365 days from the effective date of this Prospectus, unless extended by our director for an additional 90 days. We may however, at any time and for any reason terminate the offering.

All expenses incurred in this offering are being paid for by the Company. The Company will utilize offering proceeds from this offering to pay for any offering expenses however, the Company may also elect to use available existing cash on hand to pay for any offering expenses.

The proceeds from the sale of the securities sold on behalf of the Company will be placed directly into the Company's account; any investor who purchases shares will have no assurance that any monies, beside their own, will be subscribed to the prospectus. All proceeds from the sale of the securities are non-refundable, except as may be required by applicable laws.

The Company qualifies as an "emerging growth company" as defined in the Jumpstart Our Business Startups Act, which became law in April 2012 and will be subject to reduced public company reporting requirements.

**THESE SECURITIES ARE SPECULATIVE AND INVOLVE A HIGH DEGREE OF RISK. YOU SHOULD PURCHASE SHARES ONLY IF YOU CAN AFFORD THE COMPLETE LOSS OF YOUR INVESTMENT. PLEASE REFER TO "RISK FACTORS" BEGINNING ON PAGE 3.**

**NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.**

You should rely only on the information contained in this Prospectus and the information we have referred you to. We have not authorized any person to provide you with any information about this Offering, the Company, or the shares of our Common Stock offered hereby that is different from the information included in this Prospectus. If anyone provides you with different information, you should not rely on it.

The following table of contents has been designed to help you find important information contained in this prospectus. We encourage you to read the entire prospectus.

------

iv

------

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
|  | **PAGE** |
| **[PART I. PROSPECTUS](#_PART_I._PROSPECTUS)** |  |
| [PROSPECTUS SUMMARY](#_PROSPECTUS_SUMMARY) | 1 |
| [RISK FACTORS](#_RISK_FACTORS) | 5 |
| [SUMMARY OF OUR FINANCIAL INFORMATION](#_SUMMARY_OF_OUR) | 12 |
| [MANAGEMENT](#_MANAGEMENT_S_DISCUSSION_AND)['](#_MANAGEMENT_S_DISCUSSION_AND)[S DISCUSSION AND ANALYSIS](#_MANAGEMENT_S_DISCUSSION_AND) | 13 |
| [FORWARD-LOOKING STATEMENTS](#_FORWARD-LOOKING_STATEMENTS) | 17 |
| [DESCRIPTION OF BUSINESS](#_DESCRIPTION_OF_BUSINESS) | 17 |
| [USE OF PROCEEDS](#_USE_OF_PROCEEDS) | 21 |
| [DETERMINATION OF OFFERING PRICE](#_DETERMINATION_OF_OFFERING) | 21 |
| [DILUTION](#_DILUTION) | 22 |
| [PLAN OF DISTRIBUTION](#_PLAN_OF_DISTRIBUTION) | 23 |
| [DESCRIPTION OF SECURITIES](#_DESCRIPTION_OF_SECURITIES) | 25 |
| [LEGAL OPINION](#_LEGAL_OPINION) | 26 |
| [EXPERTS](#_EXPERTS) | 26 |
| [REPORTS TO SECURITIES HOLDERS](#_REPORTS_TO_SECURITIES) | 26 |
| [DIRECTORS AND EXECUTIVE OFFICERS](#_DIRECTORS_AND_EXECUTIVE) | 27 |
| [EXECUTIVE COMPENSATION](#_EXECUTIVE_COMPENSATION) | 30 |
| [SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT](#_SECURITY_OWNERSHIP_OF) | 32 |
| [CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS](#_CERTAIN_RELATIONSHIPS_AND) | 33 |
| [FINANCIAL STATEMENTS](#_FINANCIAL_STATEMENTS_AND) | 35 |
| **[PART II. INFORMATION NOT REQUIRED IN PROSPECTUS](#_PART_II._INFORMATION)** |  |
| [OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION](#_OTHER_EXPENSES_OF) | II-1 |
| [INDEMNIFICATION OF OFFICERS AND DIRECTORS](#_INDEMNIFICATION_OF_DIRECTOR) | II-1 |
| [RECENT SALES OF UNREGISTERED SECURITIES](#_RECENT_SALES_OF) | II-2 |
| [EXHIBITS TO THE REGISTRATION STATEMENT](#_EXHIBITS_TO_REGISTRATION) | II-2 |
| [UNDERTAKINGS](#_UNDERTAKINGS) | II-3 |
| [SIGNATURES](#_SIGNATURES) | II-4 |

---

You should rely only on the information contained in this prospectus or contained in any free writing prospectus filed with the Securities and Exchange Commission. We have not authorized anyone to provide you with additional information or information different from that contained in this prospectus filed with the Securities and Exchange Commission. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We are offering to sell, and seeking offers to buy, our common stock only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of shares of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date.

Through, 2026 all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers' obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.

The date of this prospectus is ___________, 2026.

------

v

------

**PART I. PROSPECTUS**

**PROSPECTUS SUMMARY**

*In this Prospectus, "DentonX Inc," "DentonX," the "Company," "we," "us," and "our," refer to DentonX Inc, unless the context otherwise requires. Unless otherwise indicated, the term "fiscal year" refers to our fiscal year ending September 30th. Unless otherwise indicated, the term "common stock" refers to shares of the Company's common stock.*

This Prospectus, and any supplement to this Prospectus include "forward-looking statements". To the extent that the information presented in this Prospectus discusses financial projections, information or expectations about our business plans, results of operations, products or markets, or otherwise makes statements about future events, such statements are forward-looking. Such forward-looking statements can be identified by the use of words such as "intends", "anticipates", "believes", "estimates", "projects", "forecasts", "expects", "plans" and "proposes". Although we believe that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. These include, among others, the cautionary statements in the "Risk Factors" section and the "Management's Discussion and Analysis of Financial Position and Results of Operations" section in this Prospectus.

This summary only highlights selected information contained in greater detail elsewhere in this Prospectus. This summary may not contain all of the information that you should consider before investing in our common stock. You should carefully read the entire Prospectus, including "Risk Factors" beginning on Page 8, and the financial statements, before making an investment decision.

**Our Company**

DentonX Inc, a Wyoming corporation (the "Company") was incorporated under the laws of the State of Wyoming on September 3, 2025. The Company is a technology infrastructure company seeking to develop a non-bank lending platform that consolidates the fragmented mortgage and financial services industry. The Company intends to integrate scalable technology infrastructure with lending operations to provide flexible, data-driven credit solutions to underserved borrowers, including self-employed individuals, real estate investors, small and medium-sized enterprises (SMEs), and diverse communities often excluded by traditional qualified mortgage (QM) standards. The Company's model contemplates generating dual revenue streams from platform fees and lending activities, supported by proprietary acquisition and automation frameworks that enable workflow efficiency and ecosystem intelligence-creating a scalable network that learns from transactions, expands capacity, and delivers compounded value across participants in non-QM and SME lending. The Company does not originate loans, extend credit, underwrite financial products, broker securities, or provide consumer financial services. All regulated financial activities are conducted exclusively by independent licensed entities, that utilize the Company platform for internal operational and infrastructure purposes.

We are an early stage, emerging growth company headquartered in Oakland, California. We have a limited operating history and have generated no revenues to date. We require funding from this offering to expand and further develop our operations.

Our principal executive office is located at 1999 Harrison Street, Suite 1800, Oakland, CA 94612. Our phone number is +1 (925) 220-2187.

As of the date of this filing, Mr. Pinuer, our Chief Executive Officer and Chief Financial Officer owns 200,000 shares of our common stock representing 1.06% of our issued and outstanding shares of common stock. Mr. Luis Carlos Ung, our sole director, President and Secretary owns 2,000,000 shares of common stock of which 500,000 are held directly and 1,500,000 indirectly, representing 10.64% of our issued and outstanding common stock and two shareholders, AG Partners I Inc. and OutstandingX LLC, own 6,600,000 and 6,080,000 shares of common stock, respectively, representing in the aggregate 67.49% of our issued and outstanding common stock. AG Partners I Inc. and OutstandingX LLC collectively will continue to control our Company if no shares are sold in this offering. If all 3,000,000 shares are sold, AG Partners I Inc. and OutstandingX LLC collectively will hold 58.19% of the outstanding common stock.

------

In the development of the Company's operations, the Company entered into the following material agreements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On November 11, 2025, DentonX Outstanding Investment Co. ("DentonX OIC"), a Wyoming corporation to be formed and majority-owned by the Company, entered into an Exclusive Management Cooperation Agreement with Outstanding Investment Co., Inc. ("OIC") which granted DentonX OIC exclusive authority to manage and direct OIC's business operations while OIC retains all regulatory licenses and compliance responsibilities. Under the agreement, OIC engaged DentonX OIC to provide strategic management and control over OIC's operations and financial decisions, including direction of OIC's lending and investment business. OIC established a Management Committee (the "Committee") which shall serve as the governing and executive body of OIC for purposes of strategic, operational, and financial decision-making with two members appointed by DentonX OIC and three members appointed by OIC. OIC shall pay DentonX OIC a Monthly Management Fee for the strategic, operational, and financial management of OIC's entire business, including both the existing business and any new business developed after the effective date. The Management Fee shall be calculated as 5% of the existing business and 10% of the new business. For any new business developed under DentonX OIC's management, OIC shall pay DentonX OIC a performance participation fee equal to 5%–20% of the net profits attributable to such new business. OIC shall have the right to appoint one member to DentonX OIC's Board of Directors for so long as it holds at least 10% of DentonX OIC's issued and outstanding shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On November 11, 2025, DentonX OIC entered into a Lease Agreement with Purchase Option with OIC which provided for the lease of OIC's existing business operations to DentonX OIC in exchange for fixed lease payments and includes a purchase option allowing DentonX OIC to acquire certain business assets at a future date under defined terms. Under the agreement, OIC leases its pre-closing "Existing Business" lending assets including brand, systems, client base and know-how to DentonX OIC for a three-year term (renewable for another three years), excluding post-closing "New Business" originated by DentonX OIC. DentonX OIC pays monthly lease payments (to be determined but to be approximating OIC's historical profit from existing business) adjusted annually for inflation (lesser of 4% or CPI-U change). DentonX OIC has the exclusive option to purchase the assets after one year at a multiple of 8x trailing 12-month EBITDA. DentonX OIC exercises strategic/financial control and directs operations via the Committee pursuant to the Management Agreement, with step-in rights for non-compliance, full access/audit rights, and consolidation of assets in DentonX OIC 's financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On January 10, 2026, DentonX OIC, entered into an Equity & Vesting Agreement dated November 11, 2025 with OIC, pursuant to which DentonX OIC agreed to issue to OIC and its principals equity representing 20% of DentonX OIC's fully diluted share capital upon the closing of a strategic transaction involving the lease and potential acquisition of certain OIC business assets. The equity grant vests over a 36-month period from the grant date in equal quarterly installments, with full acceleration in the event of a change of control of DentonX OIC or an initial public offering or public listing of DentonX OIC or its successor. The agreement includes clawback and forfeiture provisions for unvested shares in cases of termination for cause or voluntary resignation by OIC, discretionary acceleration for "good leaver" terminations, a 12-month lock-up period restricting transfers of shares, and a right of first refusal for DentonX or DentonX OIC on any proposed transfers of vested shares thereafter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On January 10, 2026, the Company entered into a Share Grant Agreement dated November 11, 2025 with OIC and its designated Key Person(s), led by Steven Guang Leung, pursuant to which DentonX agreed to grant to the individual Key Person(s) a one-time award of 360 Series B Preferred Shares upon the closing of a strategic transaction involving the formation of DentonX OIC as a majority-owned subsidiary, the lease and potential acquisition of certain OIC business assets, and related equity issuances. The parties intend to finalize the terms of the Series B Preferred Shares prior to issuance. The grant will vest over a three-year period from the grant date in twelve equal quarterly installments, contingent upon the Key Person's continued service under the Exclusive Management Cooperation Agreement, compliance with management directives, and adherence to confidentiality, exclusivity, and non-compete obligations, with full acceleration in the event of a change of control of DentonX or an initial public offering or public listing of DentonX OIC or its successor. The agreement includes clawback and forfeiture provisions for unvested shares in cases of termination for cause, voluntary resignation, or violations of related agreements, discretionary acceleration for "good leaver" terminations such as death or disability, a 12-month lock-up period restricting transfers of shares, and requirements for compliance with applicable securities laws and DentonX's insider trading policy.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On January 10, 2026, DentonX entered into an Investment Rights Agreement dated November 11, 2025 with OIC and/or its principals, granting OIC the right to purchase up to 10% of DentonX's total outstanding shares through November 11, 2026 at a 15% discount to the 30-day volume-weighted average price, exercisable in one or more tranches. The agreement includes preemptive rights for OIC to participate in new equity offerings, piggyback registration rights in public offerings, a six-month lock-up period restricting transfers of purchased shares, a right of first refusal for DentonX on any proposed transfers of shares after the lock-up, mutual representations and warranties regarding organization, authority, and compliance, and reciprocal indemnification provisions for breaches.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On November 11, 2025, DentonX, OIC and its principals, and DentonX OIC entered into a Shareholders Agreement governing the ownership, management, and operation of DentonX OIC, the issuance of 20% fully diluted equity in DentonX OIC to OIC subject to a 36-month quarterly vesting schedule with acceleration upon change of control or IPO, clawback for unvested shares upon termination for cause or voluntary resignation, and discretionary acceleration for good leaver events. The agreement provides for a three-member board with two directors appointed by DentonX and one by OIC (contingent on OIC holding at least 10% equity), requires special approval including by the OIC director for reserved matters such as amendments to governing documents, equity issuances, asset sales, mergers, and budgets, imposes a 12-month lock-up on share transfers followed by rights of first refusal, tag-along and drag-along rights, grants information rights, includes non-competition and non-solicitation covenants, confidentiality obligations, pro rata dividend distributions, dispute resolution through negotiation, mediation and arbitration, piggyback registration rights in an IPO, and forms part of an integrated cooperation structure with related management, lease with purchase option, and earn-out agreements, governed by Wyoming law, and was executed on January 10, 2026.

**Our Offering**

We have authorized capital stock consisting of 800,000,000 shares of common stock, $0.0001 par value per share ("Common Stock") and 200,000,000 shares of preferred stock, $0.0001 per value per share. We have 18,789,173 shares of Common Stock issued and outstanding. Through this offering we will register a total of 3,000,000 shares. We will endeavor to sell all 3,000,000 shares of common stock after this registration becomes effective. The price at which we, the company, offer these shares is at a fixed price of $5.00 per share for the duration of the offering. There is no arrangement to address the possible effect of the offering on the price of the stock. We will receive all proceeds from the sale of our common stock less offering expenses and commissions paid to broker dealers if we elect to engage a broker dealer.

---

| | |
|:---|:---|
| **Securities being offered by the Company** | 3,000,000 shares of common stock, at a fixed price of $5.00 offered by us in a direct offering. |
| **Offering price per share** | We will sell the shares at a fixed price per share of $5.00 for the duration of this Offering. |
| **Number of shares of common stock outstanding before the offering of common stock** | 18,789,173 common shares are currently issued and outstanding. |
| **Number of shares of common stock outstanding after the offering of common stock** | 21,789,173 common shares will be issued and outstanding if we sell all of the shares we are offering. |
| **The minimum number of shares to be sold in this offering** | None. |

---

------

---

| | |
|:---|:---|
| **The minimum number of shares to be sold in this offering** | None. |
| **Market for the common shares** | There is no public market for the common shares. The price per share is $5.00.<br>We may not be able to meet the requirement for a public listing or quotation of our common stock. Furthermore, even if our common stock is quoted or granted listing, a market for the common shares may not develop.<br>The offering price for the shares will remain at $5.00 per share for the duration of the offering. |
| **Lock Up** | Purchasers of shares in this offering will be required to enter into lock-up agreements with the Company as a condition of purchase, restricting their ability to sell or transfer the purchased shares for a period of one year following the commencement of trading on the Principal Trading Market (as defined herein), with limited leak-out sales permitted starting six months after the closing of this offering (see "Plan of Distribution" and the form of Subscription Agreement). These restrictions may limit liquidity for investors who purchase in this offering and could adversely affect the trading price or market for our Common Stock after quotation begins. |
| **Use of Proceeds** | If we achieve the maximum offering, we will generate $15,000,000 in gross proceeds less 7% commission to the broker/dealer (if engaged) and less legal fees, printing fees, and other miscellaneous expenses equal to approximately $120,000. We intend to use the gross proceeds from this offering to us to fund offering expenses, technology platform development and research and development, operational affiliate integration and platform scaling, capital markets readiness and public company costs, sales, marketing and business development and working capital and general corporate purposes. Funds may be allocated in differing quantities should the Company decide at a later date it would be in the Company's best interests.<br>|
| **Termination of the Offering** | This offering will terminate upon the earlier to occur of (i) 365 days after this registration statement becomes effective with the Securities and Exchange Commission, or (ii) the date on which all 3,000,000 shares registered hereunder have been sold. We may, at our discretion, extend the offering for an additional 90 days. At any time and for any reason we may also terminate the offering. |
| **Terms of the Offering** | Our Chief Executive Officer will sell the 3,000,000 shares of common stock on behalf of the company, upon effectiveness of this registration statement, on a BEST-EFFORTS basis. |
| **Subscriptions** | All subscriptions once accepted by us are irrevocable.<br>|
| **Risk Factors** | See "Risk Factors" and the other information in this prospectus for a discussion of the factors you should consider before deciding to invest in shares of our common stock. |

---

You should rely only upon the information contained in this prospectus. We have not authorized anyone to provide you with information different from that which is contained in this prospectus. We are offering to sell common stock and seeking offers to common stock only in jurisdictions where offers and sales are permitted.

------

**RISK FACTORS**

*Please consider the following risk factors and other information in this prospectus relating to our business before deciding to invest in our common stock.*

*This offering and any investment in our common stock involves a high degree of risk. You should carefully consider the risks described below and all of the information contained in this prospectus before deciding whether to purchase our common stock. If any of the following risks actually occur, our business, financial condition, and results of operations could be harmed. The trading price of our common stock could decline due to any of these risks, and you may lose all or part of your investment.*

*We consider the following to be the material risks for an investor regarding this offering. Our company should be viewed as a high-risk investment and speculative in nature. An investment in our common stock may result in a complete loss of the invested amount.*

*An investment in our common stock is highly speculative and should only be made by persons who can afford to lose their entire investment in us. You should carefully consider the following risk factors and other information in this prospectus before deciding to become a holder of our common stock. If any of the following risks actually occur, our business and financial results could be negatively affected to a significant extent.*

**Risks Relating to Our Company and Our Industry**

***We are a development-stage company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objectives.***

We are a development-stage company incorporated in September 2025 with limited operating results to date. Because we lack an operating history, you have no basis upon which to evaluate our ability to achieve our business objectives of developing and deploying our technology infrastructure platform for non-bank lending. We have no revenues and may not begin to generate revenues for an extended period, if at all. We are subject to the business risks and uncertainties associated with any new business, including the risk that we will not achieve our business objectives. If we do not successfully develop our platform, we will be unable to generate revenues and will incur losses. As a consequence, any predictions you make about our future success or viability may not be as accurate as they could be if we had an operating history.

***We have incurred net losses since our inception and expect to continue to incur significant losses as we develop our platform, and we may never achieve or sustain profitability.***

We have incurred net losses since our inception and anticipate that we will continue to incur significant losses for the foreseeable future as we invest in platform development, marketing, and other growth initiatives. Our ability to achieve profitability depends on successfully completing our technology infrastructure, attracting partners and borrowers, and generating revenue from platform fees and management income through our subsidiary, DentonX OIC. There can be no assurance that we will ever achieve profitability or positive cash flows.

***Our business model depends on our ability to successfully develop and deploy our proprietary technology capabilities, and any failure to do so could materially harm our business.***

Our operations rely on the functionality and reliability of our technology systems and related infrastructure. We rely, in part, on third-party service providers and consultants to support aspects of development, maintenance, and implementation. If our technology systems experience interruptions, defects, delays, security vulnerabilities, or fail to perform as required, or if we are unable to effectively manage third-party relationships, our business, financial condition, and results of operations could be adversely affected. In addition, changes in technology or market standards may require additional investment to maintain competitiveness. .

***We rely on third-party consultants and vendors for critical functions, and any disruption in these relationships could adversely affect our operations.***

We depend on consultants for executive leadership, software development, financial advisory, and other services. For example, our agreements with LocusX for automation framework licensing and development, and with Fairbanks Global Partners for corporate development, are terminable and involve milestone-based payments. If these consultants

------

fail to perform, terminate agreements, or demand unfavorable terms, we could face delays in platform rollout, increased costs, or operational disruptions. Our limited resources as a startup may hinder our ability to replace them promptly.

***We operate in a highly competitive industry, and we may not be able to compete effectively.***

The technology infrastructure and non-bank lending sectors are competitive, with established players like Upstart Holdings, Inc., Blend Labs, Inc., Rocket Companies, Inc., and UWM Holdings Corporation offering similar platforms or services for non-QM mortgages and SME lending. These competitors have greater resources, brand recognition, and market share. If we cannot differentiate through our hybrid model or data network effects, we may fail to attract partners, borrowers, or talent, adversely impacting our growth.

***Changes in economic conditions, interest rates, or credit markets could reduce demand for our services and harm our business.***

Our target markets-non-QM mortgages for self-employed and investors, and SME financing-are sensitive to economic downturns, rising interest rates, inflation, or tightening credit. In a recession, borrowing demand may decline, defaults increase, and non-bank lenders (our partners) could face liquidity issues. For instance, higher rates could reduce mortgage originations in the U.S. market.

***Regulatory changes in the financial services industry could adversely affect our business model and increase compliance costs.***

Although we do not originate loans, our platform supports licensed entities like OIC in non-QM and SME lending, subjecting us to indirect regulatory risks. Changes in laws such as the Truth in Lending Act, Equal Credit Opportunity Act, or state licensing requirements could impact our partners' operations, reducing platform usage. Evolving regulations (e.g., on AI credit decisions or data privacy under CCPA/GDPR) may require costly adaptations. Non-compliance by us or partners could result in fines, restrictions, or reputational harm.

***Cybersecurity threats, data breaches, or system failures could damage our reputation and lead to liabilities.***

Our platform handles sensitive borrower and transaction data, making us vulnerable to cyberattacks, hacking, or breaches. Despite security measures, a successful incident could expose confidential information, disrupt operations, or violate privacy laws, leading to legal claims, regulatory penalties, and loss of trust. Our reliance on technology and cloud infrastructure amplifies these risks if vulnerabilities arise.

***We may be unable to adequately protect our intellectual property rights, or we may be accused of infringing intellectual property rights of third parties, which could harm our business, financial condition, and results of operations.***

Our business relies, in part, on proprietary technology, processes, and know-how, as well as intellectual property licensed or developed with third parties. We rely on a combination of contractual protections, confidentiality obligations, trade secrets, and intellectual property laws to protect these assets. However, these measures may be insufficient to prevent unauthorized use, disclosure, or misappropriation, and we may be unable to detect or enforce violations of our intellectual property rights in a timely or cost-effective manner. In addition, we may be subject to claims that our operations or technologies infringe the intellectual property rights of third parties. Any such claims, regardless of merit, could result in significant costs, diversion of management attention, limitations on our ability to use certain technologies, or adverse impacts on our business, financial condition, and results of operations.

***If we fail to establish, maintain, or expand strategic relationships and partnerships, our business growth and platform adoption could be significantly impaired.***

Our business model relies heavily on building an ecosystem of strategic partnerships with non-bank lenders, brokers, service providers (e.g., for insurance, appraisals, and servicing), and technology vendors to drive origination, distribution, and integrations within our marketplace and network layers. If we are unable to form new partnerships on commercially favorable terms, or if existing partners like consultants (e.g., Fairbanks Global Partners or Alphega Global Partners) or licensors (e.g., LocusX) terminate relationships due to performance issues, disputes, or competitive pressures, our ability to scale the network and achieve data intelligence compounding could suffer. Partners may underperform, fail to meet integration standards, or shift to competitors offering better incentives, leading to reduced

------

borrower acquisition, lower transaction volumes, and diminished network effects. In a fragmented market, reliance on partners exposes us to risks such as their regulatory non-compliance, financial instability, or operational failures, which could indirectly harm our reputation or trigger liabilities. Without robust partnerships, we may struggle to penetrate the non-QM mortgage and SME lending segments, resulting in slower revenue growth, increased customer acquisition costs, and failure to realize our roll-up strategy, ultimately adversely affecting our competitive position and long-term viability.

***The loss of one or more of our key personnel, or our failure to attract and retain other highly qualified personnel in the future, could harm our business.***

We currently depend on the continued services and performance of key members of our management team, including Lionel Pinuer (our Chief Executive Officer and Chief Financial Officer) and Luis Carlos Ung (our Director, President and Secretary), whose expertise in strategic advisory, business development, and technology infrastructure operations is critical to executing our platform development and growth strategy. The loss of these individuals, whether due to resignation, incapacity, or other reasons, could disrupt our operations, delay key initiatives like technology rollouts or acquisitions, and negatively impact investor confidence. We do not maintain "key person" life insurance policies, and our consulting agreements with these personnel allow for termination with notice, increasing vulnerability. The technology infrastructure industry is highly competitive for talent, with larger companies like Upstart or SoFi offering more attractive compensation packages, equity incentives, or resources. If we cannot replace lost personnel promptly or at all, or if transitions lead to internal disruptions, our ability to innovate, comply with regulations, and achieve business objectives could be severely compromised, potentially leading to missed opportunities, cost overruns, and material adverse effects on our financial condition and results of operations.

***If we are unable to attract, integrate, and retain suitably qualified and experienced personnel, or motivate our existing team, we may not be able to grow effectively or execute our business plan.***

Our future success is substantially dependent on our ability to recruit, train, and retain qualified personnel with expertise in software development, data analytics, lending operations, regulatory compliance, and sales/marketing. As a development-stage company with limited resources and no established track record, we face intense competition for talent from well-funded technology infrastructure firms, banks, and tech giants in a market where demand for skilled professionals often exceeds supply. Factors such as our remote or limited office infrastructure, lack of comprehensive benefits (e.g., no current pension or stock option plans), and startup risks may make us less appealing to candidates. If we cannot offer competitive salaries, equity incentives, or career advancement opportunities, we may experience high turnover, recruitment delays, or reliance on less experienced hires, leading to errors in platform development, compliance lapses, or inefficient operations. Additionally, motivating our small team-including our sole employee, Mr. Pinuer, who currently devotes only up to 30 hours per week-could become challenging if growth stalls or financial pressures mount. Failure to build a robust workforce could hinder innovation, slow market entry, increase dependency on external consultants (with associated costs and control risks), and ultimately prevent us from achieving profitability or competing effectively in the fast-evolving non-bank lending space.

***Our quarterly results may fluctuate significantly and may not fully reflect the underlying performance of our business.***

Our quarterly financial results, including revenue, net income (loss), and cash flows, are likely to vary significantly in the future due to a variety of factors, many of which are outside our control. For example, as a startup, our results may be influenced by timing of platform launches or partner onboarding, which could lead to uneven revenue recognition from platform fees. Macroeconomic conditions, such as interest rate changes, inflation, or economic downturns, could reduce demand for non-QM loans and SME financing, causing seasonal or cyclical dips-e.g., slower mortgage originations in winter months or during high-rate periods. Additional variability may arise from fluctuating administrative and marketing expenses, such as consulting fees, software development costs, or legal expenses related to IP protection or regulatory compliance. If our results fall below the expectations of investors or securities analysts, or if we fail to provide accurate guidance, the price of our common stock could decline substantially. These fluctuations may not accurately indicate long-term trends, as early-stage investments in technology and talent could pressure short-term profitability while aiming for future growth. Historical results, given our limited operating history, are not indicative of future performance, and ongoing losses could exacerbate volatility, potentially leading to risks or difficulty in raising additional capital.

------

***Our largest shareholders control the Company and will continue to hold significant voting power.***

As of the date of this prospectus, AG Partners I Inc. and OutstandingX LLC own approximately 67.49% of our common stock and will retain control post-offering, influencing director elections and other matters submitted to stockholders for approval.

**Risks Related to this Offering**

***The offering price for our common stock has been arbitrarily determined and may not reflect the actual market value of the shares.***

The offering price of our common stock was determined arbitrarily by our management based on factors such as our development stage, business prospects, and market conditions, without an independent valuation or appraisal. This price may not be indicative of the market price of our common stock after this offering, if a market develops, or the value that an underwriter might assign in a traditional underwritten offering. If the market price falls below the offering price, investors could experience immediate and substantial dilution or loss.

***This is a best-efforts offering with no minimum amount of securities required to be sold, and we may not raise sufficient funds to achieve our business objectives.***

This offering is being conducted on a "best-efforts" basis without a minimum offering amount, meaning we may close the offering and use proceeds even if we sell only a small number of shares. If we raise limited funds, we may not have sufficient capital to fully develop our platform, execute acquisitions, or sustain operations, which could lead to business failure. Investors in a partial offering would bear a greater risk, as their investment would support a scaled-down plan with uncertain viability.

***We are conducting this offering without an underwriter, which means there has been no independent due diligence or review of our business or this prospectus.***

Unlike a firm-commitment underwritten offering, this self-underwritten offering lacks the involvement of an investment bank to conduct due diligence, market the shares, or stabilize the price post-offering. As a result, the terms of this offering may be less favorable to investors, and there is a higher risk that the information in this prospectus has not been independently verified. This could increase the likelihood of undisclosed risks materializing.

***Our sole executive officer has limited experience conducting a securities offering, which may impair our ability to successfully complete this offering.***

Mr. Pinuer, our CEO and CFO, has no prior experience managing a best-efforts securities offering. This lack of experience could result in ineffective marketing, delays, or failure to comply with securities laws, potentially leading to an unsuccessful offering. If we do not raise adequate funds, our business plan may fail, and investors could lose their entire investment.

***Investors in this offering will experience immediate and substantial dilution.***

Purchasers of our common stock in this offering will experience immediate dilution in the net tangible book value per share due to the difference between the offering price and our current net tangible book value, which is negative or minimal as a development-stage company. Additional dilution may occur from future issuances, including under consulting agreements that allow for equity compensation.

***Your ability to resell the shares you acquire in this offering will be limited by the terms of the lock up agreement you will be required to sign.***

Investors in this offering will be subject to lock-up agreements that restrict resale of the shares they purchase, which may limit liquidity and increase volatility. As a condition to purchasing shares in this offering, each investor will be required to execute a lock-up agreement that prohibits sales or other dispositions of the purchased shares (and certain related securities) for up to one year after trading commences on the OTCQB, OTCID, or other Principal Trading Market. Limited monthly sales (pro rata share of 5% of the prior month's trading volume) are permitted only after six months. These restrictions apply only to purchasers in this offering and not to our existing shareholders. Such lock-up obligations could reduce available trading volume from new investors, make it more difficult or impossible for

------

purchasers to sell their shares in the near term, increase price volatility, or depress the market price once quotation begins. There is no assurance that an active trading market will develop even after the lock-up period ends.

***There may be future sales of our securities or other dilution of our equity, which may adversely affect the market price of our common stock.***

We are not restricted from issuing additional common stock or convertible securities post-offering. Such issuances, including for acquisitions, employee incentives, or additional financing, could dilute existing stockholders' ownership and voting power. The perception of potential future sales could also depress our stock price.

***A large number of shares may be sold in the market following this offering, which may significantly depress the market price of our common stock.***

All shares sold in this offering will be freely tradable without restriction (except for affiliates). If a substantial number of these shares are sold in the public market shortly after the offering, or if the market anticipates such sales, the price of our common stock could decline significantly, even if our business is performing well.

***We may allocate the net proceeds from this offering in ways that differ from the estimates discussed in this prospectus, and such changes could adversely affect our business.***

Our management has broad discretion over the use of proceeds from this offering. We intend to use funds for platform development, acquisitions, working capital, and general corporate purposes, but actual allocation may vary based on unforeseen events, such as delays in technology rollout or higher-than-expected costs. If we reallocate proceeds in a manner that investors deem unfavorable, it could harm our financial condition and the value of our common stock.

***We do not intend to pay dividends for the foreseeable future, limiting returns to stock appreciation, which may never occur.***

We have never paid dividends and do not anticipate doing so in the foreseeable future, as we intend to reinvest any earnings into our business. Investors seeking current income should not purchase our shares, as returns will depend solely on capital appreciation, which is uncertain given our development stage and lack of operating history.

***Our common stock has no prior trading market, and an active market may never develop, which could make it difficult for you to sell your shares.***

There is no established public trading market for our common stock, and we cannot assure you that one will develop or be sustained after this offering. We intend to apply for quotation on the OTCQB, but approval is not guaranteed, and trading may be thin or sporadic. Without an active market, you may be unable to sell your shares at a desirable price or at all, potentially resulting in a total loss of investment.

***If a market for our common stock develops, the trading price may be highly volatile.***

If quoted, our stock price could fluctuate significantly due to factors like our operating results, economic conditions, regulatory changes, or market sentiment toward startups. As a small company, our stock may be subject to greater volatility than larger issuers, exacerbated by low trading volume, which could lead to sharp price declines.

***Our common stock may be considered a "penny stock," which would subject brokers to additional sales practice requirements and may limit the market for our shares.***

If our common stock trades below $5.00 per share, it may be deemed a "penny stock" under SEC rules, requiring brokers to provide extensive disclosures, determine suitability, and obtain written consent before transactions. These requirements could reduce market liquidity, deter broker-dealers from making a market, and make it harder for you to buy or sell shares.

***We will incur significant increased costs as a result of operating as a public company, and if we fail to maintain compliance, it could harm our business and the value of our stock.***

As a public company, we will face substantial costs for SEC reporting, auditing, legal compliance, and internal controls under the Sarbanes-Oxley Act. We estimate these costs at approximately $100,000 annually initially, which could

------

strain our limited resources. Failure to comply with reporting obligations could result in delisting, fines, or legal actions, making it difficult for investors to trade our shares.

***As an emerging growth company and smaller reporting company, we intend to take advantage of reduced disclosure requirements, which may make our common stock less attractive to investors.***

Under the JOBS Act, as an emerging growth company, we may delay adopting new accounting standards, provide reduced executive compensation disclosures, and be exempt from auditor attestation on internal controls. As a smaller reporting company, we may provide even less disclosure. These exemptions could make our financial statements less comparable to peers, reduce investor confidence, and adversely affect our stock price and liquidity.

***The Company is electing not to opt out of the JOBS Act extended accounting transition period, which may make its financial statements more difficult to compare to other companies.***

This election allows us to adopt new or revised accounting standards on the private company timeline, potentially delaying implementation and complicating comparisons with public companies using earlier adoption dates. This could hinder analysts' and investors' ability to evaluate our performance.

***Our largest shareholders will retain significant control after this offering, which could limit your ability to influence corporate matters and delay or prevent a change in control.***

Post-offering, AG Partners I Inc. and OutstandingX LLC will own a substantial portion of our voting stock, enabling them to control director elections, mergers, and other significant decisions. This concentration may discourage potential acquirers, reduce the likelihood of a control premium, and entrench management, even if not in the best interest of minority shareholders.

***Sales of shares by our affiliates or insiders could depress the market price of our common stock.***

Our officers, directors, and major shareholders may sell shares subject to Rule 144 restrictions. Large or frequent sales by these insiders could create an overhang, reducing demand and lowering our stock price.

***We may become involved in securities litigation, which could divert management's attention and harm our business.***

Technology infrastructure companies like ours are susceptible to stockholder lawsuits alleging misleading disclosures in offering documents or violations of securities laws. Defending such litigation, regardless of merit, could be costly, divert resources, and damage our reputation, adversely affecting our operations and stock price.

***You may face difficulties in protecting your interests as a stockholder, as Wyoming corporate law provides for certain indemnification of officers and directors.***

Our amended and restated articles of incorporation and amended and restated bylaws provide for indemnification of officers and directors to the fullest extent permitted by Wyoming law, which may limit their accountability for breaches of fiduciary duty. This could make it more difficult for stockholders to pursue successful claims against management.

***The requirements of being a public company may strain our resources and distract management.***

Complying with Exchange Act reporting, Sarbanes-Oxley, and stock exchange rules (if listed) will require significant management time and resources. As a startup, we may lack the infrastructure to handle these demands efficiently, potentially leading to errors, delays, or non-compliance.

***There may be state securities laws ("blue sky" laws) that limit the resale of our shares in certain jurisdictions.***

We intend to register or qualify this offering under applicable state securities laws, but failure to do so in any state could restrict resale there. Investors in those states may face liquidity issues or need to rely on exemptions, increasing risk.

------

**Emerging Growth Company**

The recently enacted JOBS Act is intended to reduce the regulatory burden on emerging growth companies. The Company meets the definition of an emerging growth company and so long as it qualifies as an "emerging growth company," it will, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·be temporarily exempted from the internal control audit requirements Section 404(b) of the Sarbanes-Oxley Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·be temporarily exempted from various existing and forthcoming executive compensation-related disclosures, for example: "say-on-pay", "pay-for- performance", and "CEO pay ratio";

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·be temporarily exempted from any rules that might be adopted by the Public Company Accounting Oversight Board requiring mandatory audit firm rotation or supplemental auditor discussion and analysis reporting;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·be temporarily exempted from having to solicit advisory say-on-pay, say-on-frequency and say-on-golden-parachute shareholder votes on executive compensation under Section 14A of the Securities Exchange Act of 1934, as amended;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·be permitted to comply with the SEC's detailed executive compensation disclosure requirements on the same basis as a smaller reporting company; and,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·be permitted to adopt any new or revised accounting standards using the same timeframe as private companies (if the standard applies to private companies).

Our company will continue to be an emerging growth company until the earliest of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the last day of the fiscal year during which we have annual total gross revenues of $1.235 billion or more;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the last day of the fiscal year following the fifth anniversary of the first sale of our common equity securities in an offering registered under the Securities Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the date on which we issue more than $1 billion in non-convertible debt securities during a previous three-year period; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the date on which we become a large accelerated filer, which generally is a company with a public float of at least $700 million (Exchange Act Rule 12b-2).

------

**SUMMARY OF OUR FINANCIAL INFORMATION**

The following tables set forth selected financial data for the periods indicated. The statement of operations data for the period from our inception (September 3, 2025) to September 30, 2025, and for the three months ended December 31, 2025, and the balance sheet data as of September 30, 2025, and December 31, 2025, are derived from our audited financial statements included elsewhere in this prospectus. The statement of operations data for the period from our inception (September 3, 2025) to December 31, 2025, has been derived from our audited financial statements and reflects the cumulative results for the full period.

Our financial statements are prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). The selected financial data set forth below should be read in conjunction with our financial statements, the related notes, and "Management's Discussion and Analysis of Financial Condition and Results of Operations" included elsewhere in this prospectus. The selected financial data in this section is not intended to replace our financial statements and the related notes. Our historical results are not necessarily indicative of the results that may be expected for any period in the future. As a development-stage company, we have not generated any revenues to date and have incurred significant operating losses since inception.

---

| | | | |
|:---|:---|:---|:---|
| **Statement of Operations Data** | **Period from Inception**<br> **(Sept. 3, 2025) to Sept. 30, 2025** | **Three Months Ended**<br> **December 31, 2025** | **Period from Inception**<br> **(Sept. 3, 2025) to Dec. 31, 2025** |
| Revenue | $- | $- | $- |
| Total operating expenses | (232689) | (719258) | (951947) |
| Loss from operations | (232689) | (719258) | (951947) |
| Other income (expense), net | 20 | 55 | 76 |
| Net loss | (232669) | (719203) | (951872) |
| Basic and diluted net loss per share | (0.03) | (0.05) | (0.08) |
| Weighted average shares outstanding – basic and diluted | 8043489 | 13406712 | 21450201 |

---

---

| | | |
|:---|:---|:---|
| **Balance Sheet Data** | **As of September 30, 2025** | **As of December 31, 2025** |
| Cash and cash equivalents | $359981 | $135550 |
| Total current assets | 399981 | 227409 |
| Total assets | 399981 | 227409 |
| Total current liabilities | 232330 | 597097 |
| Total liabilities | 232330 | 597097 |
| Accumulated deficit | (232669) | (951871) |
| Total stockholders' equity (deficit) | 167650 | (369687) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Cash Flow Data** | **Period from Inception**<br> **(Sept. 3, 2025) to Sept. 30, 2025** | **Three Months Ended**<br> **December 31, 2025** | **Period from Inception**<br> **(Sept. 3, 2025) to Dec. 31, 2025** |
| Net cash used in operating activities | $(40019) | $(225091) | $(265110) |
| Net cash provided by financing activities | 400000 | 660 | 400660 |
| Net increase (decrease) in cash and cash equivalents | 359981 | (224431) | 135550 |
| Cash and cash equivalents at end of period | 359981 | 135550 | 135550 |

---

As of December 31, 2025, we had an accumulated deficit of $951,871 and negative working capital of $369,687. These factors, among others, raise substantial doubt about our ability to continue as a going concern, as described in Note 1 to our financial statements. We have not generated any revenues since inception and expect to continue incurring losses as we develop our platform and pursue our business objectives.

------

**MANAGEMENT'S DISCUSSION AND ANALYSIS**

*The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the section of this prospectus entitled "Summary of Our Financial Information", "Description of Business", and our financial statements and related notes thereto, included elsewhere in this prospectus. In addition to historical financial information, the following discussion contains forward-looking statements that reflect our current plans, expectations, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this prospectus, particularly in the sections entitled "Risk Factors" and "Forward-Looking Statements."*

**Plan of Operations**

DentonX Inc, a Wyoming corporation (the "Company") was incorporated under the laws of the State of Wyoming on September 3, 2025. The Company is a technology infrastructure company focused on modernizing and integrating mortgage and small-business lending operations through a platform-based operating model. The Company provides data-driven and software-enabled workflow automation, centralized operational processes, governance frameworks, and enterprise infrastructure designed to support scalable, efficient, and compliant lending operations conducted by independent licensed entities. The company's platform is intended to enhance operational efficiency, consistency, reporting, and oversight across managed lending operations without directly engaging in regulated financial activities. The Company does not originate loans, extend credit, underwrite financial products, broker securities, or provide consumer financial services. All regulated financial activities are conducted exclusively by independent licensed entities, that utilize the Company platform for internal operational and infrastructure purposes.

In the development of the Company's operations, the Company entered into the following material agreements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On November 11, 2025, DentonX Outstanding Investment Co. ("DentonX OIC"), a Wyoming corporation to be formed and majority-owned by the Company, entered into an Exclusive Management Cooperation Agreement with Outstanding Investment Co., Inc. ("OIC") which granted DentonX OIC exclusive authority to manage and direct OIC's business operations while OIC retains all regulatory licenses and compliance responsibilities. Under the agreement, OIC engaged DentonX OIC to provide strategic management and control over OIC's operations and financial decisions, including direction of OIC's lending and investment business. OIC established a Management Committee (the "Committee") which shall serve as the governing and executive body of OIC for purposes of strategic, operational, and financial decision-making with two members appointed by DentonX OIC and three members appointed by OIC. OIC shall pay DentonX OIC a Monthly Management Fee for the strategic, operational, and financial management of OIC's entire business, including both the existing business and any new business developed after the effective date. The Management Fee shall be calculated as 5% of the existing business and 10% of the new business. For any new business developed under DentonX OIC's management, OIC shall pay DentonX OIC a performance participation fee equal to 5%–20% of the net profits attributable to such new business. OIC shall have the right to appoint one member to DentonX OIC's Board of Directors for so long as it holds at least 10% of DentonX OIC's issued and outstanding shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On November 11, 2025, DentonX OIC entered into a Lease Agreement with Purchase Option with OIC which provided for the lease of OIC's existing business operations to DentonX OIC in exchange for fixed lease payments and includes a purchase option allowing DentonX OIC to acquire certain business assets at a future date under defined terms. Under the agreement, OIC leases its pre-closing "Existing Business" lending assets including brand, systems, client base and know-how to DentonX OIC for a three-year term (renewable for another three years), excluding post-closing "New Business" originated by DentonX OIC. DentonX OIC pays monthly lease payments (to be determined but to be approximating OIC's historical profit from existing business) adjusted annually for inflation (lesser of 4% or CPI-U change). DentonX OIC has the exclusive option to purchase the assets after one year at a multiple of 8x trailing 12-month EBITDA. DentonX OIC exercises strategic/financial control and directs operations via the Committee pursuant to the Management Agreement, with step-in rights for non-compliance, full access/audit rights, and consolidation of assets in DentonX OIC 's financial statements.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On January 10, 2026, DentonX OIC, entered into an Equity & Vesting Agreement dated November 11, 2025 with OIC, pursuant to which DentonX OIC agreed to issue to OIC and its principals equity representing 20% of DentonX OIC's fully diluted share capital upon the closing of a strategic transaction involving the lease and potential acquisition of certain OIC business assets. The equity grant vests over a 36-month period from the grant date in equal quarterly installments, with full acceleration in the event of a change of control of DentonX OIC or an initial public offering or public listing of DentonX OIC or its successor. The agreement includes clawback and forfeiture provisions for unvested shares in cases of termination for cause or voluntary resignation by OIC, discretionary acceleration for "good leaver" terminations, a 12-month lock-up period restricting transfers of shares, and a right of first refusal for DentonX or DentonX OIC on any proposed transfers of vested shares thereafter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On January 10, 2026, the Company entered into a Share Grant Agreement dated November 11, 2025 with OIC and its designated Key Person(s), led by Steven Guang Leung, pursuant to which DentonX agreed to grant to the individual Key Person(s) a one-time award of 360 Series B Preferred Shares upon the closing of a strategic transaction involving the formation of DentonX OIC as a majority-owned subsidiary, the lease and potential acquisition of certain OIC business assets, and related equity issuances. The parties intend to finalize the terms of the Series B Preferred Shares prior to issuance. The grant will vest over a three-year period from the grant date in twelve equal quarterly installments, contingent upon the Key Person's continued service under the Exclusive Management Cooperation Agreement, compliance with management directives, and adherence to confidentiality, exclusivity, and non-compete obligations, with full acceleration in the event of a change of control of DentonX or an initial public offering or public listing of DentonX OIC or its successor. The agreement includes clawback and forfeiture provisions for unvested shares in cases of termination for cause, voluntary resignation, or violations of related agreements, discretionary acceleration for "good leaver" terminations such as death or disability, a 12-month lock-up period restricting transfers of shares, and requirements for compliance with applicable securities laws and DentonX's insider trading policy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On January 10, 2026, DentonX entered into an Investment Rights Agreement dated November 11, 2025 with OIC and/or its principals, granting OIC the right to purchase up to 10% of DentonX's total outstanding shares as of the closing date at a 15% discount to the 30-day volume-weighted average price, exercisable in one or more tranches within twelve months following the closing of a strategic transaction involving the formation of DentonX OIC, the lease and potential acquisition of certain OIC business assets, and related equity issuances. The agreement includes preemptive rights for OIC to participate in new equity offerings, piggyback registration rights in public offerings, a six-month lock-up period restricting transfers of purchased shares, a right of first refusal for DentonX on any proposed transfers of shares after the lock-up, mutual representations and warranties regarding organization, authority, and compliance, and reciprocal indemnification provisions for breaches.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On November 11, 2025, DentonX, OIC and its principals, and DentonX OIC entered into a Shareholders Agreement governing the ownership, management, and operation of DentonX OIC, the issuance of 20% fully diluted equity in DentonX OIC to OIC subject to a 36-month quarterly vesting schedule with acceleration upon change of control or IPO, clawback for unvested shares upon termination for cause or voluntary resignation, and discretionary acceleration for good leaver events. The agreement provides for a three-member board with two directors appointed by DentonX and one by OIC (contingent on OIC holding at least 10% equity), requires special approval including by the OIC director for reserved matters such as amendments to governing documents, equity issuances, asset sales, mergers, and budgets, imposes a 12-month lock-up on share transfers followed by rights of first refusal, tag-along and drag-along rights, grants information rights, includes non-competition and non-solicitation covenants, confidentiality obligations, pro rata dividend distributions, dispute resolution through negotiation, mediation and arbitration, piggyback registration rights in an IPO, and forms part of an integrated cooperation structure with related management, lease with purchase option, and earn-out agreements, governed by Wyoming law, and was executed on January 10, 2026.

Our immediate goal is to deploy and commercialize our technology platform by identifying use cases, integrating licensed technologies, onboarding initial partners, and establishing a scalable operating framework. These efforts include building internal capabilities, deploying minimum viable platform functionality, and preparing operational and governance systems, subject to sufficient funding and market demand.

------

Given our development-stage status, limited operating history, and dependence on external funding, there can be no assurance that these efforts will be successful. Our success depends on factors beyond our control, including market conditions, partner adoption, regulatory developments affecting our partners, availability of capital, and the acceptance of our platform by licensed operators.

**Results of Operations**

***Period from Inception (September 3, 2025) to September 30, 2025 (Audited)***

Since its inception on September 3, 2025, the Company has focused on establishing its corporate and operational foundation as a development-stage technology infrastructure company. Activities during this initial period were limited and primarily related to organizational formation, strategic planning, and early-stage platform development efforts.

Operating activities during the period included the incorporation of the Company in the State of Wyoming, development of the Company's business and operating model, initial technology architecture planning, and preliminary discussions with technology providers and potential strategic partners. The Company did not generate any revenue during this period.

Total operating expenses for the period from September 3, 2025, through September 30, 2025, amounted to approximately $232,689. These expenses consisted primarily of general and administrative costs related to organizational and start-up activities, including legal and accounting fees, consulting expenses, and other professional service costs. Research and development expenses during this period were minimal and primarily related to preliminary platform design and planning activities.

As a result of these activities, the Company incurred a net operating loss of approximately $232,689 for the period. The Company expects to continue to incur operating losses as it advances its business plan and has not yet commenced revenue-generating operations.

***Three Months Ended December 31, 2025 (Unaudited)***

During the three months ended December 31, 2025, the Company continued to focus on advancing its development-stage operations and executing key components of its business strategy. Operating activities during this period included continued business planning, coordination of technology development efforts, partner and affiliate structuring, and fundraising activities.

During this period, the Company issued shares of its common stock with an aggregate fair value of approximately $181,205 to officers, directors, and consultants as compensation for services rendered in support of the Company's ongoing operations. In addition, on September 25, 2025, the Company entered into a Non-Exclusive License Agreement and a Technical Consulting Agreement with LocusX Technologies Inc., providing access to proprietary automation technologies and development services critical to the development of the Company's enterprise automation platform.

Total operating expenses for the three months ended December 31, 2025, amounted to approximately $719,258, consisting primarily of general and administrative expenses, professional and consulting fees, and research and development costs related to platform architecture, workflow automation design, and technology integration efforts.

The Company did not generate any revenue during the three months ended December 31, 2025, and incurred a net loss of approximately $719,203 for the period. These losses were expected as the Company remains in the development stage and continues to invest in platform development, operational infrastructure, and public company readiness.

***Liquidity and Capital Resources***

As of December 31, 2025, the Company's primary source of liquidity consisted of cash proceeds from private placements of common stock. Management believes that existing cash resources of approximately $135,550 will not be sufficient to support the Company's near-term operating needs for a period of twelve months. As a development-stage company with no material revenue, the Company will require additional capital to fully execute its business plan and support ongoing operations.

------

The Company's ability to continue executing its business plan is dependent on its ability to raise additional capital through equity offerings, debt financings, or other sources. There can be no assurance that such additional financing will be available on acceptable terms, or at all. If adequate financing is not obtained when needed, the Company may be required to reduce, delay, or curtail planned operations, including technology development, platform deployment, and partner onboarding activities, which could have a material adverse effect on the Company's business, financial condition, and results of operations.

***Off-Balance Sheet Arrangements***

The Company has no off-balance sheet arrangements.

------

**FORWARD-LOOKING STATEMENTS**

This prospectus contains forward-looking statements that involve risk and uncertainties. We use words such as "anticipate", "believe", "plan", "expect", "future", "intend", and similar expressions to identify such forward-looking statements. Investors should be aware that all forward-looking statements contained within this filing are good faith estimates of management as of the date of this filing. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks faced by us as described in the "Risk Factors" section and elsewhere in this prospectus.

**DESCRIPTION OF BUSINESS**

**The Company**

DentonX Inc (the "Company," "we," "us," or "our") is a Wyoming corporation incorporated on September 3, 2025. We are a development-stage technology infrastructure ("TechInfra") company focused on building a scalable technology platform designed to consolidate the fragmented non-bank mortgage and financial services industry. Our vision is to create the first intelligent financial infrastructure for non-bank lending, where every transaction generates both capital and intelligence, forming a network that learns, scales, and rewards participants.

Unlike traditional banks, which are often rigid and exclude non-qualified mortgage ("non-QM") borrowers, our platform aims to address inefficiencies in the non-bank lending ecosystem by integrating advanced technology with strategic lending operations through our majority-owned subsidiary to be formed, DentonX Outstanding Investment Co. ("DentonX OIC"). We do not originate loans, extend credit, underwrite financial products, broker securities, or provide consumer financial services. All regulated financial activities are conducted exclusively by independent licensed entities, such as Outstanding Investment Co., Inc. ("OIC"), which utilize our platform for operational and infrastructure support.

Our target customers include underserved segments such as self-employed borrowers (e.g., bank statement and verification of employment ("VOE") loans), real estate investors (e.g., debt service coverage ratio ("DSCR"), jumbo adjustable-rate mortgages ("ARMs"), and short-term refinances), small and medium-sized enterprises ("SMEs") seeking working capital or bridge financing, and diverse communities with high loan-to-value ("LTV") needs.

We operate at the intersection of TechInfra platforms and alternative lending where non-bank lenders are gaining share; the non-QM segment; and an SME credit gap. As a startup, we are in the early stages of development, with limited operations and no revenue to date. Our success depends on executing our plan to build and deploy the platform, secure partnerships, and navigate regulatory landscapes.

**Recent Developments**

Since incorporation, we have entered into several consulting and strategic agreements to support platform development and operations:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●**Consulting Agreements**: We engaged consultants for executive leadership, strategic advisory, accounting, and financial reporting. For example, on September 10, 2025, we appointed Lionel Pinuer as a consultant, later naming him Chief Executive Officer and Chief Financial Officer effective January 1, 2026. Other agreements include those with Soho Capital Solutions Inc (October 3, 2025) for U.S. GAAP support and Fairbanks Global Partners II LLC (amended September 23, 2025) for corporate development and SEC readiness, with compensation including retainers, hourly fees, and success-based incentives.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●**Technical and Licensing Agreements with LocusX Technologies Inc.**: On September 25, 2025, we entered a Technical Consulting Agreement for software development, including automation engines, API integrations, and blockchain-based automation framework, with milestone payments totaling approximately $400,000–$450,000. Concurrently, a Non-Exclusive Licensing Agreement grants us use of LocusX's proprietary blockchain framework for internal purposes, in exchange for an initial fee (via 500,000 shares), royalties (7% on relevant net revenues), and minimum annual fees.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●**Strategic Agreement with Far Sun Global Group LLC**: On September 27, 2025, for corporate development and capital raising support, including an $80,000 retainer and performance-based fees.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●**Agreements with OIC**: DentonX, through its majority-owned subsidiary DentonX OIC, entered into a series of agreements with Outstanding Investment Co., Inc. ("OIC") and its principals effective November 11, 2025, granting DentonX OIC exclusive management control over OIC's lending and investment operations via a Management Committee (two DentonX appointees, three OIC), in exchange for management fees (5% on existing business, 10% on new), and performance participation (5-20% of net profits from new business). OIC leases its pre-closing existing business assets (brand, systems, clients, know-how) to DentonX OIC for three years (renewable), with monthly payments approximating historical profits (inflation-adjusted) and an exclusive purchase option after one year at 8x trailing EBITDA. DentonX OIC issues 20% fully diluted equity in itself to OIC (vesting over 36 months quarterly, with acceleration on change of control or IPO, clawback/forfeiture on bad leaver events, 12-month lock-up, and ROFR). The Company grants 360 Series B Preferred Shares to OIC's key persons (e.g., Steven Guang Leung), vesting over three years with similar acceleration and forfeiture terms. OIC receives rights to purchase up to 10% of DentonX shares at a 15% VWAP discount within 12 months post-closing, plus preemptive, piggyback registration, and ROFR rights. The parties intend to finalize the terms of the Series B Preferred Shares prior to issuance. A Shareholders Agreement governs DentonX OIC's board (two DentonX, one OIC if ≥10% held), reserved matters requiring special approval, non-compete covenants, tag/drag rights, and dispute resolution. These integrated arrangements provide DentonX strategic/financial control and economics from OIC's operations while offering OIC equity upside and protections.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●**Master Services Agreement with Alphega Global Partners Corp**: On November 26, 2025, the Company entered into a Master Services Agreement (the "MSA") with Alphega Global Partners Corp. (the "Alphega"), under which the Consultant provides consulting and corporate development services. The services, as detailed in the accompanying Statement of Work, include business operations support, marketing and communications assistance, administrative coordination for government services and compliance (non-legal), strategic corporate development, project management, and related activities to support the Company's growth, compliance, and capital market readiness. Alphega expressly does not provide legal advice, act as a broker-dealer or underwriter, draft securities-related content, or prepare financial statements. The Company paid a $30,000 retainer upon execution, maintained throughout the engagement and applied against final invoices upon termination (with surplus refunded). Professional services are compensated on a time-and-materials basis at hourly rates set forth in the agreement's fee schedule (effective through December 31, 2026), payable generally in cash but potentially in equity (at fair market value with a discount) or other non-cash forms by mutual agreement. Late payments may accrue interest, convert to convertible promissory notes (subject to consent), or incur additional fees. Alphega is entitled to success-based compensation (payable in cash, equity, or other forms at its discretion) for achieving mutually agreed milestones, such as business development outcomes, financial introductions, M&A transactions, or performance exceeding targets, calculated using a modified Lehman formula (Lehman 2.0, doubling standard rates: 10% on the first $1 million of transaction value, 8% on the second $1 million, 6% on the third, 4% on the fourth, and 2% thereafter).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●**Far Sun Consulting Agreement**. On September 27, 2025, the Company entered into a Strategic Business Consulting Agreement (the "Agreement") with Far Sun Global Group LLC ("Far Sun"), under which Far Sun provides strategic business consulting services. The services, as detailed in the accompanying Service Order, include advising on corporate structuring and SEC reporting readiness, capital raising support, strategic growth and expansion advisory, financial and valuation advisory, and corporate development program management to support the Company's formation as a public reporting entity, capital raising, and expansion plans. The Consultant acts as a subcontractor to a prior agreement with Fairbanks Global Partners II LLC dated September 23, 2025, and expressly does not provide legal advice, act as a broker-dealer or underwriter, or offer services related to securities sales. The Company paid an $80,000 retainer in two installments ($40,000 upon execution and $40,000 by November 5, 2025), maintained throughout the engagement and applied against final invoices upon termination (with surplus refunded). Professional services are compensated on a time-and-materials basis at hourly rates set forth in the agreement's fee schedule, payable generally in cash but potentially in equity (at fair market value with a discount) or other non-cash forms by mutual agreement. Far Sun is entitled to success-based compensation (payable in cash, equity, or other forms as mutually agreed) for achieving

------

mutually agreed milestones, such as strategic partnerships, transactions, or growth benchmarks, calculated using a modified Lehman formula (Lehman 2.0, doubling standard rates: 10% on the first $1 million of transaction value, 8% on the second $1 million, 6% on the third, 4% on the fourth, and 2% thereafter). Ms. Chung, a former executive officer of the Company and the controlling person of Apex Stratum LLC, is a shareholder of the Company.

We believe these agreements position us to accelerate platform development while maintaining compliance and operational efficiency.

**Overview of Current Operations**

We are currently focused on developing our core technology infrastructure, including data convergence, SaaS workflow automation, marketplace origination networks, insurance/appraisal/servicing tools, TechInfra academy for talent development, and ecosystem intelligence layers. Our platform will enable partners to personalize loans with speed and flexibility, targeting non-QM products like VOE, bank statement, jumbo ARMs, and DSCR loans.

As of December 31, 2025, operations are limited to planning, consulting, and initial software builds. We have no contracted clients yet but intend to onboard non-bank lenders and borrowers through OIC and future acquisitions.

**Plan of Operation**

Over the next 12-24 months, we plan to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●Complete platform development and testing, including proof-of-concept pilots.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●Execute roll-up acquisitions of regional lenders using DentonX OIC's capacity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●Launch marketplace and distribution networks for borrower/partner acquisition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●Expand into SME financing and non-QM mortgages, leveraging data analytics for risk assessment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●Secure additional funding for growth, including potential public listing.

We anticipate generating initial revenue from platform fees and management income from OIC within the next fiscal year.

**Revenue**

We are seeking to develop dual revenue streams: (1) Technology and platform fees (e.g., SaaS subscriptions, transaction fees) from partners using our infrastructure; and (2) Indirect lending-related income through DentonX OIC, including management fees and performance participation from OIC's operations. No revenue has been generated to date.

**Marketing**

Our marketing strategy will focus on digital channels, industry partnerships, and targeted outreach to non-bank lenders, brokers, and underserved borrowers. We plan to emphasize personalization for self-employed and multicultural segments, using data-driven campaigns to highlight efficiency gains.

**Competition**

We operate in a competitive landscape with TechInfra platforms and non-bank lenders. Competitors include Upstart Holdings, Inc. (AI lending tech), Blend Labs, Inc. (digital mortgage platforms), nCino, Inc. (cloud lending software), Rocket Companies, Inc. (digital mortgages), and UWM Holdings Corporation (wholesale non-QM lending). Our differentiation lies in our hybrid roll-up model with vertically integrated data intelligence, which no single public competitor fully combines. However, larger players have greater resources, and we face risks from market consolidation.

**Employees**

As of December 31, 2025, we have one employee, our CEO and CFO, Mr. Pinuer, who devotes up to 30 hours per week but can increase as needed. We rely on consultants for additional support and may adopt benefit plans in the future. There are no current personal benefits for officers or directors.

------

**Government Regulation**

We are subject to U.S. securities laws and general corporate regulations. While we do not engage in regulated financial activities, our partners (e.g., OIC) must comply with lending laws such as the Truth in Lending Act, Equal Credit Opportunity Act, and state licensing requirements. We monitor developments in technology regulations, including data privacy (e.g., CCPA). No immediate government approvals are required for our current operations, but future expansions may necessitate compliance with additional rules. We commit to adhering to all applicable laws in jurisdictions where we operate.

**Description of Facilities**

The Company's office space is located at 1999 Harrison Street, Suite 1800, Oakland, CA 94612 and our contact number is +1 925-220-2187. The space is provided to the Company at no cost by a former officer, who is now solely a shareholder of the Company. The Company does not pay rent or other consideration for the use of this office space.

**Legal Proceedings**

From time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.

------

**USE OF PROCEEDS**

Our offering is being made on a self-underwritten basis: no minimum number of shares must be sold in order for the offering to proceed. The offering price per share is $5.00. The following table sets forth the uses of proceeds assuming the sale of 100%, 75%, 50% and 25% of the securities offered for sale by the Company. There is no assurance that we will raise the full $15,000,000 as anticipated.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Use of Proceeds Category** | **If 750,000 shares**<br> **(25%) are sold:** | **If 1,500,000 shares**<br> **(50%) are sold:** | **If 2,250,000 shares**<br> **(75%) are sold:** | **If 3,000,000 shares**<br> **(100%) are sold:** |
| Gross Proceeds | $3750000 | $7500000 | $11250000 | $15000000 |
| Offering Expenses | $120000 | $120000 | $120000 | $120000 |
| Placement Agent Commission (7%) (1) | $262500 | $525000 | $787500 | $1050000 |
| **Net Proceeds** | **$3367500** | **$6855000** | **$10342500** | **$13830000** |
| Technology Platform Development & R&D | $1347000 | $2742000 | $4137000 | $5532000 |
| Operational Affiliate Integration & Platform Scaling | $841875 | $1713750 | $2585625 | $3457500 |
| Capital Markets Readiness & Public Company Costs | $404100 | $822600 | $1241100 | $1659600 |
| Sales, Marketing & Business Development | $471450 | $959700 | $1447950 | $1936200 |
| Working Capital & General Corporate Purposes | $303075 | $616950 | $930825 | $1244700 |
| **Total Proceeds** | **$3750000** | **$7500000** | **$11250000** | **$15000000** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The shares will be offered directly through our officers and directors. No commission or other compensation related to the sale of the shares will be paid to our officers and directors. The Company may engage and offer the shares through one or more broker-dealers. A commission of seven percent (7%) will be offered in cash from proceeds of the offering to any engaged broker-dealer. No commission or other consideration will be paid to officers or directors for their involvement in this offering. Our officers and directors will not register as a broker/dealer with the Securities and Exchange Commission in reliance on Rule 3a4-1 of the Securities and Exchange Act of 1934. The intended methods of communication include, without limitation, in-person contact, telephone contact, and facsimile or electronic transmission contact.

The above figures represent only estimated costs for the next 12 months. Funds may be allocated in differing quantities should the Company decide at a later date it would be in the Company's best interests.

All expenses incurred in this offering are being paid for by the Company. The Company will utilize offering proceeds from this offering to pay for any offering expenses however, the Company may also elect to use available existing cash on hand to pay for any offering expenses.

**DETERMINATION OF OFFERING PRICE**

Since our shares are not listed or quoted on any exchange or quotation system, the offering price of the shares of common stock was arbitrarily determined. The offering price was determined by us and is based on our own assessment of our financial condition and prospects, limited offering history, and the general condition of the securities market. It does not necessarily bear any relationship to our book value, assets, past operating results, financial condition or any other established criteria of value. Although our common stock is not listed or quoted on a public exchange, we will be filing to obtain a listing on the OTCQB or OTCID concurrently with the filing of this prospectus. In order to be quoted on the OTCQB or OTCID, a market maker must file an application on our behalf in order to make a market for our common stock.

There is no assurance that our common stock will trade at market prices in excess of the initial public offering price as prices for the common stock in any public market which may develop will be determined in the marketplace and may be influenced by many factors, including the depth and liquidity of the market for the common stock, investor perception of us and general economic and market conditions.

------

**DILUTION**

The offering price of the Shares of Common Stock being offered for sale pursuant to this Offering is substantially higher than the book value per share of the Common Stock. Accordingly, investors purchasing the Shares pursuant to this Offering will experience an immediate and significant dilution in the book value per share of the Shares purchased. We may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders. See Management's Discussion and Analysis. We may require additional capital to finance our operations in the future, but that capital may not be available when it is needed and could be dilutive to existing stockholders and we can sell additional shares of common stock without consulting stockholders and without offering shares to existing stockholders, which would result in dilution of stockholders' interests in our company and could depress our stock price.

The price of the current offering is fixed at $5.00 per common share.

Assuming completion of the offering, there will be up to 21,789,173 common shares outstanding. The following table illustrates the per common share dilution that may be experienced by investors at various funding levels based on the Company's tangible net worth of $369,688 as of December 31, 2025, respectively.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Funding Level** | **100%** | **75%** | **50%** | **25%** |
| Gross Proceeds | $15000000 | $11250000 | $7500000 | $3750000 |
| Offering Price | $5.00 | $5.00 | $5.00 | $5.00 |
| Net Tangible Book Value per Share of Common Stock before this Offering | $(0.02) | $(0.02) | $(0.02) | $(0.02) |
| Increase in Net Tangible Book Value per Share Attributable to New Investors in this Offering | $0.8 | $0.6 | $0.4 | $0.2 |
| Net Tangible Book Value per Share of Common Stock after this Offering | $0.78 | $0.58 | $0.38 | $0.18 |
| Dilution per share to Investors in the Offering | $4.22 | $4.42 | $4.62 | $4.82 |

---

------

**PLAN OF DISTRIBUTION**

The Company has 18,789,173 shares of common stock issued and outstanding as of the date of this filing. Pursuant to this offering the Company is registering 3,000,000 shares of its common stock for sale at the fixed price of $5.00 per share for the duration of the offering. Any engaged broker-dealer will be entitled to a commission equal to seven percent (7%) of the amount of cash raised through this offering.

There is no arrangement to address the possible effect of the offering on the price of the stock.

In connection with the Company's selling efforts in the offering, our Chief Executive Officer will not register as a broker-dealer pursuant to Section 15 of the Exchange Act, but rather will rely upon the "safe harbor" provisions of SEC Rule 3a4-1, promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act").

Generally speaking, Rule 3a4-1 provides an exemption from the broker-dealer registration requirements of the Exchange Act for persons associated with an issuer that participate in an offering of the issuer's securities. Our Chief Executive Officer is not subject to any statutory disqualification, as that term is defined in Section 3(a)(39) of the Exchange Act. Our Chief Executive Officer, will not be compensated in connection with his participation in the offering by the payment of commissions or other remuneration based either directly or indirectly on transactions in our securities. Mr. Pinuer has not, nor has he been within the past 12 months, a brokers or dealer, and she has not, nor has been within the past 12 months, an associated person of a broker or dealer. At the end of the offering, our Chief Executive Officer will continue to primarily perform substantial duties for the Company or on its behalf otherwise than in connection with transactions in securities. Our Chief Executive Officer will not participate in selling an offering of securities for any issuer more than once every 12 months other than in reliance on Exchange Act Rule 3a4-1(a)(4)(i) or (iii).

The Company will receive all proceeds from the sale of the 3,000,000 shares being offered on behalf of the Company itself. The price per share is fixed at $5.00 for the duration of this offering. Although our common stock is not listed or quoted on a public exchange or quoted over-the counter, we intend to seek to have our shares of common stock quoted on the OTC Marketplace. In order to be quoted on the OTC Marketplace a market maker must file an application on our behalf in order to make a market for our common stock. There can be no assurance that a market maker will agree to file the necessary documents with FINRA, nor can there be any assurance that such an application for quotation will be approved. However, sales by the Company must be made at the fixed price of $5.00 for the duration of this offering. The shares of common stock sold by the Company may be occasionally sold in one or more transactions; all shares sold under this prospectus will be sold at a fixed price of $5.00 per share.

Upon completion of this Offering, we will attempt to have the shares quoted on the OTCQB or OTCID operated by OTC Markets Group, Inc. There is no assurance that the Shares will ever be quoted on the OTCQB or OTCID. Although we believe that in the future we will meet the eligibility requirements in order to be quoted on the OTCQB or OTCID, we cannot quantify the likelihood that this will be the case. To be quoted on the OTCQB or OTCID, a market maker must apply to make a market in our common stock. As of the date of this Prospectus, we have not made any arrangement with any market makers to quote our shares. Additionally, there is the possibility a market maker may not apply to make a market in our common stock.

*Investor Lock-Up Agreements*

As a condition to purchasing shares in this offering, each subscriber will be required to execute a lock-up agreement and referenced in the form of Subscription Agreement filed as Exhibit 99.1). Under the lock-up agreement, during the Lock-Up Period (from the Closing Date of the investor's purchase until the first anniversary of the date the Common Stock commences trading on the Principal Trading Market), the purchasing investor may not, without our prior written consent, directly or indirectly offer, sell, pledge, transfer, hedge, or otherwise dispose of the shares purchased in this offering (or securities convertible into or exercisable for Common Stock), or publicly announce any intention to do so.

Commencing six months after the Closing Date (the Leak-Out Start Date), purchasing investors may sell their locked-up shares subject to monthly limitations: in any calendar month, sales may not exceed the investor's pro rata portion (based on their relative holdings among all lock-up signatories/purchasers) of 5% of the aggregate reported trading volume of the Common Stock during the immediately preceding calendar month. All sales must be made in compliance with applicable securities laws (including Rule 144, if applicable) through broker's transactions. Investors

------

must provide us with advance written notice of proposed sales (at least two business days), and we may impose stop-transfer instructions or other enforcement mechanisms.

Permitted exceptions include certain non-value transfers (e.g., bona fide gifts to family members or trusts, transfers by will/intestacy, or to affiliates, with the transferee agreeing to be bound), exercise of options/warrants (with underlying shares remaining locked), establishment of compliant Rule 10b5-1 plans (no sales during full lock-up except per leak-out), or transfers in a change-of-control transaction approved by our board (if not completed, shares remain locked).

These investors lock-up provisions are intended to promote an orderly market following quotation by preventing immediate large-scale resales by new purchasers. However, because the lock-up applies only to shares purchased in this offering (and not to shares held by our existing shareholders, officers, directors, or significant holders), it may have a limited overall impact on trading volume or liquidity. Investors should consider these restrictions carefully before subscribing, as they could materially limit the ability to realize value from their investment in the short to medium term.

In order to comply with the applicable securities laws of certain states, the securities will be offered or sold in those states only if they have been registered or qualified for sale; an exemption from such registration or if qualification requirement is available and with which the Company has complied.

In addition and without limiting the foregoing, the Company will be subject to applicable provisions, rules and regulations under the Exchange Act with regard to security transactions during the period of time when this Registration Statement is effective.

All expenses incurred in this offering are being paid for by the Company. The Company will utilize offering proceeds from this offering to pay for any offering expenses however, the Company may also elect to use available existing cash on hand to pay for any offering expenses.

*Procedures for Subscribing (Shares offered by us, the "Company")*

If you decide to subscribe for any shares in this offering that are offered by us, "The Company", you must

-Execute and deliver a subscription agreement; and

-Deliver a check or certified funds to us for acceptance or rejection.

All checks for subscriptions must be made payable to "DentonX Inc" No escrow agent is involved in this offering and we will receive the proceeds directly from any subscriptions. Wire transfer and telegraphic transfer are also accepted. The Company will deliver stock certificates attributable to shares of common stock purchased directly to the purchasers within ninety (90) days of the close of the offering.

*Right to Reject Subscriptions (Shares offered by us, the "Company")*

We have the right to accept or reject subscriptions in whole or in part, for any reason or for no reason. All monies from rejected subscriptions will be returned immediately by us to the subscriber, without interest or deductions. Subscriptions for securities will be accepted or rejected with letter by mail within 48 hours after we receive them.

------

**DESCRIPTION OF SECURITIES**

We have authorized capital stock consisting of 800,000,000 shares of common stock, $0.0001 par value per share ("Common Stock") and 200,000,000 shares of preferred stock, $0.0001 par value per share ("Preferred Stock"). As of the date of this filing, we have 18,789,173 shares of Common Stock issued and outstanding and no shares of Preferred Stock were issued or outstanding.

**Common Stock**

The holders of outstanding shares of Common Stock are entitled to receive dividends out of assets or funds legally available for the payment of dividends of such times and in such amounts as the board from time to time may determine. Holders of Common Stock are entitled to one vote for each share held on all matters submitted to a vote of shareholders. There is no cumulative voting of the election of directors then standing for election. The Common Stock is not entitled to pre-emptive rights and is not subject to conversion or redemption. Upon liquidation, dissolution or winding up of our Company, the assets legally available for distribution to stockholders are distributable ratably among the holders of the Common Stock after payment of liquidation preferences, if any, on any outstanding payment of other claims of creditors.

**Preferred Stock**

The preferred stock of the Company may be issued from time to time by the Board of Directors in one or more series. The description of shares of each series of preferred stock will be set forth in resolutions adopted by the Board of Directors and a Certificate of Designation to be filed as required by Wyoming law prior to issuance of any shares of the series. The Certificate of Designation will set the number of shares to be included in each series of preferred stock and set the designations, preferences, conversion or other rights, voting powers, restrictions, limitations as to distribution, qualifications, or terms and conditions of redemption relating to the shares of each series. However, the Board of Directors is not authorized to change the right of the common stock to vote one vote per share on all matters submitted for shareholder action. The authority of the Board of Directors with respect to each series of preferred stock includes, but is not limited to, setting or changing the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●The designation of the series and the number of shares constituting the series, provided that the aggregate number of shares constituting all series of preferred stock may not exceed 200,000,000 without amending the corporate by-laws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●The annual distribution rate on shares of the series, whether distributions will be cumulative and, if so, from which date or dates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●Whether the shares of the series will be redeemable and, if so, the terms and conditions of redemption, including the date or dates upon and after which the shares will be redeemable, and the amount per share payable in case of redemption, which amount may vary under different conditions and at different redemption dates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●The obligation, if any, of the Company to redeem or repurchase shares of the series pursuant to a sinking fund;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●Whether shares of the series will be convertible into, or exchangeable for, shares of stock of any other class or classes and, if so, the terms and conditions of conversion or exchange, including the price or prices or the rate or rates of conversion or exchange and the terms of adjustment, if any;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●Whether the shares of the series will have voting rights, in addition to the voting rights provided by law, and, if so, the terms of the voting rights;

The Company is authorized to issue up to 200,000,000 shares of preferred stock, with a par value of $0.0001 per share. As of the date of this Prospectus, the Company has not filed any certificates of designation with the State of Wyoming, nor has it issued any shares of preferred stock.

**Options and Warrants**

None.

------

**Convertible Notes**

None.

**Dividend Policy**

We have not paid any cash dividends to shareholders. The declaration of any future cash dividends is at the discretion of our board of directors and depends upon our earnings, if any, our capital requirements and financial position, general economic conditions, and other pertinent conditions. It is our present intention not to pay any cash dividends in the foreseeable future, but rather to reinvest earnings, if any, in our business operations.

**Transfer Agent**

The Company intends to retain a transfer agent and registrar for its Common Stock.

**LEGAL OPINION**

The validity of the shares of common stock offered hereby will be passed upon for us by Fleming PLLC. Fleming PLLC holds 870,913 shares of common stock of the Company.

**EXPERTS**

The financial statements included in this prospectus and the registration statement have been audited by RBSM LLP, to the extent and for the periods set forth in their report appearing elsewhere herein and in the registration statement and are included in reliance upon such report given upon the authority of said firm as experts in auditing and accounting.

**REPORTS TO SECURITIES HOLDERS**

We will and will continue to make our financial information equally available to any interested parties or investors through compliance with the disclosure rules of Regulation S-K for a smaller reporting company under the Securities Exchange Act. In addition, we will file Form 8-K and other proxy and information statements from time to time as required. The public may read and copy any materials that we file with the SEC at the SEC's Public Reference Room at 100 F Street NE, Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site (http://www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

------

**DIRECTORS AND EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE**

Biographical information regarding the officers and directors of the Company, who will continue to serve as officers and Directors of the Company are provided below:

**Officer Biographies**

---

| | | |
|:---|:---|:---|
| **NAME** | **AGE** | **POSITION** |
| Lionel Pinuer | 49 | Chief Executive Officer and Chief Financial Officer |
| Luis Carlos Ung | 45 | President, Director and Secretary |

---

***Lionel Pinuer***, has over 15 years of experience in corporate finance, operational excellence, business intelligence, and data science. A specialist in corporate turnarounds and organizational change management, Mr. Pinuer has a proven track record of revitalizing distressed enterprises by implementing rigorous cash flow optimization strategies and operational restructuring. He integrates these financial recovery tactics with expert Business Process Management (BPM), leveraging advanced data analytics and digital transformation to drive decision-making. Mr. Pinuer is also the Founder and Principal of Lionel Pinuer Business Consulting, a firm specializing in operational excellence, business process improvement, and corporate financial analysis. Mr. Pinuer holds an MBA and a Master's in Finance from Universidad de Chile. He also earned a Bachelor of Science in Food Engineering from Universidad Austral de Chile. Reinforcing his technical expertise, Mr. Pinuer holds a Diploma in Big Data from QLU and is a certified Lean Six Sigma Black Belt.

***Luis Carlos Ung***, has over 20 years of experience in entrepreneurship, investment, and operations. Mr. Ung presently serves as the President, CEO, Secretary and Director of Alphega Innovations Corporation. Mr. Ung is the President of Equipos PTY Group, a diversified company with operations in construction, industrial equipment, chemicals, logistics, and energy across Latin America. He is also the Founder and CEO of World Engineering Corporation, an early-stage company focused on innovative solutions for the construction and building industry. In addition to his professional roles, Mr. Ung is a recognized scholar in private education in Panama and Latin America, specializing in finance, administration, and operations. He is a Doctoral Candidate in Business Administration in International University of Mexico. Mr. Ung holds advanced degrees, including an MBA from the University of Louisville, a Master of Engineering Management (MEM), a Master of Education (MEd), and a Master's in Finance from Universidad de Chile. He also earned a Bachelor of Science in Electromechanical Engineering from Universidad Tecnológica de Panamá. He is the co-author of The SMART Enterprise Digital Transformation Basics: Managing the Process (ISBN: 978-1-7359118-4-7, 2023, forthcoming) and other scholarly articles. Mr. Ung is also an active Rotary member and philanthropist.

**Corporate Governance**

The Company promotes accountability for adherence to honest and ethical conduct; endeavors to provide full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with the Securities and Exchange Commission (the "SEC") and in other public communications made by the Company; and strives to be compliant with applicable governmental laws, rules and regulations. The Company has not formally adopted a written code of business conduct and ethics that governs the Company's employees, officers and Directors as the Company is not required to do so.

In lieu of an Audit Committee, the Company's Board of Directors, is responsible for reviewing and making recommendations concerning the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of the Company's financial statements and other services provided by the Company's independent public accountants. The Board of Directors, the Chief Executive Officer and the Chief Financial Officer of the Company review the Company's internal accounting controls, practices and policies.

**Committees of the Board**

Our Company currently does not have nominating, compensation, or audit committees or committees performing similar functions nor does our Company have a written nominating, compensation or audit committee charter. Our Directors believe that it is not necessary to have such committees, at this time, because the Director(s) can adequately perform the functions of such committees.

------

**Audit Committee Financial Expert**

Our Board of Directors has determined that we do not have a board member that qualifies as an "audit committee financial expert" as defined in Item 407(D)(5) of Regulation S-K, nor do we have a Board member that qualifies as "independent" as the term is used in Item 7(d)(3)(iv)(B) of Schedule 14A under the Securities Exchange Act of 1934, as amended, and as defined by Rule 4200(a)(14) of the FINRA Rules.

We believe that our Director(s) are capable of analyzing and evaluating our financial statements and understanding internal controls and procedures for financial reporting. The Director(s) of our Company does not believe that it is necessary to have an audit committee because management believes that the Board of Directors can adequately perform the functions of an audit committee. In addition, we believe that retaining an independent Director who would qualify as an "audit committee financial expert" would be overly costly and burdensome and is not warranted in our circumstances given the stage of our development and the fact that we have not generated any positive cash flows from operations to date.

**Involvement in Certain Legal Proceedings**

Our Director and our Executive Officer have not been involved in any of the following events during the past ten years:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.Such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.Such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.Such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of: (i) Any Federal or State securities or commodities law or regulation; or (ii) Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or (iii) Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.Such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

**Independence of Directors**

We are not required to have independent members on our Board of Directors, and do not anticipate having independent Directors until such time as we are required to do so.

**Code of Ethics**

We have not adopted a formal Code of Ethics. The Board of Directors evaluated the business of the Company and the number of employees and determined that since the business is operated by a small number of persons, general rules

------

of fiduciary duty and federal and state criminal, business conduct and securities laws are adequate ethical guidelines. In the event our operations, employees and/or Directors expand in the future, we may take actions to adopt a formal Code of Ethics.

**Shareholder Proposals**

Our Company does not have any defined policy or procedural requirements for shareholders to submit recommendations or nominations for Directors. The Board of Directors believes that, given the stage of our development, a specific nominating policy would be premature and of little assistance until our business operations develop to a more advanced level. Our Company does not currently have any specific or minimum criteria for the election of nominees to the Board of Directors and we do not have any specific process or procedure for evaluating such nominees. The Board of Directors will assess all candidates, whether submitted by management or shareholders, and make recommendations for election or appointment.

A shareholder who wishes to communicate with our Board of Directors may do so by directing a written request addressed to our President, at the address appearing on the first page of this Information Statement.

------

**EXECUTIVE COMPENSATION**

**Summary Compensation Table:**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Name and principal position<br> (a) | Year ended September 30,<br> (b) | Salary<br> ($)<br> (c) | Bonus<br> ($)<br> (d) | Stock<br> Compensation<br> ($)<br> (e) | Option<br> Awards<br> ($)<br> (f) | Non-Equity Incentive<br> Plan Compensation<br> ($)<br> (g) | Nonqualified Deferred<br> Compensation<br> Earnings ($)<br> (h) | All Other<br> Compensation<br> ($)<br> (i) | Total<br> ($)<br> (j) |
| Luis Carlos Ung<br> Title: President and Former Chief Executive Officer <sup>(1)</sup> | 2025 | – | – | $150 | – | – | – | $144500 | $144650 |
| Irene Ying Ying Chung<br> Title: Former Secretary and Treasurer | 2025 | – | – | $1 | – | – | – | $6879 | $6880 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Resigned as Chief Executive Officer as of January 1, 2026.

**Summary of Compensation**

Stock Option Grants

We have not granted any stock options to our executive officer since our incorporation.

Employment Agreements

We do not have an employment agreement with our Officer or Director; provided, however, we have entered into the below consulting agreements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On September 3, 2025, the Company entered into a Consulting Agreement with Irene Ying Ying Chung, pursuant to which Ms. Chung served as the Company's Secretary and Treasurer, providing corporate administration, documentation management, treasury support, and other reasonably requested services under the direction of executive management and the Board. Ms. Chung resigned as the Company's Secretary and Treasurer which effectively terminated the agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On September 10, 2025, the Company entered into a Consulting Agreement with Lionel Pinuer, pursuant to which Mr. Pinuer provides strategic advisory, business development, operational guidance, market analysis, capital strategy input, and other reasonably requested consulting services under the Board's direction. Services are aligned with Company objectives and detailed in service orders. Compensation is based on invoiced time at mutually agreed hourly or project rates, payable in cash, equity, or a combination; monthly invoices are submitted within five business days. Mr. Pinuer must provide regular status reports. The initial term is 12 months, renewable, with termination on 30 days' notice. Mr. Pinuer was appointed as Chief Executive Officer and Chief Financial Officer on January 1, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On September 3, 2025, the Company entered into a Consulting Agreement with Luis Carlos Ung, pursuant to which Mr. Ung serves as the Company's CEO and President, providing executive leadership, strategic planning, operational oversight, business development, capital strategy, and other reasonably requested services under the Board's direction. Services are detailed in service orders, with deliverables to meet Company standards. Compensation is based on invoiced time at a mutually agreed hourly rate, payable in cash, equity, or a combination; monthly invoices are submitted within five business days. Mr. Ung must provide regular status reports. The initial term is 12 months, renewable, with termination on 30 days' notice. Mr. Ung resigned as the Company's CEO but continues to serve as a director, President and Secretary of the Company.

The Company did not pay any compensation to its executive officers in their capacity as executive officers during the periods presented. The Company's Chief Executive Officer and President, Luis Carlos Ung, and Chief Financial Officer, [Ms. Chung], provided services to the Company pursuant to separate consulting arrangements, initially in

------

their individual capacities and subsequently through their respective consulting entities, including "Alphega Global Partner Corp" for Luis Carlos Ung.

Under these consulting arrangements, the officers provided executive leadership, strategic planning, operational oversight, and other management services. Compensation for such services was based on invoiced time at agreed-upon hourly rates and was payable in cash, equity, or a combination thereof, in accordance with the applicable consulting agreements.

Amounts incurred under these consulting arrangements are reflected in the Company's financial statements as Consulting and legal and professional services expense. No amounts were paid as executive compensation, however shares has been issued against services, which are reflected in the executive compensation table accordingly for the named executive officers for the periods presented.

Director Compensation

Our Board of Directors does not currently receive any consideration for their services as members of the Board of Directors. The Board of Directors reserves the right in the future to award the members of the Board of Directors cash or stock-based consideration for their services to the Company, which awards, if granted shall be in the sole determination of the Board of Directors.

Executive Compensation Philosophy

Our Board of Directors determines the compensation given to our executive officers in their sole determination. Our Board of Directors reserves the right to pay our executives or any future executives a salary, and/or issue them shares of common stock issued in consideration for services rendered and/or to award incentive bonuses which are linked to our performance, as well as to the individual executive officer's performance. This package may also include long-term stock based compensation to certain executives, which is intended to align the performance of our executives with our long-term business strategies. Additionally, while our Board of Directors has not granted any performance base stock options to date, the Board of Directors reserves the right to grant such options in the future, if the Board in its sole determination believes such grants would be in the best interests of the Company.

Incentive Bonus

The Board of Directors may grant incentive bonuses to our executive officer and/or future executive officers in its sole discretion, if the Board of Directors believes such bonuses are in the Company's best interest, after analyzing our current business objectives and growth, if any, and the amount of revenue we are able to generate each month, which revenue is a direct result of the actions and ability of such executives.

Long-term, Stock Based Compensation

In order to attract, retain and motivate executive talent necessary to support the Company's long-term business strategy we may award our executives and any future executives with long-term, stock-based compensation in the future, at the sole discretion of our Board of Directors, which we do not currently have any immediate plans to award.

------

**SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT**

As of this offering, the Company has 18,789,173 shares of common stock issued and outstanding. The following table sets forth certain information as of March 19, 2026, the beneficial ownership of our common stock by the following persons:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●each person or entity who, to our knowledge, owns more than 5% of our common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●our executive officers named in the Summary Compensation Table above; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●each director.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name and Address** | **Position** | **Class of**<br> **Equity** | **Number of**<br> **Shares**<br> **Owned** | **Percent**<br> **of**<br> **Class<sup>(5)</sup>** |
| Luis Carlos Ung<sup>(1)(4)</sup> | President, Secretary, Director | Common | 2000000 | 10.6% |
| Lionel Pinuer <sup>(1)</sup> | CEO and CFO | Common | 200000 | 1.1% |
| AG Partners I Inc. <sup>(1)</sup> | Beneficial Owner | Common | 6600000 | 35.1% |
| OutstandingX LLC<sup>(1)</sup> | Beneficial Owner | Common | 6080000 | 32.4% |
| Fairbanks Global Partners II LLC<sup>(1)(2)</sup> | Beneficial Owner | Common | 1500000 | 8.0% |
| Apex Stratum LLC<sup>(1)(3)</sup> | Beneficial Owner | Common | 1500000 | 8.0% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Mailing Address: c/o DentonX Inc, 1999 Harrison Street, Suite 1800, Oakland, CA 94612.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The control person for Fairbanks Global Partners II LLC is Luis Carlos Ung.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)The control person for Apex Stratum LLC is Irene Ying Ying Chung.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)Includes 500,000 shares of common stock held individually by Mr. Ung and 1,500,000 shares of common stock held by Fairbanks Global Partners II LLC.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)Beneficial ownership in the table above has been determined in accordance with Rule 13d-3 under the Exchange Act. Under this rule, certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares (for example, upon exercise of an option or warrant) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares is deemed to include the amount of shares beneficially owned by such person by reason of such acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the following table does not necessarily reflect the person's actual voting power at any particular date.

------

**CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS**

On September 3, 2025, the Company entered into a Consulting Agreement with Irene Ying Ying Chung, pursuant to which Ms. Chung served as the Company's Secretary and Treasurer, providing corporate administration, documentation management, treasury support, and other reasonably requested services under the direction of executive management and the Board. Ms. Chung resigned as the Company's Secretary and Treasurer which effectively terminated the agreement.

On September 10, 2025, the Company entered into a Consulting Agreement with Lionel Pinuer, pursuant to which Mr. Pinuer provides strategic advisory, business development, operational guidance, market analysis, capital strategy input, and other reasonably requested consulting services under the Board's direction. Services are aligned with Company objectives and detailed in service orders. Compensation is based on invoiced time at mutually agreed hourly or project rates, payable in cash, equity, or a combination; monthly invoices are submitted within five business days. Mr. Pinuer must provide regular status reports. The initial term is 12 months, renewable, with termination on 30 days' notice. Mr. Pinuer was appointed as Chief Executive Officer and Chief Financial Officer on January 1, 2026.

On September 3, 2025, the Company entered into a Consulting Agreement with Luis Carlos Ung, pursuant to which Mr. Ung serves as the Company's CEO and President, providing executive leadership, strategic planning, operational oversight, business development, capital strategy, and other reasonably requested services under the Board's direction. Services are detailed in service orders, with deliverables to meet Company standards. Compensation is based on invoiced time at a mutually agreed hourly rate, payable in cash, equity, or a combination; monthly invoices are submitted within five business days. Mr. Ung must provide regular status reports. The initial term is 12 months, renewable, with termination on 30 days' notice. Mr. Ung resigned as the Company's CEO but continues to serve as a director, President and Secretary of the Company.

On October 3, 2025, the Company entered into a Consulting Agreement with Soho Capital Solutions Inc, pursuant to which Soho provides U.S. GAAP accounting and financial reporting support, pre-audit and compliance assistance, M&A due diligence, and additional financial advisory services as requested. Compensation includes a $8,500 non-refundable initial retainer (due upon execution), plus $75 per hour (70% cash, 30% equity unless otherwise agreed); monthly invoices are due within 15 days, with 1.5% monthly late fees. The agreement continues until terminated with 30 days' notice or immediately for uncured material breach (15 days to cure).

On September 23, 2025, the Company entered into an Amended and Restated Corporate Development and Financial Consulting Agreement with Fairbanks Global Partners II LLC, superseding a prior agreement dated September 3, 2025, pursuant to which Fairbanks provides corporate development and financial advisory services as specified in service orders, including corporate structuring and SEC readiness, capital raising support, strategic growth and expansion advisory, financial and valuation advisory, and program management. Compensation includes an $80,000 retainer ($40,000 upon signing and $40,000 on November 5, 2025), time-based professional fees at hourly rates ranging from $80 to $1,350 (payable in cash or equity at a 30% discount to fair market value), success-based compensation tied to milestones (using Lehman 2.0 formula for business development, financial introductions, and M&A), and a 2% performance override for exceeding targets; pre-effective services are ratified and billable, with late payments subject to 9.5% interest promissory notes and 15% handling fees. The agreement continues until services are completed (or earlier termination), with rights to terminate on 60 days' notice or for uncured material breach (10 days to cure), requiring payment for services through termination.

On September 27, 2025, DentonX Inc. entered into a Strategic Business Consulting Agreement (the "Agreement") with Far Sun Global Group LLC ("Far Sun"), under which Far Sun provides strategic business consulting services. The services, as detailed in the accompanying Service Order, include advising on corporate structuring and SEC reporting readiness, capital raising support, strategic growth and expansion advisory, financial and valuation advisory, and corporate development program management to support the Company's formation as a public reporting entity, capital raising, and expansion plans. The Consultant acts as a subcontractor to a prior agreement with Fairbanks Global Partners II LLC dated September 23, 2025, and expressly does not provide legal advice, act as a broker-dealer or underwriter, or offer services related to securities sales. The Company paid an $80,000 retainer in two installments ($40,000 upon execution and $40,000 by November 5, 2025), maintained throughout the engagement and applied against final invoices upon termination (with surplus refunded). Professional services are compensated on a time-and-materials basis at hourly rates set forth in the agreement's fee schedule, payable generally in cash but potentially in equity (at fair market value with a discount) or other non-cash forms by mutual agreement. Far Sun is entitled to success-based compensation (payable in cash, equity, or other forms as mutually agreed) for achieving mutually agreed milestones, such as strategic partnerships, transactions, or growth benchmarks, calculated using a modified

------

Lehman formula (Lehman 2.0, doubling standard rates: 10% on the first $1 million of transaction value, 8% on the second $1 million, 6% on the third, 4% on the fourth, and 2% thereafter). Ms. Chung, a former executive officer of the Company and the controlling person of Apex Stratum LLC, is a shareholder of the Company.

On November 26, 2025, the Company entered into a Master Services Agreement (the "MSA") with Alphega Global Partners Corp. (the "Alphega"), under which the Consultant provides consulting and corporate development services. The services, as detailed in the accompanying Statement of Work, include business operations support, marketing and communications assistance, administrative coordination for government services and compliance (non-legal), strategic corporate development, project management, and related activities to support the Company's growth, compliance, and capital market readiness. Alphega expressly does not provide legal advice, act as a broker-dealer or underwriter, draft securities-related content, or prepare financial statements. The Company paid a $30,000 retainer upon execution, maintained throughout the engagement and applied against final invoices upon termination (with surplus refunded). Professional services are compensated on a time-and-materials basis at hourly rates set forth in the agreement's fee schedule (effective through December 31, 2026), payable generally in cash but potentially in equity (at fair market value with a discount) or other non-cash forms by mutual agreement. Late payments may accrue interest, convert to convertible promissory notes (subject to consent), or incur additional fees. Alphega is entitled to success-based compensation (payable in cash, equity, or other forms at its discretion) for achieving mutually agreed milestones, such as business development outcomes, financial introductions, M&A transactions, or performance exceeding targets, calculated using a modified Lehman formula (Lehman 2.0, doubling standard rates: 10% on the first $1 million of transaction value, 8% on the second $1 million, 6% on the third, 4% on the fourth, and 2% thereafter).

**Review, Approval and Ratification of Related Party Transactions**

Given our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described above, with our executive officer, Director and significant stockholders. We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional Directors, so that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an appropriate committee thereof. On a moving forward basis, our Director will continue to approve any related party transaction.

------

**FINANCIAL STATEMENTS AND EXHIBITS INDEX TO FINANCIAL STATEMENTS**

---

| | |
|:---|:---|
|  | **Page** |
| **Financial Statements for Year Ended September 30, 2025 (Audited)** |  |
| [REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM](#report) (PCAOB ID #587) | F-1 |
| [Balance Sheets](#bs) | F-2 |
| [Statements of Operations](#sop) | F-3 |
| [Statements of Changes in Stockholders' Equity](#sse) | F-4 |
| [Statements of Cash Flows](#cfs) | F-5 |
| [Notes to the Financial Statement](#notes) | F-6 |
| **Financial Statements for Three months ended December 31, 2025 (Unaudited)** |  |
| [Balance Sheets](#bs2) | F-14 |
| [Statements of Operations](#sop2) | F-15 |
| [Statements of Changes in Stockholders' (Deficit) Equity](#sse2) | F-16 |
| [Statements of Cash Flows](#cfs2) | F-17 |
| [Notes to the Financial Statement](#notes2) | F-18 |

---

------

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the Board of Directors

of DentonX Inc.

**Opinion on the Financial Statements**

We have audited the accompanying balance sheet of DentonX Inc. (the "Company") as of September 30, 2025, and the related statements of operation, stockholders' equity, and cash flow for the period from September 3, 2025 (date of inception) to September 30, 2025, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of September 30, 2025, and the results of its operation and its cash flow for the period September 3, 2025 (date of inception) to September 30, 2025, in conformity with accounting principles generally accepted in the United States of America.

**Explanatory Paragraph – Going Concern**

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the accompanying financial statements, the Company has incurred a loss from operations and has not yet commenced revenue generating activities that raise substantial doubt about the company's ability to continue as a going concern. Management's evaluation of the events and conditions and management's plans regarding these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

**Basis for Opinion**

The financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provide a reasonable basis for our opinion.

*/s/ RBSM LLP*

We have served as the Company's auditor since 2025.

San Francisco

March 20, 2026

PCAOB ID 587

------

**DentonX Inc.**

**Balance Sheet**

**As of September 30, 2025**

---

| | |
|:---|:---|
|  | **2025** |
|  | **(USD)** |
| **Assets** |  |
| **Current Assets** |  |
| Cash and Bank | $359981 |
| Prepaid expense | 40000 |
| **Total Current Assets** | **399981** |
| **Total Assets** | $**399981** |
| **Liabilities and Stockholder's Equity** |  |
| **Current Liabilities:** |  |
| Accounts Payable | $45 |
| Due to Related Parties | 232285 |
| **Total Current Liabilities** | **232330** |
| **Total Liabilities** | **232330** |
| **Contingencies And Commitments** | **-** |
| **Stockholders' Equity:** |  |
| Common stock $0.0001 par value; 800,000,000 shares authorized;<br> 9,789,900 shares issued and outstanding as of September 30, 2025. | 979 |
| Preferred stock $0.0001 par value; 200,000,000 shares authorized;<br> No shares were issued and outstanding as of September 30, 2025 | - |
| Additional Paid-in Capital | - |
| Subscription Receivable | (660) |
| Advance from share subscription | 400000 |
| Accumulated Deficit | (232669) |
| **Total Stockholders' Equity** | **167650** |
| **Total Liabilities and Stockholder's Equity** | $**399981** |

---

The accompanying notes are an integral part of these financial statements.

------

**DentonX Inc.**

**Statement of Operations**

**From September 03, 2025 (inception) to September 30, 2025**

---

| | |
|:---|:---|
|  | **2025** |
|  | **(USD)** |
| **Revenue** | $- |
| **Expenses** |  |
| Consulting | 6880 |
| Legal and Professional Services | 225751 |
| Software and Subscriptions | 18 |
| Bank Fees & Service Charges | 40 |
| **Total Expenses** | **232689** |
| **Loss from Operations** | **(232689)** |
| **Other Income (Expense)** |  |
| Interest Income | 20 |
| **Loss Before Provision for Income Taxes** | **(232669)** |
| Provision for Income Taxe | - |
| **Net Loss** | $**(232669)** |
| Net loss per share - Basic and diluted | $(0.03) |
| Weighted average shares outstanding - Basic and Diluted | 8043489 |

---

The accompanying notes are an integral part of these financial statements.

------

**DentonX Inc**

**Statement of changes in Stockholder`s Equity**

**For the Period from September 3, 2025 (inception) to September 30, 2025**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | **Preferred stock**<br> **as per par value** | **Preferred stock**<br> **as per par value** | **Advance**<br> **Against**<br> **issue of**<br> **shares** | **Subscription**<br> **Receivable** | **Additional**<br> **Paid-In-**<br> **Capital** | **Accumulated**<br> **Deficit** | **Total** |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Amount** | **Amount** | **Amount** | **Amount** | **Amount** |
| Balance at September 03, 2025 (inception) | - | $- | - | $- | $- | $- | $- | $- | $- |
| Issuance of Common Stock to founders | 3189900 | 319 | - | - | - |  | - |  | 319 |
| Sales of common stock for cash | 6600000 | 660 |  |  | - | (660) |  |  | - |
| Advance against issue of shares |  |  |  |  | 400000 |  |  |  | 400000 |
| Net Loss |  |  |  |  |  |  |  | (232669) | (232669) |
| Balance as of September 30, 2025 | **9789900** | **$979** | **-** | **$-** | **$400000** | **$(660)** | **$-** | **$(232669)** | **$167650** |

---

The accompanying notes are an integral part of these financial statements.

------

**DentonX Inc**

**Statement of Cash Flows**

**For the Period from September 3, 2025 (inception) to September 30, 2025**

---

| | |
|:---|:---|
|  | **2025** |
|  | **(USD)** |
| **Cash flows from operating activities** |  |
| Net (loss)/ Income | $(232669) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |
| Issuance of Common Stock to founders at inception | 319 |
| **Net change in operating assets and liabilities:** |  |
| Due to Related Party | 232285 |
| Accounts payable | 45 |
| Prepaid expense | (40000) |
| **Net Cashflow used in operating activities** | **(40019)** |
| **Cashflow from financing activities** |  |
| Advance against issue of shares | 400000 |
| **Net Cashflow from financing activities** | **400000** |
| **Net Movement in Cash** | **359981** |
| Cash at beginning of the period | $- |
| **Cash at the end of the period** | $**359981** |
| **Supplemental cash flow information:** |  |
| Cash paid for interest | $- |
| Cash paid for Income Taxes | $- |

---

The accompanying notes are an integral part of these financial statements.

------

**DentonX Inc.**

**Notes to the Financial Statements**

**NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS**

DentonX Inc. ("DentonX" or "the Company") was incorporated in the State of Wyoming on September 3, 2025. The Company provides end-to-end data infrastructure and automation tools that support modern lending ecosystems. DentonX's platform enables non-bank lenders, financial institutions, and credit platforms to operate with greater speed, accuracy, and confidence, regardless of the complexity of their loan portfolios. The Company's solutions integrate data management, workflow automation, and analytical capabilities to streamline lending operations, enhance decision-making, and improve operational efficiency. As a development-stage company, DentonX is currently focused on building its platform, developing technology solutions, and preparing for commercial deployment. The Company's operations are designed to support scalable lending activities and provide advanced automation tools for financial services organizations.

**Going Concern Consideration**

The Company's audited financial statements as of September 30, 2025, have been prepared using generally accepted accounting principles in the United States of America ("GAAP") applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The Company has accumulated losses as of September 30, 2025, totaling $232,669. These factors, among other, raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period. The company plans to raise capital through private placement or borrowing arrangements. As of the issuance of these financial statements, the Company has commenced limited operations. The Company has financed its activities through equity financing. Management expects to commence operations in the third quarter of 2026.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plan is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its minimal operating expenses and seeking third-party equity and/or debt financing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

**NOTE.2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Basis of Presentation**

The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the rules and regulations of the SEC.

**Emerging Growth Company Status**

The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act of 1933, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"). As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies, including, but not limited to, exemption from the requirement to obtain an attestation report on internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in periodic reports and proxy statements, and exemptions from the requirements to hold a nonbinding advisory vote on executive compensation and shareholder approval of certain golden parachute payments.

Further, Section 102(b)(1) of the JOBS Act provides that an emerging growth company is not required to comply with new or revised financial accounting standards until such standards are applicable to private companies. The JOBS Act permits an emerging growth company to elect to opt out of the extended transition period; however, any such election is irrevocable. The Company has elected not to opt out of the extended transition period, and therefore, the Company will adopt new or revised accounting standards at the time such standards become effective for private companies. As a result, the Company's financial statements may not be comparable to the financial statements of public companies

------

that are neither emerging growth companies nor emerging growth companies that have elected to opt out of the extended transition period.

**Use of Estimates**

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

**Liquidity and Capital Resources Note**

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of September 30, 2025, the Company had cash of $359,981 and working capital of $167,651.

In connection with the Company's assessment of going concern considerations in accordance with ASC 205-40, "Presentation of Financial Statements - Going Concern," as of September 30, 2025, the Company does believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the Company does not raise sufficient capital to meet its business objectives, the Company has insufficient funds available to operate its business prior over the next twelve months."

**Cash and Cash Equivalents**

Cash and cash equivalents consist of cash on hand and demand deposits with financial institutions, as well as all highly liquid investments with original maturities of three months or less at the time of purchase. Cash and cash equivalents are carried at cost, which approximates fair value. The Company maintains its cash balances at financial institutions, which at times may exceed federally insured limits; however, management does not believe the Company is exposed to significant credit risk related to these balances.

The Federal Deposit Insurance Corporation ("FDIC") covers up to $250,000 per depositor, per insured bank. As of September 30, 2025, the Company maintained cash and cash equivalents totaling $359,981, of which approximately $109,981 was in excess of FDIC insurance limits.

**Fair Values of Financial Instrument**

The Company's financial instruments include cash and cash equivalents, accounts receivable, prepaid expenses, accounts payable, accrued expenses, and other current liabilities. The carrying amounts of these financial instruments approximate their fair values due to their short-term maturity. The Company does not hold any financial instruments that are required to be measured at fair value on a recurring basis. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

**Prepaid Expense**

Prepaid expenses represent payments made in advance for goods or services to be received in future periods and are recorded as assets until the related benefits are consumed. Prepaid expenses are amortized to operating expenses on a straight-line basis over the period to which the related benefits apply.

------

**Income Taxes**

The Company complies with the accounting and reporting requirements of ASC Topic 740, "Income Taxes," which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company's management determined that the United States is the Company's only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of September 30, 2025, and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

The Company may be subject to potential examination by United States taxing authorities in income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with United States tax laws. The Company's management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is incorporated in the United States and is subject to U.S. federal and applicable state income tax laws. The Company has no operations or taxable presence in any other jurisdiction. Due to operating losses incurred during the periods presented, the Company did not recognize any provision for income taxes and had no current income tax expense. Accordingly, the Company's tax provision was zero for the periods presented.

**Net Loss Per Share**

Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period in accordance with ASC 260, Earning per Share. For the period from September 03, 2025, to September 30, 2025, the weighted average number of shares outstanding was 8,043,489 ordinary shares.

There were no securities that could potentially dilute income (loss) per share in the future.

**Stock-based Compensation**

The Company grants common stock awards to non-employees in exchange for services provided. The Company measures the fair value of these awards using the fair value of the services provided or the fair value of the awards granted, whichever is more reliably measurable. The fair value measurement date of these awards is generally the date the performance of services is complete. The fair value of the awards is recognized on a straight-line basis as services are rendered. The share-based payments related to common stock awards for the settlement of services provided by non-employees is recorded in accordance with ASC 718 on the statement of operations in the same manner and charged to the same account as if such settlements had been made in cash.

**Segment Reporting**

ASC Topic 280, Segment Reporting, establishes standards for companies to report, in their financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company's chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

The Company's CODM has been identified as the Chief Financial Officer, who reviews the assets, operating results and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment.

------

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as net income or loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the Company's performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

---

| | |
|:---|:---|
|  | **September 30, 2025** |
| Cash and bank | $359981 |
| Prepaid expense | 40000 |
| Total Assets | $399981 |
|  | **For the period from**<br> **September 03, 2025 (inception)**<br> **to September 30, 2025** |
|  | **For the period from**<br> **September 03, 2025 (inception)**<br> **to September 30, 2025** |
| Consulting | $(6880) |
| Legal and professional | (225751) |
| Other expense | (58) |
| Interest income | 20 |
| Net loss | $(232669) |

---

**Recently Issued Accounting Standards**

In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on December 4, 2024, its date of incorporation.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. This ASU is effective for fiscal years beginning after December 15, 2024, and allows for adoption on a prospective basis, with a retrospective option. We are currently evaluating the impacts of the new standard.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

**Dividend Policy**

We have not paid any cash dividends to shareholders. The declaration of any future cash dividends is at the discretion of our board of directors and depends upon our earnings, if any, our capital requirements and financial position, general economic conditions, and other pertinent conditions. It is our present intention not to pay any cash dividends in the foreseeable future, but rather to reinvest earnings, if any, in our business operations.

------

**NOTE.3 STOCKHOLDERS EQUITY**

Common and Preferred Stock

Authorized: 800,000,000 shares of voting common stock with a par value of $0.0001, 200,000,000 shares of preferred stock with a par value of $0.0001. As of September 30, 2025, the Company had 9,789,900 shares of common stock issued and outstanding. There was no preferred stock issued and outstanding as of September 30, 2025.

For the period from inception (September 03, 2025) to September 30, 2025, the Company engaged in the following equity events:

Sale of Common Stock and Subscriptions

On September 08, 2025, the Company issued 6,600,000 shares of the Company's common stock to investor Alphega Global Partners Inc. at a par value of $0.0001 per share for an aggregate purchase price of $660. The Company did not receive the proceeds from the investor until September 30, 2025. The Company booked it as subscription receivable as of September 30, 2025.

Shares issued to founders

During the period from September 3, 2025, to September 30, 2025, the Company issued common shares at a par value of $0.0001 per share to its founders in exchange for services rendered.

---

| | | | |
|:---|:---|:---|:---|
| **Date of Issuance** | **Recipient** | **Number of Shares** | **Purpose** |
| 9/3/2025 | Irene Ying Ying Chung | 10000 | As compensation for services rendered in connection with corporate administration, documentation management, treasury support, and the direction and supervision of the Company's executive management. This issuance is for the initial founder shares at inception. |
| 9/8/2025 | Cintron Management Ltd. | 179900 | In consideration of costs, expenditures, and other contributions of value made on behalf of the Company. This issuance is for the initial founder shares at inception. |
| 9/8/2025 | Fairbanks Global Partners II LLC | 1500000 | In consideration of costs, expenditures, and other contributions of value made on behalf of the Company. This issuance is for the initial founder shares at inception. |
| 9/8/2025 | Apex Stratum LLC | 1500000 | In consideration of costs, expenditures, and other contributions of value made on behalf of the Company. This issuance is for the initial founder shares at inception. |
|  | **Total shares issued against services** | **3189900** |  |

---

**NOTE.4 RELATED PARTY TRANSACTIONS**

The related parties had transactions for the period from September 03, 2025 (inception) to September 30, 2025, consisting of the following:

---

| | | |
|:---|:---|:---|
| **Name of the related parties** | **Nature of relationship** |  |
| Fairbanks Global Partners II LLC | Shareholder |  |
| Irene Ying Ying Chung | Shareholder |  |
| Alphega Global Partners Corp | Shareholder |  |
| **Accrued Services** |  | **September 30, 2025** |
| Irene Ying Ying Chung |  | $6879 |
| Fairbanks Global Partners II LLC |  | $184606 |
| Alphega Global Partners Corp |  | $40800 |
| Total Due to related party |  | $232285 |

---

------

As of September 30, 2025, balances due to related parties primarily represent the initial services provided by the shareholders in regards to the Company's foundation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On September 03, 2025, the Company issued 10,000 shares of its common stock at a price of $0.0001 per share to Irene Ying Ying Chung, with an aggregate value of $1, As compensation for services rendered in connection with corporate administration, documentation management, treasury support, and the direction and supervision of the Company's executive management.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On September 08, 2025, the Company issued 1,500,000 shares of its common stock at a price of $0.0001 per share to Fairbanks Global Partners II LLC, with an aggregate value of $150, in consideration for costs, expenditures, and other contributions of value made on behalf of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●During the period, the Company made aggregate cash payments of $40,000 to Far Sun Global Group as a retainer for services rendered.

**NOTE.5 INCOME TAX**

We have not yet filed tax returns for the period ended September 30, 2025. As of September 30, 2025, we had net operating loss carry forwards, on a book basis, of $232,669 that may be available to reduce various future years' Federal taxable income for 20 years through 2045. Net operating losses may be limited as a result of possible changes in business. Future tax benefits which may arise because of these losses have not been recognized in the accompanying financial statements, as their realization is determined not likely to occur and accordingly, we have recorded a valuation allowance for the deferred tax asset relating to the net operating loss carry forwards.

The following table presents the current income tax provision for federal and state income taxes for the period ended September 30, 2025.

---

| | |
|:---|:---|
|  | **For the period September 03, 2025 (Inception), to September 30, 2025** |
| Current tax provisions: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Federal | $– |
| &nbsp;&nbsp;&nbsp;&nbsp;State | – |
| Total provision for income taxes | $– |

---

Reconciliation of the U.S. federal statutory rate to the actual tax rate for the period ended September 30, 2025:

---

| | |
|:---|:---|
|  | **For the period September 03, 2025 (Inception), to September 30, 2025** |
| US federal statutory income tax rate | 21% |
| State income tax, net of federal benefit | 0% |
| Permanent differences | 0% |
| Increase in valuation reserve | -21% |
| Total provision for income taxes | 0% |

---

The components of our deferred tax assets as of September 30, 2025, consisted of the following:

---

| | |
|:---|:---|
|  | **September 30,**<br> **2025** |
| Net operating loss carry forwards | $48860 |
| Less: valuation allowance | (48860) |
| Net deferred tax assets | $- |

---

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences will become deductible. The Company has recorded a full valuation allowance against its net deferred tax assets because management has determined that it is more likely than not that these assets will not be realized.

------

**NOTE.6 CONTINGENCIES AND COMMITMENTS**

There are no contingencies and commitments at balance sheet date.

**NOTE.7 SUBSEQUENT EVENTS**

On October 15, 2025, the Company's common stock had a fair value of $0.0625 per share. The Company issued 495,000 shares of its common stock to Irene Ying Ying Chung on that date in exchange for services rendered. The Company recognized stock based compensation expense based on the fair value of common stock on the grant date of valued at $30,938.

On October 15, 2025, the Company's common stock had a fair value of $0.0625 per share. The Company issued 200,000 shares of its common stock to Lionel Pinuer E on that date in exchange for services rendered. The Company recognized stock based compensation expense based on the fair value of common stock on the grant date of valued at $12,500.

On October 15, 2025, the Company's common stock had a fair value of $0.0625 per share. The Company issued 500,000 shares of its common stock to Luis Carlos Ung on that date in exchange for services rendered. The Company recognized stock based compensation expense based on the fair value of common stock on the grant date of value $31,250.

After September 30, 2025, the Company entered into a legal retainer agreement with Fleming PLLC on October 23, 2025, for services related to the preparation and filing of a Form S-1 registration statement, for a flat fee of $25,000 and the issuance of common shares equal to 5% of the Company's outstanding shares following a recent investment. On November 30, 2025, the Company issued 870,913 shares of its common stock to Fleming PLLC at a price of $0.0625 per share, for an aggregate value of $54,432.

In addition, the Company had executed a non-exclusive license agreement with LocusX Technologies Inc. on September 25, 2025, pursuant to which the Company agreed to issue 500,000 common shares as consideration for a $50,000 license fee, with such shares to be issued within 180 days of the effective date. Subsequently, on December 8, 2025, the Company issued 500,000 shares of its common stock at a price of $0.10 per share, for an aggregate value of $50,000.

On September 10, 2025, the Company received $400,000 in cash in connection with shares subscription. Subsequent to September 30, 2025, on November 30, 2025, the Company issued an aggregate of 6,400,000 shares of common stock at a price of $0.0625 per share, including 6,080,000 shares to OutstandingX LLC and 320,000 shares to John Tam, in settlement of this subscription.

On October 3, 2025, the Company entered into a consulting agreement with Soho Capital Solutions Inc. to provide financial reporting pre-audit compliance support, as well as financial and advisory services. In consideration for these services, the Company agreed to pay 70% in cash and 30% in common stock. On November 30, 2025, the Company issued 33,360 shares of its common stock, valued at $0.0625 per share, to Soho Capital Solutions Inc. pursuant to the agreement.

On November 11, 2025, the Company entered into an Exclusive Management Cooperation Agreement through DentonX Outstanding Investment Co. ("DentonX OIC"), a Wyoming corporation to be formed and majority-owned by the Company, with Outstanding Investment Co., Inc. ("OIC"). Under the agreement, DentonX OIC was granted exclusive authority to manage and direct OIC's business operations and financial decisions, while OIC retains all regulatory licenses and compliance responsibilities. OIC agreed to pay DentonX OIC a monthly management fee equal to 5% of existing business and 10% of new business, as well as a performance participation fee ranging from 5% to 20% of net profits attributable to new business developed under DentonX OIC's management.

On January 1, 2026, Luis Carlos Ung resigned from his position as Chief Executive Officer of the Company.

On November 11, 2025, DentonX Outstanding Investment Co. ("DentonX OIC") entered into a Lease Agreement with Purchase Option with Outstanding Investment Co., Inc. ("OIC"). The agreement provides for the lease of OIC's pre-closing existing business assets, including brand, systems, client base, and know-how, to DentonX OIC for an initial three-year term, renewable for an additional three years, in exchange for monthly lease payments approximating

------

OIC's historical profits from the existing business and adjusted annually for inflation (lesser of 4% or CPI-U). The agreement also grants DentonX OIC an exclusive option to purchase certain leased assets after one year at 8× trailing twelve-month EBITDA.

On January 10, 2026, DentonX Outstanding Investment Co. ("DentonX OIC") entered into an Equity and Vesting Agreement with Outstanding Investment Co., Inc. ("OIC"), dated November 11, 2025. Pursuant to the agreement, DentonX OIC agreed to issue equity representing 20% of its fully diluted share capital to OIC and its principals, contingent upon the closing of a strategic transaction relating to the lease and potential acquisition of certain OIC business assets. The equity award vests over a 36-month period in equal quarterly installments and provides for accelerated vesting upon a change of control or a public offering. The agreement includes customary transfer restrictions and forfeiture provisions.

On January 10, 2026, the Company entered into a Share Grant Agreement with Outstanding Investment Co., Inc. ("OIC") and its designated key person(s), dated November 11, 2025. Pursuant to the agreement, the Company agreed to grant 360 Series B Preferred Shares to certain key person(s), contingent upon the closing of a strategic transaction involving the formation of DentonX Outstanding Investment Co. as a majority-owned subsidiary, the lease and potential acquisition of certain OIC business assets, and related equity issuances. The shares vest over a three-year period in equal quarterly installments, subject to continued service, with accelerated vesting upon a change of control or a public offering. The agreement includes customary forfeiture and transfer restriction provisions.

On January 10, 2026, the Company entered into an Investment Rights Agreement with Outstanding Investment Co., Inc. ("OIC") and/or its principals, dated November 11, 2025. Under the agreement, OIC was granted the right to purchase up to 10% of the Company's outstanding shares at the closing date at a 15% discount to the 30-day volume-weighted average price, exercisable within twelve months following the closing of a strategic transaction involving the formation of DentonX Outstanding Investment Co., the lease and potential acquisition of certain OIC business assets, and related equity issuances. The agreement also provides OIC with customary participation and registration rights and includes transfer restrictions.

On January 10, 2026, the Company, Outstanding Investment Co., Inc. (OIC") and its principals, and DentonX Outstanding Investment Co. ("DentonX OIC" Not Incorporated) entered into a Shareholders Agreement, dated November 11, 2025, governing the ownership and management of DentonX OIC. The agreement provides for the issuance of 20% of DentonX OIC's fully diluted equity to OIC, subject to a 36-month quarterly vesting schedule with acceleration upon a change of control or initial public offering, and includes customary governance rights, transfer restrictions, and shareholder protections.

On January 20, 2026, the Company received $10,000 from an investor pursuant to an investment agreement dated December 03, 2025. The investment is structured as $8,000 of convertible debt and the issuance of 2,000 common shares at $1 per share. The "Conversion Price" shall equal eighty percent (80%) of the price per share or per unit paid by cash investors in the Qualified Financing (20% discount), or, if applicable, the price determined pursuant to the Valuation Cap.

------

**DentonX Inc**

**Condensed Balance Sheet**

---

| | | |
|:---|:---|:---|
|  | **As of**<br> **December 31, 2025** | **As of**<br> **September 30, 2025** |
|  | (Unaudited) |  |
| **Assets** |  |  |
| **Current Assets** |  |  |
| Cash and Bank | $135550 | $359981 |
| Prepaid expense | 91859 | 40000 |
| **Total Current Assets** | **227409** | **399981** |
| **Total Assets** | **$227409** | **$399981** |
| **Liabilities and Stockholder's (Deficit) Equity** |  |  |
| **Current Liabilities:** |  |  |
| Accounts Payable | $563 | $45 |
| Due to Related Parties | 596534 | 232285 |
| **Total Current Liabilities** | **597097** | **232330** |
| **Total Liabilities** | **597097** | **232330** |
| **Contingencies And Commitments** | **-** | **-** |
| **Stockholders' (Deficit) Equity:** |  |  |
| Common stock $0.0001 par value; 800,000,000 shares authorized;<br> 18,789,173 and 9,789,900 shares were issued and outstanding as of<br> December 31, 2025, and September 30, 2025, respectively. | 1879 | 979 |
| Preferred stock $0.0001 par value; 200,000,000 shares authorized;<br> No shares were issued and outstanding as of December 31, 2025,<br> and September 30, 2025, respectively. | - | - |
| Additional Paid-in Capital | 580305 | - |
| Subscription Receivable | - | (660) |
| Advance from share issuance | - | 400000 |
| Accumulated Deficit | (951871) | (232669) |
| **Total Stockholders' (Deficit) Equity** | **(369687)** | **167650** |
| **Total Liabilities and Stockholder's (Deficit) Equity** | **$227409** | **$399981** |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

------

**DentonX Inc**

**Unaudited Condensed Statement of Operations**

---

| | | |
|:---|:---|:---|
|  | **For the Period of Three Months Ended December 31, 2025** | **For the period from September 3, 2025 (Inception) to September 30, 2025** |
|  | **(USD)** | **(USD)** |
| **Revenue** | - | - |
| **Expenses** |  |  |
| License Fee | $50000 | $- |
| Consulting | 69738 | 6880 |
| Legal and Professional Services | 592974 | 225751 |
| Software and Subscriptions | - | 18 |
| Travel | 6300 | - |
| Bank Fees & Service Charges | 246 | 40 |
| **Total Expenses** | **719258** | **232689** |
| **Loss from Operations** | **(719258)** | **(232689)** |
| **Other Income (Expense)** |  |  |
| Interest Income | 55 | 21 |
| **Loss Before Provision for Income Taxes** | **(719203)** | **(232669)** |
| Provision for Income Taxes | - | - |
| **Net Loss** | **$(719203)** | **$(232669)** |
| Net loss per share - Basic and diluted | $(0.05) | $(0.03) |
| Weighted average shares outstanding - Basic and Diluted | 13406712 | 8043489 |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

------

**DentonX Inc**

**Unaudited Condensed Statement of changes in Stockholders' (deficit) Equity**

**For the Period from September 3, 2025 (Inception) to September 30, 2025, and for the Three Months Ended December 31, 2025**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | **Preferred stock** | **Preferred stock** | **Advance**<br> **against**<br> **issue of**<br> **shares** | **Subscription**<br> **Receivable** | **Additional**<br> **Paid-In-**<br> **Capital** | **Accumulated**<br> **Deficit** | **Total** |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Amount** | **Amount** | **Amount** | **Amount** | **Amount** |
| Balance on September 03, 2025 (inception) | - | $- | - | $- | $- | $- | $- | $- | $- |
| Issuance of Common Stock to founders | 3189900 | 319 | - | - | - |  | - |  | 319 |
| Sales of common stock for cash | 6600000 | 660 |  |  | - | (660) |  |  | - |
| Advance against issue of shares |  |  |  |  | 400000 |  |  |  | 400000 |
| Net Loss |  |  |  |  |  |  |  | (232669) | (232669) |
| Balance as of September 30, 2025 | 9789900 | 979 | - | - | 400000 | (660) | - | (232669) | 167650 |
| Balance as of October 01, 2025 | 9.789900 | 979 | - | - | 400000 | (660) | - | (232669) | 167650 |
| Issuance of Common Stock against services | 2599273 | 260 | - | - | - |  | 180945 |  | 181205 |
| Proceed against the sale of common stock |  |  |  |  | - | 660 |  |  | 660 |
| Issuance of shares against advance | 6400000 | 640 | - | - | (400000) |  | 399360 |  | - |
| Net Loss |  |  |  |  |  |  |  | (719203) | (719203) |
| Balance as of December 31, 2025, | 18789173 | $1879 | - | $- | $- | $- | $580305 | $(951871) | $(369688) |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

------

**DentonX Inc**

**Unaudited Condensed Statement of Cash Flows**

---

| | | |
|:---|:---|:---|
|  | **For the Period of Three Months Ended December 31, 2025** | **For the period from September 03, 2025, (Inception) to September 30, 2025** |
|  | **(USD)** | **(USD)** |
| **Cash flows from operating activities** |  |  |
| Net (loss)/ Income | $(719203) | $(232669) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| Issuance of Common Stock against services | 181205 | 319 |
| **Net change in operating assets and liabilities:** |  |  |
| Due to Related Party | 364249 | 232285 |
| Accounts payable | 518 | 45 |
| Prepaid expense | (51860) | (40000) |
| **Net Cashflow used in operating activities** | **(225091)** | **(40019)** |
| **Cashflow from financing activities** |  |  |
| Proceeds against the issued shares | 660 | 400000 |
| **Net Cashflow from financing activities** | **660** | **400000** |
| **Net increase (decrease) in Cash** | **(224431)** | **359981** |
| Cash at beginning of the period | $359981 | $- |
| **Cash at the end of the period** | **$135550** | **$359981** |
| **Supplemental cash flow information:** |  |  |
| Cash paid for interest | - | - |
| Cash paid for Income Taxes | - | - |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

------

**DentonX Inc**

**Notes to Unaudited Condensed Financial Statements**

**For the period of three months ended December 31, 2025**

**NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS**

DentonX Inc ("DentonX" or "the Company") was incorporated in the State of Wyoming on September 3, 2025. The Company provides end-to-end data infrastructure and automation tools that support modern lending ecosystems. DentonX's platform enables non-bank lenders, financial institutions, and credit platforms to operate with greater speed, accuracy, and confidence, regardless of the complexity of their loan portfolios. The Company's solutions integrate data management, workflow automation, and analytical capabilities to streamline lending operations, enhance decision-making, and improve operational efficiency. As a development-stage company, DentonX is currently focused on building its platform, developing technology solutions, and preparing for commercial deployment. The Company's operations are designed to support scalable lending activities and provide advanced automation tools for financial services organizations.

**Going Concern Consideration:**

The Company's unaudited financial statements as of December 31, 2025, have been prepared using generally accepted accounting principles in the United States of America ("GAAP") applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The Company has accumulated losses as of December 31, 2025, totaling $951,871. These factors, among other, raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period. The company plans to raise capital through private placement or borrowing arrangements. As of the issuance of these financial statements, the Company has not commenced operations. The Company has financed its activities through equity financing. Management expects to commence operations in the third quarter of 2026.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plan is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its minimal operating expenses and seeking third-party equity and/or debt financing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

**NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Basis of Presentation**

The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the rules and regulations of the SEC. "The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and in accordance with Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company's prospectus for its Initial Public Offering included in this Form S-1, The interim results for the three months ended December 31, 2025, are not necessarily indicative of the results for any future periods.

------

**Emerging Growth Company**

The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

**Use of Estimates**

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

**Liquidity and Capital Resources Note**

As of December 31, 2025, the Company had cash of $135,550 and working capital of $(369,687).

In connection with the Company's assessment of going concern considerations in accordance with ASC 205-40, "Presentation of Financial Statements - Going Concern," as of December 31, 2025, the Company does believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the Company does not raise sufficient capital to meet its business objectives, the Company has insufficient funds available to operate its business prior over the next twelve months."

**Cash and Cash Equivalents**

Cash and cash equivalents consist of cash on hand and demand deposits with financial institutions, as well as all highly liquid investments with original maturities of three months or less at the time of purchase. Cash and cash equivalents are carried at cost, which approximates fair value. The Company maintains its cash balances at financial institutions, which at times may exceed federally insured limits; however, management does not believe the Company is exposed to significant credit risk related to these balances.

The Federal Deposit Insurance Corporation ("FDIC") insures deposits up to $250,000 per depositor, per insured bank. As of December 31, 2025, the Company maintained cash and cash equivalents totaling $135,550. The Company's cash balances did not exceed FDIC insurance limits as of that date.

**Fair Values of Financial Instrument**

The Company's financial instruments include cash and cash equivalents, accounts receivable, prepaid expenses, accounts payable, accrued expenses, and other current liabilities. The carrying amounts of these financial instruments approximate their fair values due to their short-term maturity. The Company does not hold any financial instruments that are required to be measured at fair value on a recurring basis. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

------

**Prepaid Expense**

Prepaid expenses represent payments made in advance for goods or services to be received in future periods and are recorded as assets until the related benefits are consumed. Prepaid expenses are amortized to operating expenses on a straight-line basis over the period to which the related benefits apply.

**Income Taxes**

The Company complies with the accounting and reporting requirements of ASC Topic 740, "Income Taxes," which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company's management determined that the United States is the Company's only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of December 31, 2025, and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

The Company may be subject to potential examination by United States taxing authorities in income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with United States tax laws. The Company's management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is incorporated in the United States and is subject to U.S. federal and applicable state income tax laws. The Company has no operations or taxable presence in any other jurisdiction. Due to operating losses incurred during the periods presented, the Company did not recognize any provision for income taxes and had no current income tax expense. Accordingly, the Company's tax provision was zero for the periods presented.

**Net Loss Per Share**

Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period in accordance with ASC 260, Earning per Share. For the period from October 01, 2025, to December 31, 2025, the weighted average number of shares outstanding was 13,406,712 ordinary shares. There were no securities that could potentially dilute income (loss) per share in the future.

**Stock-based Compensation**

The Company follows ASC 718-10, Stock Compensation, which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options.

**Segment Reporting**

ASC Topic 280, Segment Reporting, establishes standards for companies to report, in their financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company's chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

------

The Company's CODM has been identified as the Chief Financial Officer, who reviews the assets, operating results and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment.

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as net income or loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the Company's performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

---

| | |
|:---|:---|
|  | **December 31, 2025** |
| Cash and bank | $359981 |
| Prepaid expense | 40000 |
| Total Assets | $399981 |
|  | **For the period of**<br> **Three months ended**<br> **December 31, 2025** |
|  | **For the period of**<br> **Three months ended**<br> **December 31, 2025** |
| Consulting | $(6880) |
| Legal and professional | (225751) |
| Other expense | (58) |
| License Fee |  |
| Interest income | 20 |
| Net loss | $(232669) |

---

**Recently Issued Accounting Standards**

In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on December 4, 2024, its date of incorporation.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. This ASU is effective for fiscal years beginning after December 15, 2024, and allows for adoption on a prospective basis, with a retrospective option. We are currently evaluating the impacts of the new standard.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

**Dividend Policy**

We have not paid any cash dividends to shareholders. The declaration of any future cash dividends is at the discretion of our board of directors and depends upon our earnings, if any, our capital requirements and financial position, general economic conditions, and other pertinent conditions. It is our present intention not to pay any cash dividends in the foreseeable future, but rather to reinvest earnings, if any, in our business operations.

------

**NOTE 3. STOCKHOLDERS DEFICIT**

Common and Preferred Stock

Authorized: 800,000,000 shares of voting common stock with a par value of $0.0001, 200,000,000 shares of preferred stock with a par value of $0.0001. As of December 31, 2025, the Company had 18,789,173 shares of common stock issued and outstanding. No preferred stock is issued as of December 31, 2025.

For the period from inception (September 03, 2025) to December 31, 2025, the Company engaged in the following equity events:

Sale of Common Stock and Subscriptions

On September 08, 2025, the Company issued 6,600,000 shares of the Company's common stock to investor Alphega Global Partners Inc. for an aggregate purchase price of $660. The Company booked these transactions as subscription receivable as of September 30, 2025. The Company received proceeds of $100 from investor Alphega Global Partners Inc. on November 28, 2025, and $560 on December 9, 2025. As of December 31, 2025, no subscription receivable remained outstanding.

On November 30, 2025, the Company issued an aggregate of 6,400,000 shares of common stock at a price of $0.0625 per share, including 6,080,000 shares to OutstandingX LLC and 320,000 shares to John Tam, in settlement of amount $400,000 that was previously received and recorded as advances against the issuance of common stock.

Shares issued to initial founders

During the period from September 3, 2025, to September 30, 2025, the Company has issued the common shares at a par value of $0.0001 per share to its founders in exchange for services rendered. Details are as follows;

---

| | | | |
|:---|:---|:---|:---|
| **Date of Issuance** | **Recipient** | **Number of Shares** | **Purpose** |
| 9/3/2025 | Irene Ying Ying Chung | 10000 | As compensation for services rendered in connection with corporate administration, documentation management, treasury support, and the direction and supervision of the Company's executive management. |
| 9/8/2025 | Cintron Management Ltd. | 179900 | In consideration of costs, expenditures, and other contributions of value made on behalf of the Company. |
| 9/8/2025 | Fairbanks Global Partners II LLC | 1500000 | In consideration of costs, expenditures, and other contributions of value made on behalf of the Company. |
| 9/8/2025 | Apex Stratum LLC | 1500000 | In consideration of costs, expenditures, and other contributions of value made on behalf of the Company. |
|  | **Total shares issued against services** | **3189900** |  |

---

Shares issued against for services

On October 15, 2025, the Company's common stock had a fair value of $0.0625 per share. The Company issued common shares to its executives on that date in exchange for services rendered. The Company recognized stock-based compensation expense based on the fair value of the common stock on the grant date. The fair value was determined based on sale of common shares to a third party.

------

The expense is included in consulting expenses in the accompanying statement of financial operations. Details of the issuance are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Date of**<br> **Issuance** | **Recipient** | **Number**<br> **of Shares** | **Stock based**<br> **compensation** | **Purpose** |
| 10/15/2025 | Irene Ying Ying Chung | 495000 | $30938 | As compensation for services rendered in connection with corporate administration, documentation management, treasury support, and the direction and supervision of the Company's executive management. |
| 10/15/2025 | Luis Carlos Ung | 500000 | $31250 | As compensation for services rendered in providing executive leadership, strategic advisory services, and the direction and oversight of the Company's Board of Directors. |
| 10/15/2025 | Lionel Pinuer E | 200000 | $12500 | As compensation for services rendered in providing strategic advisory and business planning support, market, industry, and opportunity analysis, business development and partnership support, operational and organizational guidance, capital strategy input and investor-related preparation. |
| 11/30/2025 | Soho Capital Solutions Inc | 33360 | $2085 | As compensation for services rendered to the Company during October and November 2025. |
| 11/30/2025 | Fleming PLLC | 870913 | $54432 | As consideration for legal services. |
| 12/8/2025 | LocusX Technologies Inc. | 500000 | $50000 | For License Fee |
|  | **Total shares issued against for services** | **2599273** | **$181205** |  |

---

**NOTE 4. RELATED PARTY TRANSACTIONS**

The related parties had transactions for the period of three months ended December 31, 2025, consisting of the following:

---

| | | | |
|:---|:---|:---|:---|
| **Name of the related parties** | **Nature of relationship** |  |  |
| Fairbanks Global Partners II LLC | Shareholder |  |  |
| Irene Ying Ying Chung | Shareholder |  |  |
| Alphega Global Partners Corp | Shareholder |  |  |
| Lionel Pinuer E. | Shareholder |  |  |
| Luis Carlos Ung | Shareholder |  |  |
| Far Sun Global Group | Shareholder |  |  |
| **Accrued Services** |  | **December 31, 2025** | **September 30, 2025** |
| Irene Ying Ying Chung |  | $1929 | $6879 |
| Fairbanks Global Partners II LLC |  | $308615 | $184606 |
| Far Sun Global Group |  | $141490 | $- |
| Alphega Global Partners Corp |  | $144500 | $40800 |
| **Total Due to related party** |  | **$596534** | **$232285** |

---

As of December 31, 2025, balances due to related parties primarily represent the consulting and professional services provided by the shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On October 15, 2025, the Company's common stock had a fair value of $0.0625 per share. The Company issued 495,000 shares of its common stock to Irene Ying Ying Chung on that date in exchange for services rendered. The Company recognized stock based compensation expense based on the fair value of common stock on the grant date of valued at $30,938.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●During the three months ended December 31, 2025, the Company made cash payments of $123,300 to Fairbanks Global Partners II LLC for services rendered.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On October 15, 2025, the Company's common stock had a fair value of $0.0625 per share. The Company issued 200,000 shares of its common stock to Lionel Pinuer E on that date in exchange for services rendered. The Company recognized stock based compensation expense based on the fair value of common stock on the grant date of valued at $12,500.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●On October 15, 2025, the Company's common stock had a fair value of $0.0625 per share. The Company issued 500,000 shares of its common stock to Luis Carlos Ung on that date in exchange for services rendered. The Company recognized stock based compensation expense based on the fair value of common stock on the grant date of value $31,250.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●During the period, the Company remitted aggregate cash payments of $66,600 to Far Sun Global Group for services rendered to the Company.

**NOTE 5 INCOME TAX**

As of December 31, 2025, we had net operating loss carry forwards, on a book basis, of $719,203 that may be available to reduce various future years' Federal taxable income for 20 years through 2045. Net operating losses may be limited as a result of possible changes in business. Future tax benefits which may arise because of these losses have not been recognized in the accompanying financial statements, as their realization is determined not likely to occur and accordingly, we have recorded a valuation allowance for the deferred tax asset relating to the net operating loss carry forwards.

The following table presents the current income tax provision for federal and state income taxes for the period ended December 31, 2025.

---

| | |
|:---|:---|
|  | **For the period of three months ended December 31, 2025** |
| Current tax provisions: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Federal | $– |
| &nbsp;&nbsp;&nbsp;&nbsp;State | – |
| Total provision for income taxes | $– |

---

Reconciliation of the U.S. federal statutory rate to the actual tax rate for the period ended December 31, 2025:

---

| | |
|:---|:---|
|  | **For the period of three months ended December 31, 2025** |
| US federal statutory income tax rate | 21% |
| State income tax, net of federal benefit | 0% |
| Permanent differences | 0% |
| Increase in valuation reserve | -21% |
| Total provision for income taxes | 0% |

---

The components of our deferred tax assets as of December 31, 2025, consisted of the following:

---

| | |
|:---|:---|
|  | **December 31,**<br> **2025** |
| Net operating loss carry forwards | $151032 |
| Less: valuation allowance | (151032) |
| Net deferred tax assets | $- |

---

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences will become deductible. The Company has recorded a full valuation allowance against its net deferred tax assets because management has determined that it is more likely than not that these assets will not be realized.

------

**NOTE 6. CONITNGENCIES AND COMMITMENTS**

There are no contingencies and commitments at balance sheet date.

**NOTE 7. SUBSEQUENT EVENTS**

In accordance with ASC Topic 855, "Subsequent Events", which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date and through the date of this filing. The Company has reviewed subsequent events occurring after the balance sheet date and has determined that these events necessitate adjustments to or disclosure in the accompanying financial statements.

On January 1, 2026, Luis Carlos Ung resigned from his position as Chief Executive Officer of the Company.

On January 10, 2026, DentonX Outstanding Investment Co. ("DentonX OIC") entered into an Equity and Vesting Agreement with Outstanding Investment Co., Inc. ("OIC"), dated November 11, 2025. Pursuant to the agreement, DentonX OIC agreed to issue equity representing 20% of its fully diluted share capital to OIC and its principals, contingent upon the closing of a strategic transaction relating to the lease and potential acquisition of certain OIC business assets. The equity award vests over a 36-month period in equal quarterly installments and provides for accelerated vesting upon a change of control or a public offering. The agreement includes customary transfer restrictions and forfeiture provisions.

On January 10, 2026, the Company entered into a Share Grant Agreement with Outstanding Investment Co., Inc. ("OIC") and its designated key person(s), dated November 11, 2025. Pursuant to the agreement, the Company agreed to grant 360 Series B Preferred Shares to certain key person(s), contingent upon the closing of a strategic transaction involving the formation of DentonX Outstanding Investment Co. as a majority-owned subsidiary, the lease and potential acquisition of certain OIC business assets, and related equity issuances. The shares vest over a three-year period in equal quarterly installments, subject to continued service, with accelerated vesting upon a change of control or a public offering. The agreement includes customary forfeiture and transfer restriction provisions.

On January 10, 2026, the Company entered into an Investment Rights Agreement with Outstanding Investment Co., Inc. ("OIC") and/or its principals, dated November 11, 2025. Under the agreement, OIC was granted the right to purchase up to 10% of the Company's outstanding shares at the closing date at a 15% discount to the 30-day volume-weighted average price, exercisable within twelve months following the closing of a strategic transaction involving the formation of DentonX Outstanding Investment Co., the lease and potential acquisition of certain OIC business assets, and related equity issuances. The agreement also provides OIC with customary participation and registration rights and includes transfer restrictions.

On January 10, 2026, the Company, Outstanding Investment Co., Inc. ("OIC") and its principals, and DentonX Outstanding Investment Co. ("DentonX OIC") entered into a Shareholders Agreement, dated November 11, 2025, governing the ownership and management of DentonX OIC. The agreement provides for the issuance of 20% of DentonX OIC's fully diluted equity to OIC, subject to a 36-month quarterly vesting schedule with acceleration upon a change of control or initial public offering, and includes customary governance rights, transfer restrictions, and shareholder protections.

On January 20, 2026, the Company received $10,000 from an investor pursuant to an investment agreement dated 3 December 2025. The investment is structured as $8,000 of convertible debt and the issuance of 2,000 common shares at $1 per share. The "Conversion Price" shall equal eighty percent (80%) of the price per share or per unit paid by cash investors in the Qualified Financing (20% discount), or, if applicable, the price determined pursuant to the Valuation Cap.

------

**PART II. INFORMATION NOT REQUIRED IN PROSPECTUS**

**OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION**

The estimated costs (assuming all shares are sold) of this offering are as follows:

---

| | |
|:---|:---|
| SEC Registration Fee | $2296.50 |
| Accounting fees and expenses | 15000.00 |
| Legal Fees, Auditor Fees and Expenses | 25000.00 |
| Edgar filing, printing and engraving fees | 1500.00 |
| Transfer Agent Fees | 1000.00 |
| Total | $44795.50 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)All amounts are estimates, other than the SEC's registration fee. The above expenses are to be paid by the Company.

**INDEMNIFICATION OF DIRECTOR AND OFFICERS**

The Company is incorporated under the laws of the State of Wyoming. Section 17-16-856 of the Wyoming Business Corporation Act provides that a Wyoming corporation shall have the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that such person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person's conduct was unlawful.

Section 17-16-857 of the Wyoming Business Corporation Act further provides mandatory indemnification and advancement of expenses to a director or officer who has been wholly successful, on the merits or otherwise, in the defense of any such proceeding, and permits advancement of expenses upon receipt of an undertaking by or on behalf of the director or officer to repay such amount if it shall ultimately be determined that such person is not entitled to indemnification.

Our Amended and Restated Bylaws contain provisions that implement the maximum indemnification and advancement of expenses permitted by Wyoming law. These provisions provide, in relevant part, as follows:

Every person who was or is a party or is threatened to be made a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she, or a person of whom he or she is the legal representative, is or was a director or officer of the Company or is or was serving at the request of the Company as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, shall be indemnified and held harmless by the Company to the fullest extent legally permissible under the Wyoming Business Corporation Act, as the same exists or may hereafter be amended, against all expenses, liability and loss (including attorneys' fees, judgments, fines, ERISA excise taxes or penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by such person in connection therewith. Such right of indemnification shall be a contract right and shall include the right to be paid by the Company the expenses incurred in defending any such proceeding in advance of its final disposition; provided, however, that the payment of such expenses incurred by a director or officer in advance of the final disposition of such proceeding shall be made only upon delivery to the Company of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined by a court of competent jurisdiction that such director or officer is not entitled to be indemnified under Wyoming law or otherwise.

The rights conferred above shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, bylaw, agreement, vote of stockholders or disinterested directors or otherwise. The indemnification and advancement of expenses provided by or granted pursuant to our Bylaws shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors and administrators of such person.

------

The Company may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company in such capacity for another entity, against any liability asserted against such person and incurred by such person in any such capacity, whether or not the Company would have the power to indemnify such person against such liability under the provisions of the Wyoming Business Corporation Act.

Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended (the "Securities Act"), may be permitted to directors, officers or persons controlling the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

**RECENT SALES OF UNREGISTERED SECURITIES**

The following information is furnished with regard to all securities issued by the registrant within the last three years that were not registered under the Securities Act of 1933, as amended. Unless otherwise indicated below, the issuance of such shares was deemed exempt from registration requirements of the Securities Act of 1933, as amended, as such sales were exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 of Regulation D promulgated thereunder.

On September 3, 2025, the Company issued 10,000 shares of common stock to Irene Ying Ying Chung, in consideration of incorporation costs incurred on behalf of the Company.

On September 8, 2025, the Company issued the following shares of common stock:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●6,600,000 common to AG Partners I Inc. for cash at a per share price of $0.0001.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●1,500,000 common to Apex Stratum LLC at a per share price of $0.0001 in consideration of costs, expenditures, and other contributions of value made on behalf of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●1,500,000 Common to Fairbanks Global Partners II LLC at a per share price of $0.0001 per share in consideration of costs, expenditures, and other contributions of value made on behalf of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●179,900 Common Stock to Cintron Management Ltd. at a per share price of $0.0001 per share in consideration of costs, expenditures, and other contributions of value made on behalf of the Company.

On October 15, 2025, the Company issued the following shares of common stock:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●500,000 Common Stock to Luis Carlos Ung at a price of $0.0625 per share, as compensation for services rendered to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●495,000 Common Stock to Irene Ying Ying Chung at a price of $0.0625 per share, as compensation for services rendered to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;●200,000 Common Stock to Lionel Pinuer E. at a price of $0.0625 per share, as compensation for services rendered to the Company.

The Company entered into an engagement agreement with Fleming PLLC dated October 23, 2025, whereby it issued 870,913 shares of its common stock as consideration for legal services at a per share price of $0.0625 per share.

On November 30, 2025, the Company issued 6,080,000 shares of common stock to OutstandingX LLC pursuant to a subscription agreement for cash at $0.0625 per share and 320,000 shares of common stock for cash to John Tam pursuant to a subscription agreement at $0.0625 per share.

On November 30, 2025, the Company hereby issued 33,360 shares of common stock to Soho Capital Solutions Inc at a price of $0.0625 per share, as compensation for services rendered to the Company during October and November 2025.

------

The Company issued 500,000 shares of its common stock to LocusX Technologies Inc. at a price of $0.10 per share, in satisfaction of the license fee owed under the license agreement between the Company and LocusX Technologies Inc

**EXHIBITS TO REGISTRATION STATEMENT**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [3.1](dtnx_ex31.htm) | Amended and Restated Articles of Incorporation  |
| [3.2](dtnx_ex32.htm) | Amended and Restated By-laws  |
| [5.1](dtnx_ex51.htm) | Opinion of Fleming PLLC |
| [10.1](dtnx_ex101.htm) | Consulting Agreement between DentonX Inc and Lionel Pinuer dated September 10, 2025 |
| [10.2](dtnx_ex102.htm) | Consulting Agreement between DentonX Inc and Luis Carlos Ung September 3, 2025 |
| [10.3](dtnx_ex103.htm) | Amended and Restated Consulting Agreement between DentonX Inc and Fairbanks Global Partners II LLC dated September 23, 2025 |
| [10.4](dtnx_ex104.htm) | Technical Consulting Agreement between DentonX Inc and LocusX Technologies Inc. dated September 25, 2025 |
| [10.5](dtnx_ex105.htm) | Non-Exclusive Licensing Agreement between DentonX Inc and LocusX Technologies Inc. dated September 25, 2025 |
| [10.6](dtnx_ex106.htm) | Exclusive Management Cooperation Agreement between DentonX Outstanding Investment Co. and Outstanding Investment Co., Inc. dated November 11, 2025 |
| [10.](dtnx_ex107.htm)[7](dtnx_ex107.htm) | Lease Agreement between DentonX Outstanding Investment Co. and Outstanding Investment Co., Inc. dated November 11, 2025 |
| [10.](dtnx_ex108.htm)[8](dtnx_ex108.htm) | Equity and Vesting Agreement between DentonX Outstanding Investment Co. and Outstanding Investment Co., Inc. dated November 11, 2025 |
| [10.](dtnx_ex109.htm)[9](dtnx_ex109.htm) | DentonX Share Grant Agreement between DentonX Inc. and Outstanding Investment Co., Inc. dated November 11, 2025 |
| [10.1](dtnx_ex1010.htm)[0](dtnx_ex1010.htm) | Investment Rights Agreement between DentonX Inc. and Outstanding Investment Co., Inc. dated November 11, 2025 |
| [10.1](dtnx_ex1011.htm)[1](dtnx_ex1011.htm) | Shareholders Agreement between DentonX Inc., DentonX Outstanding Investment Co. and Outstanding Investment Co., Inc. dated November 11, 2025 |
| [10.1](dtnx_ex1012.htm)[2](dtnx_ex1012.htm) | Master Services Agreement dated November 26, 2025 between DentonX Inc. and Alphega Global Partners Corp. |
| [10.1](dtnx_ex1013.htm)[3](dtnx_ex1013.htm) | Strategic Business Consulting Agreement dated September 27, 2025 between DentonX Inc. and Far Sun Global Group LLC |
| [23.1](dtnx_ex231.htm) | Consent of RBSM LLP |
| [23.2](dtnx_ex51.htm) | Consent of Fleming PLLC (included as part of Exhibit 5.1) |
| [99.1](dtnx_ex991.htm) | Form of Subscription Agreement  |
| 107 | Calculation of Filing Fee Tables  |

---

------

**UNDERTAKINGS**

The undersigned Registrant hereby undertakes:

(a)(1)To file, during any period in which offers or sales of securities are being made, a post-effective amendment to this registration statement to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) (§230.424(b) of this chapter) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

(2)That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(4)That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

(5)That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or our securities provided by or on behalf of the undersigned registrant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

------

Insofar as indemnification for liabilities arising under the Securities Act of 1933 (the "Act") may be permitted to our directors, officers and controlling persons pursuant to the provisions above, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable.

In the event that a claim for indemnification against such liabilities, other than the payment by us of expenses incurred or paid by one of our directors, officers, or controlling persons in the successful defense of any action, suit or proceeding, is asserted by one of our directors, officers, or controlling persons in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification is against public policy as expressed in the Securities Act, and we will be governed by the final adjudication of such issue.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, at the location of Oakland, California on March 20, 2026.

**DentonX Inc**

By: */s/ Lionel Pinuer*

Name: Lionel Pinuer

Title: Chief Executive Officer and Chief Financial Officer

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| */s/ Lionel Pinuer* | Chief Executive Officer and Chief Financial Officer | March 20, 2026 |
| Lionel Pinuer |  |  |
| */s/ Luis Carlos Ung* | Director, President and Secretary | March 20, 2026 |
| Luis Carlos Ung |  |  |

---

------

## Exhibit 3.1

**AMENDED AND RESTATED**

**ARTICLES OF INCORPORATION OF**

**DENTONX INC.**

Pursuant to the provisions of the Wyoming Business Corporation Act (Wyo. Stat. Ann. §§ 17-16- 101 *et seq.*), the undersigned corporation adopts the following Amended and Restated Articles of Incorporation, which supersede and replace the original Articles of Incorporation filed with the Wyoming Secretary of State on September 3, 2025. The original Articles of Incorporation were executed and filed by Irene Ying Ying Chung as the sole incorporator.

**ARTICLE I**

**NAME**

The name of the corporation is DentonX Inc. (the "Corporation").

**ARTICLE II**

**REGISTERED AGENT AND REGISTERED OFFICE**

The name and physical address of the registered agent of the Corporation is: Vcorp Agent Services, Inc., 2232 Dell Range Blvd, Suite 200, Cheyenne, WY 82009.

The Corporation may change its registered agent or registered office in accordance with the Wyoming Registered Offices and Agents Act (Wyo. Stat. Ann. §§ 17-28-101 *et seq.*).

**ARTICLE III**

**MAILING ADDRESS AND PRINCIPAL OFFICE**

The mailing address of the Corporation is:

1999 Harrison Street, Suite 1800

Oakland, CA 94612

The principal office address of the Corporation is:

1999 Harrison Street, Suite 1800

Oakland, CA 94612

The Corporation may have such other offices, either within or without the State of Wyoming, as the Board of Directors may designate or as the business of the Corporation may require from time to time.

**ARTICLE IV PURPOSE**

------

The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the Wyoming Business Corporation Act.

**ARTICLE V**

**AUTHORIZED CAPITAL STOCK**

The total number of shares of all classes of capital stock that the Corporation shall have authority to issue is One Billion (1,000,000,000) shares, consisting of:

(a)Eight Hundred Million (800,000,000) shares of Common Stock, par value $0.0001 per share (the "Common Stock"); and

(b)Two Hundred Million (200,000,000) shares of Preferred Stock, par value $0.0001 per share (the "Preferred Stock").

**Section 5.1 Common Stock**

Each holder of Common Stock shall be entitled to one (1) vote for each share held on all matters submitted to a vote of shareholders. Subject to the preferences applicable to any series of Preferred Stock outstanding at any time, the holders of Common Stock shall be entitled to receive such dividends and other distributions in cash, property or shares of stock of the Corporation as may be declared thereon from time to time by the Board of Directors out of assets or funds of the Corporation legally available therefor. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, after payment or provision for payment of the debts and other liabilities of the Corporation and the preferential amounts to which the holders of any outstanding series of Preferred Stock may be entitled, the remaining assets of the Corporation shall be distributed ratably to the holders of the Common Stock.

The shareholders of the Corporation shall not have the right to cumulate their votes in the election of directors.

**Section 5.2 Preferred Stock**

The Preferred Stock may be issued from time to time in one or more series. The Board of Directors is hereby expressly authorized, without further action or vote of the shareholders (unless required by applicable law or the terms of any outstanding series of Preferred Stock), to provide for the issue of all or any of the shares of the Preferred Stock in one or more series, and to fix for each such series the number of shares thereof and such voting powers (full or limited, or no voting powers), and such designations, preferences and relative, participating, optional or other special rights, and such qualifications, limitations or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board of Directors providing for the issue of such series and as may be permitted by the Wyoming Business Corporation Act. Such authority includes, without limitation, the authority to determine: (i) the number of shares constituting that series and the distinctive designation of that series; (ii) the dividend rate or rates on the shares of

------

that series, whether dividends shall be cumulative, and if so, from which date or dates, and the relative rights of priority, if any, of payment of dividends on shares of that series; (iii) whether that series shall have voting rights, in addition to the voting rights provided by law, and if so, the terms of such voting rights; (iv) whether that series shall have conversion privileges, and if so, the terms and conditions of such conversion; (v) whether or not the shares of that series shall be redeemable, and if so, the terms and conditions of such redemption; (vi) whether that series shall have a sinking fund for the redemption or purchase of shares of that series, and if so, the terms and amount of such sinking fund; (vii) the rights of the shares of that series in the event of voluntary or involuntary liquidation, dissolution or winding up of the Corporation, and the relative rights of priority, if any, of payment of shares of that series; and (viii) any other relative rights, preferences and limitations of that series.

Except as otherwise required by law, holders of Common Stock shall not be entitled to vote on any amendment to these Amended and Restated Articles of Incorporation (including any certificate of designation relating to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to these Amended and Restated Articles of Incorporation (including any certificate of designation relating to any series of Preferred Stock) or pursuant to the Wyoming Business Corporation Act.

No shareholder shall have any preemptive right to subscribe to or purchase any additional shares of any class of stock of the Corporation or any security convertible into such stock.

**ARTICLE VI**

**DIRECTORS**

The number of directors of the Corporation shall be fixed from time to time by or in the manner provided in the Bylaws of the Corporation. Directors need not be shareholders of the Corporation. Election of directors need not be by written ballot unless the Bylaws of the Corporation so provide.

The Corporation elects not to be governed by Wyo. Stat. Ann. § 17-16-804 regarding the election of directors by cumulative voting.

**ARTICLE VII**

**LIMITATION OF DIRECTOR LIABILITY**

To the fullest extent permitted by the Wyoming Business Corporation Act, as the same exists or may hereafter be amended, a director of the Corporation shall not be personally liable to the Corporation or its shareholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director's duty of loyalty to the Corporation or its shareholders; (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; (iii) under Wyo. Stat. Ann. § 17-16-833; or (iv) for any transaction from which the director derived an improper personal benefit. If the Wyoming Business

------

Corporation Act is amended after the filing of these Amended and Restated Articles of Incorporation to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the Wyoming Business Corporation Act, as so amended. Any repeal or modification of this Article VII shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification.

**ARTICLE VIII**

**INDEMNIFICATION**

The Corporation shall indemnify and advance expenses to its directors, officers, employees, fiduciaries or agents and to any person who is or was serving at the request of the Corporation as a director, officer, employee, fiduciary or agent of another corporation or other enterprise (including, without limitation, any employee benefit plan), to the fullest extent permitted by law (whether in proceedings by or in the right of the Corporation or otherwise), both as now in effect or as hereafter amended. Such right to indemnification shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of his or her heirs, executors and administrators. The right to indemnification conferred by this Article VIII shall be a contract right and shall include the right to be paid by the Corporation the expenses incurred in defending any such proceeding in advance of its final disposition; provided, however, that if the Wyoming Business Corporation Act requires the payment of such expenses incurred by a director or officer in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such person while a director or officer) in advance of the final disposition of a proceeding, payment shall be made only upon delivery to the Corporation of an undertaking by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be indemnified under this Article VIII or otherwise.

The indemnification and advancement of expenses provided by, or granted pursuant to, this Article VIII shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of shareholders or disinterested directors or otherwise, both as to action in such person's official capacity and as to action in another capacity while holding such office.

The Corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person's status as such, whether or not the Corporation would have the power to indemnify such person against such liability under this Article VIII.

------

Any repeal or modification of this Article VIII shall not adversely affect any right or protection existing hereunder immediately prior to such repeal or modification.

**ARTICLE IX**

**SHAREHOLDER ACTION**

Any action required or permitted to be taken by the shareholders of the Corporation may be effected by the unanimous written consent of the shareholders entitled to vote on such action, in lieu of a meeting, unless otherwise provided in the Bylaws.

**ARTICLE X**

**AMENDMENT OF BYLAWS**

In furtherance and not in limitation of the powers conferred by the Wyoming Business Corporation Act, the Board of Directors is expressly authorized to adopt, amend or repeal the Bylaws of the Corporation, subject to the right of the shareholders entitled to vote with respect thereto to alter or repeal Bylaws adopted by the Board of Directors.

**ARTICLE XI**

**AMENDMENT**

The Corporation reserves the right to amend, alter, change or repeal any provision contained in these Amended and Restated Articles of Incorporation in the manner now or hereafter prescribed by law, and all rights and powers conferred herein on shareholders, directors and officers are subject to this reserved power.

**ARTICLE XII**

**PERPETUAL EXISTENCE**

The Corporation shall have perpetual existence.

**IN WITNESS WHEREOF**, these Amended and Restated Articles of Incorporation have been executed on behalf of the Corporation by its duly authorized officer this 13th day of March, 2026.

I consent on behalf of the business entity to accept electronic service of process at the required email address provided on the filing form under the circumstances specified in W.S. 17-28-104(e).

DENTONX INC.

By: */s/ Lionel Pinuer*

Lionel Pinuer, Chief Executive Officer and Chief Financial Officer

Email: lpinuer@dentonxinc.com

Daytime Phone #:

------

## Exhibit 3.2

**AMENDED AND RESTATED BYLAWS**

**of DENTONX INC**

___________________________________________________________________

**ARTICLE 1**

**Company Formation**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.01**FORMATION.** This Corporation is formed pursuant to the Wyoming Business Corporation Act

("the Act").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.02**CORPORATE ARTICLES COMPLIANCE.** The Board of Directors (the "Board") acknowledges and agrees that they caused the Corporation's Articles of Incorporation (the "Articles") to be filed with the Wyoming Secretary of State and all filing fees have been paid and satisfied.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.03**REGISTERED OFFICE & REGISTERED AGENT.** The name and location of the registered agent will be as stated in the Company's formation documents and comply with Title 17, Chapter 28 and Section 17-16-501 of the Act. The Corporation may change its registered office or registered agent by filing a statement with the Secretary of State setting forth the change. The Board is obligated to maintain and update the corporate records on file with the Corporation's registered agent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.04**OTHER OFFICES.** Pursuant to Section 17-16-302 of the Act, the Corporation may have other offices as selected by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.05**CORPORATE SEAL.** Pursuant to Section 17-16-302 of the Act, the Board may adopt a corporate seal with the form and inscription of their choosing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.06**PURPOSE.** Pursuant to Section 17-16-301 of the Act, this Corporation is formed to engage in any lawful business purpose.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.07**ADOPTION OF BYLAWS.** Pursuant to Section 17-16-302 of the Act, the Board has caused

the adoption of these corporate bylaws ("Bylaws") on behalf of the Corporation.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**1** of **2** |

---

------

**ARTICLE 2**

**Board of Directors**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.01**INITIAL MEETING OF THE BOARD.** Pursuant to Section 17-16-205 of the Act, the Board has conducted and completed the initial meeting of the Corporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.02**POWERS AND NUMBERS.** Pursuant to Section 17-16-801 of the Act, the management of all the Corporation's affairs, property, and interests shall be managed by or under the direction of the Board. The number of directors of the Corporation shall be fixed from time to time by resolution of the Board of Directors, but in no event shall the number be less than one (1). Consistent with Section 17-16-802 of the Act, the Board consists of at least one (1) natural person who need not be a shareholder or resident of the State of Wyoming.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.03**DIRECTOR LIABILITY.** Each director is required, individually and collectively, to act in good faith, with reasonable and prudent care, and in the best interest of the Corporation. If a director acts in accordance with Section 17-16-830 of the Act, then they shall be immune from liability arising from official acts on behalf of the Corporation. Directors are presumed to act in compliance with Section 17-16-830.

Directors who fail to comply with Section 17-16-830 of the Act shall be personally liable to the Corporation for any improper distributions and as otherwise described in Section 17-16-831 of the Act and these Bylaws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.04**CLASSES OF DIRECTORS.** Until such time as the Articles are accordingly amended, the Corporation does not have classes of directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.05**CHANGE OF NUMBER.** The number of directors may be fixed from time to time exclusively by resolution of the Board of Director. A decrease in number does not have the effect of shortening the term of any incumbent director. In the event the established number of directors is decreased, the directors shall hold their positions until the next shareholder meeting occurs and new directors are elected and qualified.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.06**ELECTION & REMOVAL OF DIRECTORS.** Pursuant to Section 17-16-803 of the Act, directors are to be voted on and elected at each annual shareholder meeting for a term of one

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) year. A director shall hold office until their successor is duly elected and qualified at the following annual shareholder meeting, unless a special meeting is expressly called to remove a director and/or fill a vacancy. If a director is elected, but is not yet qualified to hold office, then the previous director shall holdover until such time that the newly elected director is so qualified. Pursuant to Section 17-16-808 of the Act, one or more directors of the Board, may be removed by an affirmative vote by the holders of a majority of stock entitled to vote at any meeting of shareholders called expressly for that purpose.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**2** of **2** |

---

------

increase in the number of directors for a term lasting until the next annual election of directors by the shareholders at the annual meeting or a special meeting called for the purpose of electing directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.08**REGULAR MEETINGS.** Pursuant to Section 17-16-820 of the Act, the meetings of the Board or any committee may be held at the Corporation's principal office or at any other place designated by the Board or its committee, including by means of remote communication which allows all persons participating in the meeting to hear or otherwise communicate with each other at the same time. The annual meeting of the Board will be held without notice immediately after the adjournment of the annual meeting of shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.09**SPECIAL MEETINGS.** Special meetings of the Board may be held at any place and at any time, including by means of remote communication which allows all persons participating in the meeting to hear each other at the same time, and may be called by the Chairman of the Board, the President, Vice President, Secretary, or Treasurer, or at least two (2) directors. Any special meeting of the Board must be preceded by at least twenty-four (24) hours' notice of the date, time, place, and purpose of the meeting, unless these Bylaws require otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.10**ACTION BY DIRECTORS WITHOUT A MEETING.** Pursuant to Section 17-16-821 of the

Act, any action which may be taken at a meeting of the Board, or its committee, may be taken without a meeting, *provided* a majority of the directors or committee members agree, and such consent is filed with the minutes of the proceeding and sets forth the action taken by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.11**NOTICE OF MEETINGS.** Pursuant to Section 17-16-822 of the Act, the regular meetings of the Board shall be held without notice of the date, time, place, or purpose of the meeting, provided the meeting of the Board follows the adjournment of the annual shareholder meeting. Notice may be given personally, by facsimile, by mail, by electronic transmission, or in any other lawful manner, so long as the method for notice comports with Article 8 of these Bylaws. Oral notification is sufficient only if a written record of the notice is included in the Corporation's minute book. Notice is effective at the earliest of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Receipt;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Delivery to the proper address, email address or telephone number of the director(s) as shown in the Corporation's records; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Two (2) days after its deposit in the United States mail, as evidenced by the postmark, if correctly addressed and mailed with first-class postage prepaid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.12**WAIVER OF NOTICE.** Pursuant to Section 17-16-823 of the Act, a director waives the notice requirement if that director attends or participates in the meeting, unless a director attends for the express purpose of promptly objecting to the transaction of any business because the meeting was not lawfully called or convened. A director may waive notice by a signed writing, delivered to the Corporation for inclusion in the minutes before or after the meeting.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**3** of **2** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.13**QUORUM.** Per subsection 17-16-824 of the Act, a majority of the entire Board constitutes a quorum, and a quorum is necessary at all meetings to constitute a quorum to transact business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.14**REGISTERING DISSENT.** As provided in Section 17-16-824 of the Act, a director who is present at a meeting at which an action on a corporate matter is taken is presumed to have assented to such action, unless the director expressly dissents to the action. A valid dissent must be entered in the meeting's minutes, filed with the meeting's acting Secretary before its adjournment, or forwarded by registered mail to the Corporation's Secretary within twenty-four (24) hours after the meeting's adjournment. These options for dissent do not apply to a director

who voted in favor of the action or failed to express such dissent at the meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.15**EXECUTIVE AND OTHER COMMITTEES.** As permitted by Section 17-16-825 of the Act, the Board may create committees to delegate certain powers to act on behalf of the Board, provided the Board passes a resolution indicating such creation or delegation. The Board may delegate to a committee the power to appoint directors to fill vacancies on the Board. All committees must record regular minutes of their meetings and keep the minute book at the corporation's office. The creation or appointment of a committee does not relieve the Board or its members from their standard of care described in Section 2.03 of these Bylaws or in Section 17-16-830 of the Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.16**COMPENSATION.** Per Section 17-16-811 of the Act, the Board may adopt a resolution which results in directors being paid a reasonable compensation for their services rendered as directors of the Corporation. Directors may also be paid a fixed sum and expenses, if any, for attendance at each regular or special meeting of such Board. Nothing contained in these Bylaws precludes a director from receiving compensation for serving the Corporation in any other capacity, including any services rendered as an officer or employee. If the Board accordingly passes a resolution, then committee members may be allowed like compensation for attending committee meetings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.17**INDEMNIFICATION.** The Corporation shall indemnify to the fullest extent permitted by the Act and other applicable law any current or former director who was or is a party to a or threatened with any proceeding, as a consequence of the director acting in their official capacity. In the event a director is entitled to indemnification by the Corporation, the director shall be indemnified pursuant to the process outlined in Sections 17-16-851 and 17-16-852 of the Act. The Corporation shall advance expenses (including attorneys' fees) incurred by a director in defending any proceeding in advance of the final disposition of such proceeding upon receipt of an undertaking by or on behalf of the director to repay such amount if it shall ultimately be determined that the director is not entitled to be indemnified by the Corporation. The Corporation may purchase and maintain insurance on behalf of any director against any liability asserted against or incurred by the director in such capacity.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**4** of **2** |

---

------

**ARTICLE 3**

**Stock**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.01**AUTHORITY TO ISSUE.** Subject to Section 17-16-601 of the Act and the Corporation's Articles, the Corporation is authorized to issue any class of stock or securities convertible into stock of any class. Before any stock of the Corporation may be issued, the Board must pass a resolution which authorizes the issuance, sets the minimum consideration for the stock or security (or a formula to determine the minimum consideration), and fairly describes any non- monetary consideration.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.02**RESTRICTIONS.** Stock may only be issued in accordance with the Articles, and through the process described in these Bylaws. Any issuance of stock in excess of the amount described in the Articles must be authorized by the Board and approved by the affirmative vote by a majority of shareholders. Per Section 17-16-627 of the Act, any restriction on the transferability of stock shall be fully furnished to the shareholder, upon shareholder request, and without any charge to the shareholder. Per Subsection 17-16-627 of the Act, any failure to furnish such information to the shareholder does not render the restriction on stock transferability invalid or unenforceable.

As provided in Section 17-16-627 of the Act, no shareholder has a preemptive right to subscribe to any subsequent or additional issuance of stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.03**STOCK CERTIFICATES.** Under Section 17-16-625 of the Act, shareholders are entitled to stock certificates that certify the shares of the Corporation's stock held by the shareholder. Notwithstanding the shareholders' rights to stock certificates, the Board may authorize the issuance of some or all shares of any class or series of stock without certificates, provided the Board shall provide to a shareholder a written statement that contains the information required to be on stock certificates, per Section 17-16-625 of the Act.

As required by Section 17-16-625 of the Act, each stock certificate must contain on its face:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Corporation name and that the Corporation is organized under the laws of this State;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The name of the shareholder (or person to whom the stock is issued);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The number and class of shares and the designation of the series, if any, the certificate represents; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)The signature of two officers designated in these Bylaws or by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.04**MUTILATED, LOST, OR DESTROYED CERTIFICATES.**In the instance of any

mutilation, loss, or destruction of any stock certificate, another may be issued in its place on proof of such mutilation, loss or destruction. The Board may impose conditions on such issuance and may require the giving of a satisfactory bond or indemnity to the Corporation. The Board may establish other procedures as they deem necessary.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**5** of **2** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.05**FRACTIONAL SHARES OR SCRIP.** Subject to Section 17-16-604 of the Act, the Corporation may , in the event any transaction (including a stock dividend, stock split, reverse stock split, merger, consolidation, or similar corporate action) would result in the issuance of a fractional share, the Board of Directors (or a committee thereof) shall have sole discretion to determine, in its sole and absolute discretion, how to handle such fractional interests. The Board may::

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Pay to the holder thereof, in cash, the fair market value of such fractional share as determined by the Board (or the closing price of the Corporation's common stock on the principal national securities exchange on which the shares are listed, if applicable, on the trading day immediately prior to the relevant determination date);

(b) Arrange for the disposition of such fractional interests by those entitled thereto;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Issue scrip in registered form entitling the holder to receive a full share upon surrender of scrip aggregating a full share; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)(d)Round up or down to the nearest whole share, or take such other action as the Board deems appropriate

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.06**TRANSFER.** So long as there is no transferability restriction on the stock, as described in Section 3.02 of these Bylaws, the stock of the Corporation is freely transferable. Transfers of stock must be made upon the Corporation's stock transfer books. Stock transfer books shall be kept in the manner described in Article 7 of these Bylaws.

Before a new certificate is issued, the old certificate must be surrendered for cancellation. The Board may, by resolution, open a share register in any state of the United States, and may employ an agent or agents to keep such register, and to record transfers or shares therein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.07**REGISTERED OWNER.** The Corporation shall recognize an individual as the registered owner of a given stock, *provided* that individual is determined as the shareholder of record by the record date as set out in Section 4.07 of these Bylaws. Shareholders may agree to confer the right to vote or represent their stock to third parties, including trustees, proxies, or fiduciaries. The Board may resolve to adopt a procedure by which a shareholder of the Corporation may certify in writing to the Corporation that all or a portion of the stock registered in the shareholder's name are held for the account of a specified person or persons. The resolution must set forth:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The classification of shareholder who may certify;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The purpose or purposes for which the certification may be made;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The form of certification and information to be contained therein;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)If the certification is with respect to a record date or closing of the stock transfer books, the date within which the certification must be received by the Corporation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)Other provisions with respect to the procedure as are deemed necessary or desirable.

Upon receipt of a certification complying with this procedure, the Corporation must treat the persons specified in the certification as the holders of record for the number of shares specified in place of the shareholder making the certification.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**6** of **2** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.08**CLASSES OR SERIES OF STOCK.** Until such time that the Articles are amended accordingly, the stock of the Corporation is not classified, and is not in series. In the event the Board decides to classify or reclassify the stock or alter any shareholder rights or restrictions, then the Board shall cause an amendment to its Articles to be filed with the Secretary of State. The amendment must describe the rights and restrictions which are being modified or altered, along with a statement (if any) that the stock has been classified or reclassified. As required by Section 17-16-120 of the Act, the amendment shall be acknowledged and signed by either a director or an executive officer on behalf of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.09**STOCK OWNED BY ENTITIES.** Shares of stock in the Corporation held by another corporation may be voted by that corporation's officer, agent, or proxy chosen by its board of directors or, if no decision is made, by its president. Shares held by a fiduciary for a named shareholder may be voted or represented by the fiduciary, provided the fiduciary acts in the best interest of the beneficiaries.

Subject to Section 17-16-721 of the Act, the Corporation may vote shares it holds in a fiduciary capacity, but only for the benefit of the beneficiaries. The Corporation must disclose how such shares will be voted before any shareholder vote.

Shares held by the Corporation in a fiduciary capacity may be included in the total count of outstanding shares, as long as this does not create a conflict of interest or unfairly disadvantage other shareholders.

**ARTICLE 4**

**Shareholders' Meetings**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.01**MEETING PLACE.** Per Section 17-16-701 of the Act, all shareholder meetings must be held at the Corporation's principal office or other place predetermined by the Board. As permitted by Section 17-16-708 of the Act, shareholders may participate in the meeting by virtual means or remote conference, *provided* the participants can hear each other in real-time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.02**ANNUAL MEETING TIME.** The annual shareholder meeting for the election of directors and the transaction of other business properly before the meeting shall be held each year on a date selected by the Board of Directors. The meeting shall be held at a time set by the Board, and if the chosen date is a legal holiday, the meeting will be held on the next business day at the same hour.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.03**FAILURE TO HOLD ANNUAL MEETING.** Pursuant to Section 17-16-701, failure to hold an annual meeting on the date specified in or fixed within these Bylaws does not affect the validity of any corporate action.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.04**ANNUAL MEETING – ORDER OF BUSINESS.** The order of business at the annual shareholder shall be established by the Board.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**7** of **2** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.05**SPECIAL MEETINGS.** Subject to Section 17-16-702 of the Act, special shareholder meetings, for any purpose, may be called at any time by the President, the Board, or the Secretary. The Secretary may only call a special shareholder meeting if the Secretary has received a written request from the holders of at majority of all shares entitled to vote at the meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.06**NOTICE.** Pursuant to Section 17-16-705 of the Act, the Secretary shall cause notice to be given to each shareholder of record at least ten (10) days, but no more than sixty (60) days, before the shareholders' meeting. Notice shall be by electronic transmission, mailing, or personal delivery, and shall state the time, place, and purpose of the meeting (including instructions for how to virtually attend and participate). Notice is considered given to a shareholder when it is personally provided to the shareholder, left at the shareholder's residence or usual place of business, mailed to the shareholder's address of record, or by electronic transmission to the shareholder's address or number of record on file with the Corporation. A single notice can be delivered to multiple shareholders sharing the same address, unless the Corporation receives a request from a shareholder that more than a single notice be delivered.

Notice by electronic transmission shall be considered ineffective if the Corporation is unable to deliver two (2) consecutive notices and the individual responsible for sending notices to shareholders is made aware of the delivery failures. A shareholder meeting, and any actions taken by shareholders, shall not be invalidated due to an inadvertent failure to deliver notice.

Per Section 17-16-705 of the Code and Section 4.07 of these Bylaws, the notice must include the record date for determining the shareholders entitled to vote at the meeting, if such date is different than the record date for determining shareholders entitled to notice of the meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.07**WAIVER OF NOTICE.** As stated in Section 17-16-706 of the Act, a shareholder who is entitled to notice may waive the notice requirement if they provide a signed written waiver of the required notice, before or after the stated meeting time, or the shareholder is present at the meeting in person or by proxy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.08**RECORD DATE.** As provided in Section 17-16-707 of the Act, at least ten (10) days before each shareholder meeting, a complete record of the shareholders entitled to vote at the meeting must be made and maintained in the books and records of the Corporation. This list must be arranged in alphabetical order and include the address of and number of shares of stock held by each shareholder. This record must be kept on file at the Corporation's principal office for a period of ten (10) days prior to the meeting. The records must also be kept open for inspection at shareholder meetings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.09**CLOSING OF TRANSFER BOOKS AND FIXING RECORD DATE.**As permitted by

Section 17-16-707 of the Act, the Board may require that the stock transfer books must be closed in order to determine which shareholders are entitled to notice of or to vote at any shareholder meeting, or any adjournment thereof, or entitled to receive payment of any dividend. Instead of closing the stock transfer books, the Board may fix in advance a record date for determination of such shareholders. The record date must not be more than sixty (60) days or less than ten (10) days prior to the date of the meeting, adjournment, or payment.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**8** of **2** |

---

------

4.10 **SHAREHOLDER LIABILITY.** Subject to Section 17-16-622 of the Act, shareholders are not liable to the Corporation or its creditors, except that in the event the agreed upon price or consideration for the stock has not been fully paid. In the event that a subscription price or consideration for stock has not been fully paid, the following people are not personally liable for the unpaid balance:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)a transferee or assignee who acquires the stock or subscription in good faith and without knowledge or notice of the nonpayment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)a person who holds the stock as a fiduciary, although the estate in the hands of the fiduciary is liable for the nonpayment; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)a pledgee or other person who holds stock as security.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.10**VOTING RIGHTS.** Pursuant to Section 17-16-721 of the Act, each share of stock is entitled to one (1) vote on all matters.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.11**PROXIES.** As permitted by Section 17-16-722 of the Act, a shareholder may vote either in person or by proxy, signed in writing by the shareholder or the shareholder's duly authorized attorney-in-fact. No proxy is valid after eleven (11) months from the date signed, unless the proxy states otherwise. A proxy is revocable by a shareholder at any time, unless the proxy states that it is irrevocable and is coupled with an interest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.12**QUORUM.** The presence, in person or by proxy, of shareholders entitled to cast one third of all the outstanding voting stock constitutes a quorum. If a quorum is present at a shareholder meeting, then a majority of all the votes cast at the meeting is sufficient to approve any matter properly brought before the meeting unless a higher number is required by law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.13**ACTION BY SHAREHOLDERS WITHOUT A MEETING.** As permitted by Section 17-

16-704 of the Act, any action which may be taken at any annual or special shareholder meeting may be taken without a meeting if all of the shareholders are entitled to vote on the subject and consent to the action in writing. Such consent has the same force and effect as a vote of the shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.14ADVANCE NOTICE OF SHAREHOLDER BUSINESS AND NOMINATIONS. Nominations for the election of directors and proposals for any new business to be conducted at any shareholder meeting may be made by the Board or by any shareholder entitled to vote at such meeting who complies with the following requirements. To be timely, a shareholder's notice must be delivered to the Secretary at the principal executive offices of the Corporation not less than 60 days nor more than 90 days prior to the first anniversary of the preceding year's annual meeting; provided, however, that if no annual meeting was held in the preceding year or the date of the annual meeting is advanced by more than 30 days or delayed by more than 60 days from such anniversary date, notice must be received not later than the close of business on the 10th day following the day on which notice of the date of the meeting was mailed or public disclosure was made. Such notice shall include: (a) for nominations, the name, age, business and residence addresses, principal occupation, shares owned, and other information required by Regulation 14A under the Securities Exchange Act of 1934, as amended, for each nominee, plus the nominee's consent to serve; (b) for business proposals, a description of the business, the reasons for it, the shareholder's shares

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**9** of **2** |

---

------

owned, and any material interest; and (c) the name and address of the proposing shareholder. The presiding officer of the meeting may refuse to acknowledge any nomination or proposal not made in compliance with this section

**ARTICLE 5**

**Officers**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.01**DESIGNATIONS.** The Corporation shall have a Chief Executive Officer, President, Chief Financial Officer, Secretary, and Treasurer, who shall be appointed by the Board of Directors at a time determined by the Board. The Corporation may also have one or more Vice- Presidents (one shall serve as Executive Vice-President) and Assistant Secretaries and Assistant Treasurers as the Board may designate. An appointed officer will hold office for one (1) year or until a successor is elected and qualified. Subject to Section 17-16-840 of the Act, the same person may hold any two (2) or more offices concurrently. Pursuant to Section 17-16-843 of the Act, all officers may be removed at any time, with or without cause.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.02**THE CHIEF EXECUTIVE OFFICER.** The Chief Executive Officer shall be the principal executive officer of the Corporation and, subject to the direction and control of the Board of Directors, shall have general supervision, direction, and control over the business and affairs of the Corporation. The CEO shall have the following powers and duties:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To supervise and direct the day-to-day operations of the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To formulate and recommend to the Board long-range objectives, plans, and programs for the Corporation and to implement those approved by the Board;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To hire, supervise, evaluate, and (subject to any limitations imposed by the Board) terminate all other officers (except as otherwise provided in these Bylaws) and key employees of the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) To serve as the principal management liaison between the Board of Directors and the officers and employees of the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) To preside at all meetings of the shareholders and the Board of Directors in the absence of a Chairman of the Board (unless the Bylaws or Board designate another officer to preside);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) To sign, execute, and acknowledge, on behalf of the Corporation, deeds, mortgages, bonds, contracts, leases, reports, and all other documents or instruments which the Board has authorized to be executed, except in cases where the signing and execution thereof shall be expressly delegated by the Board or by these Bylaws to some other officer or agent of the Corporation, or shall be required by law to be otherwise signed or executed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) To perform such other duties and exercise such other powers as may be assigned from time to time by the Board of Directors or as are incident to the office of Chief Executive Officer under applicable law or custom.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.03**THE PRESIDENT.** Pursuant to Sections 17-16-840 and 17-16-841 of the Act, the President shall preside over all meetings of shareholders and directors, shall have general supervision of the Corporation's affairs, and perform all other duties as are incident to the office or are properly required by a resolution passed by the Board.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**10** of **2** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.04**THE CHIEF FINANCIAL OFFICER.** The Chief Financial Officer shall be the principal financial officer of the Corporation and, subject to the direction and control of the Board of Directors and the Chief Executive Officer, shall have general charge and supervision over all financial affairs of the Corporation. The CFO shall have the following powers and duties:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To have charge and custody of, and be responsible for, all funds and securities of the Corporation, and to deposit all such funds in the name of the Corporation in such banks, trust companies, or other depositories as shall be selected by the Board of Directors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To receive, and give receipts for, monies due and payable to the Corporation from any source whatsoever, and to disburse the funds of the Corporation as may be ordered by the Board of Directors or the Chief Executive Officer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To maintain adequate and correct books and records of account of the properties and business transactions of the Corporation, including accounts of its assets, liabilities, receipts, disbursements, gains, losses, capital, retained earnings, and shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) To prepare, or cause to be prepared, all financial statements, reports, budgets, forecasts, and other financial information required by the Board, the Chief Executive Officer, shareholders, or applicable law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) To oversee the financial planning, management of financial risks, cash flow management, treasury functions, tax compliance, and internal financial controls of the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) To render to the Chief Executive Officer, the Board of Directors, or the shareholders, whenever requested, an account of all transactions as Chief Financial Officer and of the financial condition of the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)To perform such other duties and exercise such other powers as may be assigned from time to time by the Board of Directors, the Chief Executive Officer, or as are incident to the office of Chief Financial Officer under applicable law or custom.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.05**VICE PRESIDENT.** During the absence or disability of the President, the Executive Vice-President may exercise all functions of the President. Each Vice-President shall have such powers and fulfill such duties as may be assigned by a resolution of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.06**SECRETARY AND ASSISTANT SECRETARIES.** Pursuant to Sections 17-16-840 and 17-

16-841 of the Act, the Secretary must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Issue notices for all meetings and actions of the Board or shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Accept all requests for special meetings of the Board or shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Accept all notices of proxy appointments and revocations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Keep the minutes of all meetings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)Accept delivery of any dissent announced at any meeting of the Board or shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)Acknowledge and execute any stock certificates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)Have charge of the corporate seal and books; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)Make reports and perform duties as are incident to the office, or are properly required of him or her by the Board of Directors.

The Assistant Secretary, or Assistant Secretaries (in the order designated by the Board), will perform all of the duties of the Secretary during the absence or disability of the Secretary, and at other times may perform such duties as are directed by the President or the Board.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**11** of **2** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.07**THE TREASURER.** Pursuant to Section 17-16-840 and 17-16-841 of the Act, the Treasurer shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Have custody of all the Corporation's monies and securities and keep regular books of

account, in accordance with Sections 17-16-841 and 17-16-1601 of the Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Disburse the Corporation's funds in payment of the just demands against the Corporation

or as may be ordered by the Board, taking proper vouchers for such disbursements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Provide the Board with an account of all his or her transactions as Treasurer and of the financial conditions of the office properly required of him or her by the Board.

If selected, the Assistant Treasurer, or Assistant Treasurers (in the order designated by the Board), must perform the duties of the Treasurer in the absence or disability of the Treasurer, and at other times may perform such other duties as are directed by the President or the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.08**DELEGATION.** In the absence or inability to act of any officer and of any person authorized to act in their place, the Board may delegate the officer's powers or duties to any other officer, director, or other person, subject to Section 5.01 of these Bylaws. Vacancies in any office arising from any cause may be filled by the Board, subject to Section 5.01 of these Bylaws, at any regular or special board meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.09**OTHER OFFICERS.** The Board may appoint other officers and agents as they deem necessary or expedient. The term, powers, and duties of such officers will be determined by the Board and described in the resolution authorizing the appointment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.10**Intentionally left blank.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.11**BONDS.** The Board may resolve to require any officer to give bonds to the Corporation, with sufficient surety or sureties, conditioned upon the faithful performance of the duties of their offices and compliance with other conditions as required by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.10**SALARIES.** Officers' salaries will be fixed from time to time by the Board. Officers are not prevented from receiving a salary by reason of the fact that he or she is also a director of the Corporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.11**INDEMNIFICATION.** Subject to Section 17-16-856 of the Act, officers shall be indemnified by the Corporation, to the fullest extent permitted by the Act and other applicable law. Any officer indemnification shall be limited to proceedings that are directly related to or have arisen out of the officer's acts on behalf of the Corporation. The Corporation shall advance expenses (including attorneys' fees) incurred by an officer in defending any proceeding in advance of the final disposition of such proceeding upon receipt of an undertaking by or on behalf of the officer to repay such amount if it shall ultimately be determined that the officer is not entitled to be indemnified by the Corporation. The Corporation may purchase and maintain insurance on behalf of any officer against any liability asserted against or incurred by the officer in such capacity

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**12** of **2** |

---

------

**ARTICLE 6**

**Capital & Finance**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.01**DIVIDENDS.** Subject to Section 17-16-640 of the Act, dividends may be declared by the Board and paid by the Corporation out of the net earnings of the unreserved and unrestricted earned surplus of the Corporation, or out of the unreserved and unrestricted net earnings of the current fiscal year, or in treasury shares of the Corporation, subject to the conditions and limitations imposed by the State of Wyoming. The stock transfer books may be closed by the Board pursuant to Section 17-16-707 of the Act and Sections 3.07 and 4.07 of these Bylaws. The Board, without closing the Corporation's books, may declare dividends payable only to holders of record at the close of business on any business day not more than sixty (60) days prior to the date on which the dividend is paid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.02**RESERVES.** The Board may, in their absolute discretion, set aside out of the Corporation's earned net surplus as they deem expedient for dividend, while maintaining any corporate property, or any other purpose, before making any distribution of earned surplus.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.03**DEPOSITORIES.** The Corporation's monies must be deposited in the Corporation's name in a bank or trust company or trust companies designated by resolution of the Board. Corporate monies may be drawn out only by check or other order for payment signed by such persons and in such manner as may be determined by resolution of the Board.

**ARTICLE 7**

**Books and Records**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.01**MEETING MINUTES.** As required by these Bylaws and Section 17-16-1601 of the Act, the Corporation must keep a complete and accurate accounting and minutes of the proceedings of its shareholders and Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.02**SHAREHOLDER LIST.** In accordance with Section 17-16-1601 of the Act, the Corporation must keep at its registered office or principal place of business a list of its shareholders, including the names and addresses of all shareholders and the number and class of shares held.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.03**LEGIBILITY OF RECORDS.** Any books, records, and minutes may be in any form, provided such form is capable of being converted into written form within a reasonable time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.04**RIGHT TO INSPECT.** Subject to Section 17-16-1602 of the Act, any shareholder or shareholder representative has the right, upon written request delivered to the Corporation, to inspect and copy during usual business hours the following documents of the Corporation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Corporate Articles (initial, restated, and as amended);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)These Bylaws, and any amendments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Minutes of any proceedings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Annual statements of affairs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)The books of account and stock ledger of the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)Any voting trust agreements;

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**13** of **2** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)All written communications to shareholders from the last three (3) years;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)Accounting records of the Corporation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Record of the shareholders.

The Corporation elects to assume any obligations that may be related to this Article of these bylaws which would otherwise attach to the registered agent of the Corporation. The Corporation acknowledges and agrees that any obligation to produce corporate documents under this Article of the Bylaws shall attach to the Secretary as part of the duties described in Section 5.04 of these Bylaws.

**ARTICLE 8**

**Notices**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.01**MAILING OF NOTICE.** Except as may otherwise be required by law, any notice to any shareholder or director may be delivered personally or by mail. If mailed, the notice will be deemed to have been delivered on the close of business of the third business day following the day when deposited in the United States mail with postage prepaid and addressed to the recipient's last known address in the records of the Corporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.02**E-NOTICE PERMITTED.** Per Section 17-16-141 of the Act, any communications required by the Act, the Bylaws, or other laws may be made by digital or electronic transmission to the recipient's known electronic address or number as known to the Corporation at the time of notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.03**DUTY TO NOTIFY.** All shareholders, directors, officers, employees, and representatives of the Corporation are required to notify the Corporation of any changes to the individual's contact information. Pursuant to the obligations under this Section of these Bylaws, the individual must notify the Corporation that electronic transmissions of notice are impracticable, impossible, frustrated, or otherwise improper and ineffective.

**ARTICLE 9**

**Special Corporate Acts**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.01**EXECUTION OF WRITTEN INSTRUMENTS.** All contracts, deeds, documents, and instruments that acquire, transfer, exchange, sell, or dispose of any assets of the Corporation must be executed by the President and ratified by the Board of Directors in order to bind the Corporation. This Section does not apply to any checks, money orders, notes, or other financial instruments for direct payment of corporate funds which are subject to Section 9.02 of these Bylaws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.02**SIGNING OF CHECKS OR NOTES.** All authorizations to distribute, pay, or immediately draw upon the financial resources of the Corporation must be signed by the Treasurer, including any expense reimbursement or compensation payments to directors, officers, employees, representatives, service providers, or contractors of the Company.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**14** of **2** |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.03**SPECIAL SIGNING POWERS.** To duly bind the Corporation to an agreement or instrument in the event the President holds an interest which exists outside of the capacity of being President, then any agreement involving such interest must be signed by an officer pursuant to either Section

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.03 or 9.02 of these Bylaws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.04**SHAREHOLDER APPROVAL.** Pursuant to Section 17-16-1201 of the Act, and until these Bylaws require otherwise, no shareholder approval is required to acquire, transfer, exchange, sell, or dispose of any assets of the Corporation in the ordinary course of business or after dissolving the Corporation. Notwithstanding any other provisions of these Bylaws, and consistent with Section 17-16-1202 of the Act, shareholder approval is required prior to any non-routine business operations, such as a merger, consolidation, share-exchange, conversion, or dissolution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.05**MERGERS & CONVERSIONS.** After approval from the shareholders, in order for any consolidation, merger, conversion, or other organizational restructuring to be effective, it must follow the respective process(es) set out in Title 17, Chapter 16, Article 11 of the Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.06**DISSOLUTION.** After approval of the shareholders, in order for the Corporation to properly be dissolved, it must follow the process set out in Title 17, Chapter 16, Article 14 of the Act.

**ARTICLE 10** 

**Forum for Adjudication of Disputes**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.01 EXCLUSIVE FORUM. Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (a) any derivative action or proceeding brought on behalf of the Corporation, (b) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, or other employee of the Corporation to the Corporation or the Corporation's shareholders, (c) any action asserting a claim arising pursuant to any provision of the Act, the Articles, or these Bylaws, or (d) any action asserting a claim governed by the internal affairs doctrine shall be a state or federal court located within the State of Wyoming. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Article 10.

**ARTICLE 11**

**Amendments**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.01** **BY SHAREHOLDERS.** These Bylaws may be altered, amended or repealed by the affirmative vote of a majority of the voting stock issued and outstanding at any regular or special shareholder meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.02** **BY DIRECTORS.** The Board of Directors may amend these Bylaws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.03** **EMERGENCY BYLAWS.** Consistent with Section 17-16-207 of the Act, the Board of Directors may adopt emergency Bylaws, subject to a vote to repeal or modify by the shareholders, which operate during any emergency in the Corporation's conduct of

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**15** of **2** |

---

------

business resulting from an attack on the United States or a nuclear or atomic disaster.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.04** **COMPLIANCE WITH STATE LAW.** Any amendment to the Corporation's Articles or these Bylaws shall be consistent with Title 17, Chapter 16, Article 10 of the Act.

These Bylaws are adopted by resolution of the Corporation's Board of Directors on this 6th day of February 2026.

*/s/ Luis Carlos Ung*

Luis Carlos Ung, Director

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Corporate Bylaws | &nbsp;&nbsp;**16** of **2** |

---

## Exhibit 5.1

**Exhibit 5.1**

**FLEMING PLLC**

**30 WALL STREET 8<sup>TH</sup> FLOOR NEW YORK NEW YORK 10005**

**TEL 516 902 6567 WWW.FLEMINGPLLC.COM**

March 19, 2025

DentonX Inc.

1999 Harrison Street, Suite 1800

Oakland, CA 94612

**Re:** **Registration Statement on Form S-1**

Ladies and Gentlemen:

We have acted as limited special counsel to **DentonX Inc.**, a Wyoming corporation (the "**Company**"), in connection with the legality of 3,000,000 shares of the Company's common stock, $0.0001 par value per share (the "**Shares**"), being offered directly by the Company (the "**Offering**"), all of which shares are being registered by the Company on a Registration Statement on Form S-1 (the "**Registration Statement**") and the prospectus included therein (the "**Prospectus**") filed with the Securities and Exchange Commission (the "**Commission**") under the Securities Act of 1933, as amended (the "**Act**"). This opinion is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Act.

As the basis for the opinions hereafter, we have examined the Amended and Restated Articles of Incorporation and Amended and Restated Bylaws of the Company, the form of subscription agreement to be used in connection with the sale of the Shares filed or incorporated by reference as exhibit 99.1 to the Registration Statement (as amended and supplemented from time to time, the "**Subscription Agreements**"), a draft of the proposed Registration Statement, as amended, and related Prospectus, and we have reviewed other documents and conducted other investigations as we have deemed necessary and appropriate to establish a basis for the opinions set forth herein.

In our examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons who have signed such documents, the authenticity of all documents submitted to us as certified copies or photocopies, and the authenticity of the originals of such documents. As to any facts material to the opinions expressed herein which we have not independently established or verified, we have relied upon statements and representations of officers and other representatives of the Company and others.

Based upon and subject to the foregoing matters discussed below, after having given due regard to such issues of law as we deemed relevant, and assuming that (i) the Registration Statement (and any amendments thereto) is declared effective and remains effective, and the Prospectus which is part thereof, and the Prospectus delivery requirements with respect thereto, are complied with and the Company fulfills all of the requirements of the Act throughout all of the periods relevant to this opinion (including the requirements of Section 10(a)(3) of the Act); (ii) all offers and sales of the Shares are made in a manner complying with the terms of the Registration Statement and the Act; (iii) the Subscription Agreements will be duly executed and delivered by the various investors and the Company in connection with the offer and sale of the Shares; and (iv) all offers and sales of the Shares are made in compliance with the securities laws of the states having jurisdiction thereto, we are of the opinion that with respect to the Shares, when offered, issued and paid for as described in the Registration Statement and applicable Prospectus, and pursuant to the Subscription Agreements, will be validly issued, fully paid and non-assessable.

This opinion is expressly limited in scope to the Shares enumerated herein which are to be expressly covered by the referenced Registration Statement.

------

We have also assumed that at the time of issuance and sale of the Shares, that the Company will receive the full amount of the consideration for which the Board authorized the issuance of such Shares; the Company will issue a share certificate or certificates to each purchaser of the Shares certifying the number of Shares held by such purchaser, or such Shares will be registered by book entry registration in the name of such purchaser, if uncertificated; and that the Company has complied, and will comply, with all securities laws and regulations and "blue sky" laws applicable to the issuance of the Shares. We express no opinion as to the enforceability of the Subscription Agreements. We express no opinion as to any county, municipal, city, town or village ordinance, rule, regulation or administrative decision. Our opinion is rendered as of the date hereof, and we assume no obligation to advise you of changes in law or fact (or the effect thereof on the opinions expressed herein) that hereafter may come to our attention.

We express no opinion as to the laws of any state or jurisdiction other than the laws governing corporations of the State of Wyoming and the federal laws of the United States of America. No opinion is expressed herein with respect to the qualification of the Shares under the securities or blue sky laws of any state or any foreign jurisdiction.

Our opinion is expressly limited to the matters set forth above, and we render no opinion, whether by implication or otherwise, as to any other matters other than those described above, relating to the Company, the Shares or the Registration Statement.

We consent to the reference to our firm under the caption "Legal Matters" in the Prospectus included in the Registration Statement and to the filing of this opinion as an exhibit to the Registration Statement.

Sincerely,

*/s/ Fleming PLLC*

Fleming PLLC

## Exhibit 10.1

![Picture 2](dtnxex101_1.jpg)

------

**CONSULTING AGREEMENT**

This Consulting Agreement (the "Agreement") is entered into by DentonX Inc (the "Company") and Lionel Pinuer E. (the "Consultant") on September 10, 2025. The Company and the Consultant may hereinafter be referred to individually as a "Party" and collectively as the "Parties."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.** **Consulting Relationship** 

During the term of this Agreement, the Consultant shall serve as a consultant to the Company. The Consultant agrees to provide strategic advisory, business development, operational guidance, and other consulting and professional services as may be reasonably requested by the Company (collectively, the "Services").

The Consultant shall perform such Services under the general direction of the Company's Board of Directors or its designees. Consultant represents that he possesses the qualifications, experience, and expertise necessary to perform these Services professionally and competently and agrees to dedicate sufficient time and attention to fulfill the responsibilities contemplated under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.** **Work to be Performed** 

As a consultant, the Consultant shall perform Services aligned with the Company's mission and business objectives. Specific tasks may include, but are not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Strategic advisory and business planning support

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Market, industry, and opportunity analysis

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Business development and partnership support

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Operational and organizational guidance

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Capital strategy input and investor-related preparation

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Other consulting services as reasonably requested by the Company

Additional task-specific assignments may be issued through written Service Orders (Appendix A). Each Service Order will define scope, deliverables, milestones, and estimated timelines. The Consultant shall deliver all work in a timely and professional manner.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.** **Compensation** 

The Company shall pay the Consultant a professional services fee based on time spent providing the Services, at an hourly or project-based rate to be mutually agreed upon by the Parties and set forth in Appendix B (Fee Schedule).

------

Private & Confidential 1

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex101_1.jpg)

------

Payment may be made in cash, equity, or a combination, as mutually agreed.

The Consultant shall submit a detailed invoice within five (5) business days following the end of each month, listing:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·hours worked

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Services performed

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·deliverables completed

The Consultant represents that all time reported is accurate and that the Services provided meet or exceed industry-standard quality.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.** **Submission of Status Report by Consultant** 

The Consultant agrees to submit a regular written status report (Refer to Appendix C "Status Report") to the Company in the format and regularity as requested by the Company. The Consultant acknowledged that submissions of the regular status reports by the Consultant to the Company are vital for a healthy relationship between the Company and Consultant and provide the ability for the Company to measure the performance of the Consultant. The Consultant understands that failure to submit status reports as requested by the Company will be considered misconduct.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.** **Term and Termination** 

This Agreement shall be for an initial term of twelve (12) months, subject to earlier termination by either the Company or the Consultant as provided herein. The term of this Agreement may be renewed for an additional period on the same terms and conditions as are set forth herein, unless the Company or Consultant gives to the other party a notice of intent not to renew. Either party may terminate the Agreement at any time upon thirty (30) days' written notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.** **Confidentiality** **and Professional Standards**

Consultant understands in carrying out its duties to fulfill this Agreement. The consultant will be provided and be exposed to confidential and trade secret information of the Company and of Company affiliates ("Confidential and Secret Information"). Consultant understands that unauthorized disclosure of Confidential and Secret Information could lead to severe losses for the Company. Consultant agrees to keep confidential and not disclose to any third party to this Agreement on a permanent basis all confidential information of Company that Consultant received or known about during his service period. "Confidential and Secret information" refers to all concepts, ideas, trade secrets, theories, inventions, creations, works, processes, designs,

------

Private & Confidential 2

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex101_1.jpg)

------

text, art, images, mockups, materials, computer software, technical secrets, intellectual property rights or other trade secret information in any jurisdiction in the world (including but not limited to customer lists, investors list, affiliate list, consultants, advisors, information and discussions with members of the Board of Directors of Company and its affiliates, company operation models, business plans, feasibility studies, pro forma information, consultant reports and other presentation and reports, financial and economic status, marketing plans, procurement information, pricing policies, financial information, supply channel information, etc.) generated by Consultant during service period with Company for the purpose of performing her service duties or by making the use of Company's material and technical conditions and business information. Consultant promises not to use or implement the above confidential information without authorization, nor to disclose the above confidential information to any parties without authorization and bear the responsibility of failure for proper protection of Confidential and Secret Information. Furthermore, Consultant agrees that after the termination of service with Company, Consultant shall not cooperate or contact any of Company's clients or related parties. If the Consultant violates this Confidentiality clause, the Company has the right to seek the Consultant to compensate the Company for any losses incurred.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.** **Professional Standards and Non-Disparagement**

It is imperative that at all times all parties maintain a positive image of the Company and all its affiliates and treat each other with utmost professional respect including safeguarding the positive image and reputation of the Company. All Parties and in specific Consultant and Company, all agree to, at all times during the performance of this agreement and on a permanent basis after the termination of service with Company, refrain from engaging in any negative talk against the other party to third parties of this agreement and agree to refrain from making any disparaging remarks of Company and Consultant or any of their members, affiliates, advisors or stakeholders under any circumstances. If any party is found to disparage the other parties to third parties to this agreement, that party shall be responsible for any losses incurred to the other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.** **Force Majeure** 

No Party shall be liable for non-fulfillment of its obligations under the Agreement if such non-fulfillment is attributable to force majeure. Force majeure shall be taken to mean events over which the relevant Party has no control and which that Party could not have prevented, avoided or anticipated, including, but not limited to, stoppage of work, strikes, lock-outs, war, terrorism, natural disasters, states of emergency and similar.

The Party claiming force majeure shall notify the other Party without undue delay. Such notice shall be provided in writing and shall contain information about the nature of the force majeure

------

Private & Confidential 3

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex101_1.jpg)

------

event and its estimated duration and consequences for the performance of the Project, including the participation of the Party affected by the force majeure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.** **Governing Law** 

This Agreement shall be governed by and construed in accordance with the laws of the State of Wyoming, USA.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.** **No Waivers, Cumulative Remedies** 

The failure of a party to insist upon strict performance or adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party's rights or deprive such party of the right thereafter to insist upon strict performance or adherence to that term or any other term of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.** **Severability** 

In the event any provision or part of this Agreement is found to be invalid or unenforceable, only that particular provision or part so found, and not the entire Agreement, will be inoperative.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12.** **Effective** 

This Agreement shall be effective upon execution by both Parties ("Effective Date").

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the dates set forth below.

---

| | |
|:---|:---|
| For "COMPANY"<br> DentonX Inc  | For "CONSULTANT"<br>|
| <br>By: /s/__________________________<br>| <br>By: /s/________________________<br>|
| Date: _________________________ | Date: Sep./10/2025 |

---

------

Private & Confidential 4

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex101_1.jpg)

------

**Appendix A**

**Service Order Form**

---

| |
|:---|
| This Service Order is an appendix to the Consulting Agreement entered into on September 10, 2025 by and between DentonX Inc (the "Company") and Lionel Pinuer E. (the "Consultant").<br>Upon acceptance of this Service Order by the Company, the Consultant is authorized to provide the services described below. |
| **Description of Services to be provided under Service Order:**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Strategic advisory and consulting services, including business planning support, operational guidance, business development assistance, and other consulting services as agreed between the Parties.  |

---

IN WITNESS WHEREOF, this Service Order takes effect as of the signing date:

---

| | |
|:---|:---|
| <br> For "COMPANY" <br> DentonX Inc  | <br> For "CONSULTANT"<br>|
| <br>By: /s/__________________________<br>| <br>By: /s/________________________<br>|
| Date: _________________________ | Date: Sep./10/2025 |

---

------

Private & Confidential 5

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex101_1.jpg)

------

**Appendix B**

**Fee Schedule**

The Consultant is to provide a Fee Schedule ("Fee Schedule") to the Company that is mutually acceptable within 15 days after the signing of the Agreement. The Fee Schedule will be considered the details of Appendix B and included as part of the Agreement.

------

Private & Confidential 6

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex101_1.jpg)

------

**Appendix C**

**Status Report**

---

| | |
|:---|:---|
| Name | Report Date |
| Project | Report Period |
| Prior Month Accomplishments  | Prior Month Accomplishments  |
| <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Each item has to lead to a deliverable. (For example: Completed 3 proposals, finished the company brochure, etc.). <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Each item should be reviewed on the basis of improvement and completion and monitored against extended tasks. This section should not include the same accomplishments every week, but in the event that a deliverable takes several weeks to accomplish, the progress should be itemized into shorter milestones. A broad milestone is not beneficial for the recipient of the report.  | <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Each item has to lead to a deliverable. (For example: Completed 3 proposals, finished the company brochure, etc.). <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Each item should be reviewed on the basis of improvement and completion and monitored against extended tasks. This section should not include the same accomplishments every week, but in the event that a deliverable takes several weeks to accomplish, the progress should be itemized into shorter milestones. A broad milestone is not beneficial for the recipient of the report.  |
| Challenges and Solutions | Challenges and Solutions |
| <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.It is the responsibility of the consultant or employee to account every problem encountered. If a problem is encountered and not reported, it becomes reprimanded. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.For every enlisted challenge, there must be a corresponding (proposed) solution. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.If there are no challenges presently, it may be stated on this section, but may raise anticipated potential challenges and potential solutions.  | <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.It is the responsibility of the consultant or employee to account every problem encountered. If a problem is encountered and not reported, it becomes reprimanded. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.For every enlisted challenge, there must be a corresponding (proposed) solution. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.If there are no challenges presently, it may be stated on this section, but may raise anticipated potential challenges and potential solutions.  |
| Next Month's Goals & Objectives | Next Month's Goals & Objectives |
| <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.This section requires items that lead to deliverables. Do not report on this section a task that has no clear purpose or deliverable. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.If any of the items enlisted on this section is added onto the following week's report's Challenges and Solutions section, and any anticipated challenges related to any of the items were not reported onto the prior week's report, the manager has the right to question why it was not discovered ahead of time.  | <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.This section requires items that lead to deliverables. Do not report on this section a task that has no clear purpose or deliverable. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.If any of the items enlisted on this section is added onto the following week's report's Challenges and Solutions section, and any anticipated challenges related to any of the items were not reported onto the prior week's report, the manager has the right to question why it was not discovered ahead of time.  |
| Exceptions (This section deals with reporting unexpected changes) | Exceptions (This section deals with reporting unexpected changes) |
| <br> ☐ Cost ☐ Schedule ☐ Other: _____________________<br>Reason: Any unexpected, unplanned change in deadline time or cost needs to be immediately reported. | <br> ☐ Cost ☐ Schedule ☐ Other: _____________________<br>Reason: Any unexpected, unplanned change in deadline time or cost needs to be immediately reported. |

---

Signature

------

Private & Confidential 7

1178 Broadway, New York, NY 10001

## Exhibit 10.2

![Picture 2](dtnxex102_1.jpg)

------

**CONSULTING AGREEMENT**

This Consulting Agreement (the "Agreement") is entered into by DentonX Inc (the "Company") and Luis Carlos Ung (the "Consultant") on September 3, 2025. The Company and the Consultant may hereinafter be referred to individually as a "Party" and collectively as the "Parties."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.** **Consulting Relationship** 

During the term of this Agreement, the Consultant shall serve as the Company's Chief Executive Officer (CEO) and President. The Consultant agrees to provide executive leadership, strategic advisory services, and such other professional services as may be reasonably requested by the Company (collectively, the "Services").

The Consultant shall perform such Services under the direction and oversight of the Company's Board of Directors. Consultant represents that he possesses the qualifications, experience, and expertise necessary to perform these duties professionally and competently and agrees to dedicate sufficient time and attention to fulfill all responsibilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.** **Work to be Performed** 

As CEO and President, the Consultant shall perform Services consistent with the Company's mission and goals. Specific tasks may include, but are not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Executive decision-making

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Strategic planning and growth management

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Corporate leadership and operational oversight

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Business development, partnership engagement, and capital strategy

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any additional duties requested by the Board

Additional task-specific assignments may be issued through written Service Orders (Appendix A). Each Service Order will define scope, deliverables, milestones, and estimated timelines. The Consultant shall deliver all work in a timely and professional manner.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.** **Compensation** 

The Company shall pay the Consultant a Professional Service Fee, based on invoiced time spent providing Services, at an hourly rate to be established and agreed upon by the Parties (see Appendix B – Fee Schedule).

------

Private & Confidential 1

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex102_1.jpg)

------

Payment may be made in cash, equity, or a combination, as mutually agreed.

The Consultant shall submit a detailed invoice within five (5) business days following the end of each month, listing:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·hours worked

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Services performed

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·deliverables completed

The Consultant represents that time reported is accurate and that the Services provided meet or exceed industry-standard quality.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.** **Submission of Status Report by Consultant** 

The Consultant agrees to submit a regular written status report (Refer to Appendix C "Status Report") to the Company in the format and regularity as requested by the Company. The Consultant acknowledged that submissions of the regular status reports by the Consultant to the Company are vital for a healthy relationship between the Company and Consultant and provide the ability for the Company to measure the performance of the Consultant. The Consultant understands that failure to submit status reports as requested by the Company will be considered misconduct.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.** **Term and Termination** 

This Agreement shall be for an initial term of twelve (12) months, subject to earlier termination by either the Company or the Consultant as provided herein. The term of this Agreement may be renewed for an additional period on the same terms and conditions as are set forth herein, unless the Company or Consultant gives to the other party a notice of intent not to renew. Either party may terminate the Agreement at any time upon thirty (30) days' written notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.** **Confidentiality** **and Professional Standards**

Consultant understands in carrying out its duties to fulfill this Agreement. The consultant will be provided and be exposed to confidential and trade secret information of the Company and of Company affiliates ("Confidential and Secret Information"). Consultant understands that unauthorized disclosure of Confidential and Secret Information could lead to severe losses for the Company. Consultant agrees to keep confidential and not disclose to any third party to this Agreement on a permanent basis all confidential information of Company that Consultant received or known about during his service period. "Confidential and Secret information" refers to all concepts, ideas, trade secrets, theories, inventions, creations, works, processes, designs,

------

Private & Confidential 2

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex102_1.jpg)

------

text, art, images, mockups, materials, computer software, technical secrets, intellectual property rights or other trade secret information in any jurisdiction in the world (including but not limited to customer lists, investors list, affiliate list, consultants, advisors, information and discussions with members of the Board of Directors of Company and its affiliates, company operation models, business plans, feasibility studies, pro forma information, consultant reports and other presentation and reports, financial and economic status, marketing plans, procurement information, pricing policies, financial information, supply channel information, etc.) generated by Consultant during service period with Company for the purpose of performing her service duties or by making the use of Company's material and technical conditions and business information. Consultant promises not to use or implement the above confidential information without authorization, nor to disclose the above confidential information to any parties without authorization and bear the responsibility of failure for proper protection of Confidential and Secret Information. Furthermore, Consultant agrees that after the termination of service with Company, Consultant shall not cooperate or contact any of Company's clients or related parties. If the Consultant violates this Confidentiality clause, the Company has the right to seek the Consultant to compensate the Company for any losses incurred.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.** **Professional Standards and Non-Disparagement**

It is imperative that at all times all parties maintain a positive image of the Company and all its affiliates and treat each other with utmost professional respect including safeguarding the positive image and reputation of the Company. All Parties and in specific Consultant and Company, all agree to, at all times during the performance of this agreement and on a permanent basis after the termination of service with Company, refrain from engaging in any negative talk against the other party to third parties of this agreement and agree to refrain from making any disparaging remarks of Company and Consultant or any of their members, affiliates, advisors or stakeholders under any circumstances. If any party is found to disparage the other parties to third parties to this agreement, that party shall be responsible for any losses incurred to the other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.** **Force Majeure** 

No Party shall be liable for non-fulfillment of its obligations under the Agreement if such non-fulfillment is attributable to force majeure. Force majeure shall be taken to mean events over which the relevant Party has no control and which that Party could not have prevented, avoided or anticipated, including, but not limited to, stoppage of work, strikes, lock-outs, war, terrorism, natural disasters, states of emergency and similar.

The Party claiming force majeure shall notify the other Party without undue delay. Such notice shall be provided in writing and shall contain information about the nature of the force majeure

------

Private & Confidential 3

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex102_1.jpg)

------

event and its estimated duration and consequences for the performance of the Project, including the participation of the Party affected by the force majeure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.** **Governing Law** 

All claims regarding this Agreement are governed by and construed in accordance with the Laws of the State of Wyoming, USA.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.** **No Waivers, Cumulative Remedies** 

The failure of a party to insist upon strict performance or adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party's rights or deprive such party of the right thereafter to insist upon strict performance or adherence to that term or any other term of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.** **Severability** 

In the event any provision or part of this Agreement is found to be invalid or unenforceable, only that particular provision or part so found, and not the entire Agreement, will be inoperative.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12.** **Effective** 

This Agreement will be effective immediately upon signing and the signing date will be the Effective Date.

IN WITNESS WHEREOF, both Parties hereto have caused this Agreement to be executed by their duly authorized representatives on the dates specified below.

---

| | |
|:---|:---|
| For "COMPANY"<br> DentonX Inc  | For "CONSULTANT"<br>|
| <br>By: /s/__________________________<br>| <br>By: /s/________________________<br>|
| Date: _________________________ | Date: _______________________ |

---

------

Private & Confidential 4

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex102_1.jpg)

------

**Appendix A**

**Service Order Form**

---

| |
|:---|
| This Service Order is an appendix to the Consulting Agreement entered into on September 3, 2025 by and between DentonX Inc (the "Company") and Luis Carlos Ung (the "Consultant").<br>Upon acceptance of this Service Order by the Company, the Consultant is authorized to provide the services described below. |
| **Description of Services to be provided under Service Order:**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Executive leadership and strategic functions as CEO and President, including operations oversight, business development, partner relations, and any additional services assigned by the Board.  |

---

IN WITNESS WHEREOF, this Service Order takes effect as of the signing date:

---

| | |
|:---|:---|
| <br> For "COMPANY" <br> DentonX Inc  | <br> For "CONSULTANT"<br>|
| <br>By: /s/__________________________<br>| <br>By: /s/________________________<br>|
| Date: _________________________ | Date: _______________________ |

---

------

Private & Confidential 5

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex102_1.jpg)

------

**Appendix B**

**Fee Schedule**

The Consultant is to provide a Fee Schedule ("Fee Schedule") to the Company that is mutually acceptable within 15 days after the signing of the Agreement. The Fee Schedule will be considered the details of Appendix B and included as part of the Agreement.

------

Private & Confidential 6

1178 Broadway, New York, NY 10001

------

![Picture 2](dtnxex102_1.jpg)

------

**Appendix C**

**Status Report**

---

| | |
|:---|:---|
| Name | Report Date |
| Project | Report Period |
| Prior Month Accomplishments  | Prior Month Accomplishments  |
| <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Each item has to lead to a deliverable. (For example: Completed 3 proposals, finished the company brochure, etc.). <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Each item should be reviewed on the basis of improvement and completion and monitored against extended tasks. This section should not include the same accomplishments every week, but in the event that a deliverable takes several weeks to accomplish, the progress should be itemized into shorter milestones. A broad milestone is not beneficial for the recipient of the report.  | <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Each item has to lead to a deliverable. (For example: Completed 3 proposals, finished the company brochure, etc.). <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Each item should be reviewed on the basis of improvement and completion and monitored against extended tasks. This section should not include the same accomplishments every week, but in the event that a deliverable takes several weeks to accomplish, the progress should be itemized into shorter milestones. A broad milestone is not beneficial for the recipient of the report.  |
| Challenges and Solutions | Challenges and Solutions |
| <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.It is the responsibility of the consultant or employee to account every problem encountered. If a problem is encountered and not reported, it becomes reprimanded. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.For every enlisted challenge, there must be a corresponding (proposed) solution. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.If there are no challenges presently, it may be stated on this section, but may raise anticipated potential challenges and potential solutions.  | <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.It is the responsibility of the consultant or employee to account every problem encountered. If a problem is encountered and not reported, it becomes reprimanded. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.For every enlisted challenge, there must be a corresponding (proposed) solution. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.If there are no challenges presently, it may be stated on this section, but may raise anticipated potential challenges and potential solutions.  |
| Next Month's Goals & Objectives | Next Month's Goals & Objectives |
| <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.This section requires items that lead to deliverables. Do not report on this section a task that has no clear purpose or deliverable. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.If any of the items enlisted on this section is added onto the following week's report's Challenges and Solutions section, and any anticipated challenges related to any of the items were not reported onto the prior week's report, the manager has the right to question why it was not discovered ahead of time.  | <br> **Instructions on how to fill out this section:**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Use a number list <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.This section requires items that lead to deliverables. Do not report on this section a task that has no clear purpose or deliverable. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.If any of the items enlisted on this section is added onto the following week's report's Challenges and Solutions section, and any anticipated challenges related to any of the items were not reported onto the prior week's report, the manager has the right to question why it was not discovered ahead of time.  |
| Exceptions (This section deals with reporting unexpected changes) | Exceptions (This section deals with reporting unexpected changes) |
| <br> ☐ Cost ☐ Schedule ☐ Other: _____________________<br>Reason: Any unexpected, unplanned change in deadline time or cost needs to be immediately reported. | <br> ☐ Cost ☐ Schedule ☐ Other: _____________________<br>Reason: Any unexpected, unplanned change in deadline time or cost needs to be immediately reported. |

---

Signature

------

Private & Confidential 7

1178 Broadway, New York, NY 10001

## Exhibit 10.3

**AMENDED AND RESTATED**

**CORPORATE DEVELOPMENT AND FINANCIAL CONSULTING AGREEMENT**

This Corporate Development and Financial Consulting Agreement (the "**Agreement**") is entered into on September 23, 2025 (the "Effective Date") by and between DentonX Inc (the "**Company**") and Fairbanks Global Partners II LLC (the "**Firm**").

**1. Services to be Provided.** The Firm shall provide services as specified in Service Order(s) from time to time submitted by the Company and accepted in writing by both the Company and the Firm ("Service Order(s)"). Each Service Order shall be in a form similar to the one attached as ***Appendix A****.* Any accepted Service Order may be amended or superseded by any new Service Order only in writing by both parties, which expressly provides that it amends or supersedes a prior Service Order. Each and all accepted Service Orders, including the Service Order in ***Appendix A,*** constitute part of this Agreement. The Company understands and acknowledges that there are instances where the Firm, at its discretion, may assign or subcontract the work to third parties.

**2. Duties of the Company.** The Company shall cooperate with the Firm in whatever way is reasonably necessary for the Firm to provide the services contemplated hereunder and shall participate with the Firm in the handling of the Company's matter. Without limiting the foregoing, the Company agrees to respond with reasonable promptness to telephone calls and other inquiries by the Firm, review documents and correspondence, and regularly communicate with the Firm about the matter in general, including but not limited to any suggestions, questions or concerns that the Company has, and to promptly pay the charges for the services rendered and expenses incurred hereunder. The Company further covenants to provide all relevant information and documentation available to and requested by the Firm and necessary for the Firm to handle the matter, and the Company acknowledges that failure to do so may result in an outcome that is less favorable than would otherwise be attainable.

**3. Fees for Services.** The Company shall pay the Firm a fee for services performed for the Company as specified in the Service Order(s). The Company shall pay the Firm for invoiced services in cash or in such other means as the parties agree upon in writing. The Company acknowledges and agrees that the Firm has provided certain preparatory and consulting services prior to the Company's incorporation and the Effective Date of this Agreement (the "Pre-Effective Services"). The Company hereby ratifies and adopts such Pre-Effective Services as having been performed for the benefit of the Company, and agrees that all fees and expenses related thereto shall be payable to the Firm in accordance with this Agreement, as though such services had been performed after the Effective Date.

**4. Estimates.** While an estimate or indication of the amount of fees and time that will likely be incurred in any particular project may be provided from time to time, such estimates are not guaranteed amounts but rather are meant to serve as guidelines only. Numerous factors on any project may affect those estimates and require that they be revised. If at any time an estimate for a particular project has been given to the Company, and it becomes apparent that the actual hours required for the project will significantly exceed the estimate, the Company will be informed of that fact, and the Company may elect to discontinue further action. The Company may, at any time, request a written estimate of projected fees and time associated with particular requirements or actions to be undertaken by the Firm.

**5. Termination.** Either party shall have the right to terminate this Agreement within sixty (60) days (the "Termination Timeframe") by a written notice. Termination and withdrawal from further engagement may occur if the Company has failed or refused to comply with its obligations hereunder and if the Company does not cure the same within ten (10) days after written notice thereof is received by the Company. In the event a termination notice is issued, the Company shall be responsible for payment of all services and costs incurred during the Termination Timeframe.

------© 2025 Fairbanks Group. All Rights Reserved. Private, Privilege and Confidential Page 1

------

**6**. **Return of the Company Records.** Upon termination, the Firm may give the Company notice that the Firm wishes to deliver the Company's records in the possession of the Firm to the Company. Within thirty (30) days, the Company shall notify the Firm as to the address to which such records shall be delivered. If the Company does not respond within said thirty (30) day period, the Firm shall be entitled to destroy such records, and the Company shall waive any and all claims relating to such destruction.

**7**. **Collection Fees.** In the event of any dispute between the parties, the prevailing party shall be entitled to reasonable costs incurred, including attorneys' fees.

**8. Objection to Billing.** In the event that the Company has any objection whatsoever to any of the fees for services rendered or the costs and disbursements that are billed, it is the Company's obligation to immediately set forth any such objection at that time, and no later than seven (7) days of receipt of such invoices and to bring it to the Firm's attention in writing within that period. The Company's failure to timely set forth any such disagreement or objection to any fee for services rendered or costs incurred shall be considered to be a waiver of any such objections.

**9. Limited Liability.** The Firm will perform the services with reasonable care and professional skill. The Firm does not warrant or provide warranties of any kind, expressed or implied, including but not limited to the merchantability or fitness for use or purpose of the work performed or non-infringement. In no event shall the Firm be liable to the Company or any third party for incidental, indirect, special, or consequential damages (including, without limitation, lost profits, loss of data, loss of use or claims of third parties) as a result of implementing this Agreement. The Company acknowledges that Firm does not provide legal advice and is not a broker-dealer or underwriter and does not provide services directly or indirectly related to the offering, issuance or sale of securities.

**10**. **Confidentiality, Non-Solicitation, and Non-Circumvention.** The Company agrees not to disclose the content of this Agreement, Service Orders, or subordinate Agreements to this Agreement to third parties and non-parties of this Agreement in any form, orally, electronically, or otherwise. Both parties agree to adhere to any executed Non-disclosure provisions of the Company and/or Firm. Furthermore, the Company understands that the Firm's business depends on its resources, which include but are not limited to human resources, knowledge, technology, intellectual property, partnerships, and contacts. The Company agrees, during the term of this Agreement and for a period of twenty-four (24) months after the termination of this Agreement, not to, directly or indirectly, solicit or circumvent, offer employment, hire, contract, or employ in any form for pay or otherwise, any of the Firm's resources including, but not limited to, employees, contractors, suppliers, investors, brokers, bankers, manufacturers, consultants, companies, introduced by Firm to the Company, its director's, employees, agents, and affiliates during the performance of this Agreement without Firm's expressed written approval. The Company shall inform in writing within seven (7) days from the Effective Date of any prior direct relationship that may affect the Firm's contribution to the Agreement, especially as described in this section.

**11. Force Majeure.** Neither party hereto shall be liable for any breach of its obligation hereunder resulting from causes beyond its reasonable control, including but not limited to fire, strikes (excluding their own employees), insurrection or riots, embargoes, wrecks, or delays in transportation, inability to obtain supplies and raw materials, or regulation of any civil or military authority. Each of the parties hereto agrees to give notice forthwith to the other upon becoming aware of an event of Force Majeure, such notice to contain details of the circumstances giving rise to the Force Majeure.

**12. Governing Law, Binding Arbitration.** This Agreement is governed by the laws of the state of Delaware. In the event of any disagreement as to the billing statements, both parties have the right to arbitration. Any dispute arising out of or relating to this Agreement or the services provided hereof,

------© 2025 Fairbanks Group. All Rights Reserved. Private, Privilege and Confidential Page 2

------

including but not limited to any disagreement and/or appeal remaining after the arbitration referred to in the previous sentence, shall be resolved through binding arbitration by an arbitrator under the place of the registration of the Firm.

**13**. **Potential Conflicts of Interest.** The Company acknowledges that the Firm has been, and may in the future be, engaged to provide services as a consultant to other companies in the industry in which the Company is involved. Subject to the confidentiality provisions of the Firm contained in Section 9 hereof, the Company acknowledges and agrees that nothing contained in this Agreement shall limit or restrict the right of the Firm or of any member, manager, officer, employee, agent, or representative of the Firm, to be a member, manager, partner, officer, director, employee, agent, or representative of, investor in, or to engage in, any other business, whether or not of a similar nature to the Company's business, nor to limit or restrict the right of the Firm to render services of any kind to any other corporation, firm, individual or association; provided that the Firm and any of its member, manager, officer, employee, agent, or representative shall not use the Information to the detriment of the Company. The Firm may, but shall not be required to, present opportunities to the Company.

**14. Severability.** In the event any of the provisions of this Agreement is held by a court or other tribunal of competent jurisdiction to be unenforceable, the other provisions of this Agreement will remain in full force and effect.

**15. Amendments.** This Agreement shall not be amended or modified except in writing signed or otherwise confirmed by the parties.

**16. Entire Agreement.** This Agreement, together with its Service Order(s), and appendices, constitutes the entire agreement between the parties and supersedes any prior understanding or representation of any kind preceding the date of this Agreement. There are no other promises, conditions, understandings, or other agreements, whether oral or written, relating to the subject matter of this Agreement. This Agreement may be modified in writing and must be signed by both the Company and the Firm.

**17. Effectiveness.** This Agreement will become effective only after it has been signed by the Company, and it has been accepted by the Firm at its principal place of business. The Company and the signing party certify that it has been given the authority to bind the Company into this Agreement.

**18**. **Right of First Refusal.** The Company agrees that if it is a party to any merger, acquisition, or any other business combination within two years of this Agreement, and it decides to engage in incubation and management services on a fee basis in connection therewith, the Company shall give prompt written notice of such an event to the Firm, and the Firm shall be entitled to a 60-day right of first refusal, beginning on the day the Firm receives such written notice from the Company of such event, to provide services to the Company. If such right of first refusal is exercised by the Firm, the terms of any such engagement of the Firm will be separately agreed upon between the Company and Firm and will be no less favorable to the Company than the engagement the Company negotiated with the other party. Nothing contained herein to the contrary shall preclude the Company from continuing to raise capital on its own behalf.

**IN WITNESS WHEREOF**, the parties hereto have executed this Agreement as of the Effective Date.

*Signature Page Follows*

------© 2025 Fairbanks Group. All Rights Reserved. Private, Privilege and Confidential Page 3

------

*Signature Page*

---

| | |
|:---|:---|
| &nbsp;&nbsp;For "**COMPANY"** | &nbsp;&nbsp;For "**FIRM"** |
| &nbsp;&nbsp; <br>By: */s/ Luis Carlos Ung* | &nbsp;&nbsp; <br>By: */s/ Nancy Wong* |
| &nbsp;&nbsp;Print Name: Luis Carlos Ung<br> Title: CEO <br> Date: September 23, 2025  | &nbsp;&nbsp;Print Name: Nancy Wong<br> Title: Managing Director<br> Date: September 23, 2025 |

---

------© 2025 Fairbanks Group. All Rights Reserved. Private, Privilege and Confidential Page 4

------

**Appendix A - Service Order**

---

| | |
|:---|:---|
| The Company: DentonX Inc<br>Address: 1999 Harrison Street, Suite 1800, Oakland, CA 94612 | Project Name: Corporate Development <br>Amendment or Superseding prior Service Order? NO<br>If so, describe: |
| <br> Upon acceptance of this Service Order (hereafter referred to as "SO") by the Company, the Firm is authorized to provide the services described below according to the Corporate Development and Financial Consulting Agreement between the Company and the Firm. | <br> Upon acceptance of this Service Order (hereafter referred to as "SO") by the Company, the Firm is authorized to provide the services described below according to the Corporate Development and Financial Consulting Agreement between the Company and the Firm. |
| **Objectives and Description of the Project** <br>The Company's primary objective is to form a reporting U.S. company ("U.S. Co") filed with the SEC of the U.S., while also raising capital to support operations and the expansion plan ("Company Objectives").<br>The objective of this project is to drive a Corporate Development effort. For this purpose, the Company has engaged the Firm exclusively to provide financial advisory and strategic consulting services as outlined in this SO.<br>**Scope of Services**<br>This SO defines the services to be provided by the Firm in support of the Company's corporate development initiatives. These services intend to help the Company achieve its stated objectives of becoming a U.S. reporting company, raising capital, and executing its expansion plan.<br>The Firm will provide the following services to the Company on a best-efforts basis:<br>**1. Corporate Structuring & SEC Readiness**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Advise on the formation of a U.S. reporting company ("U.S. Co") and prepare for SEC registration and reporting requirements. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Assist in developing governance, compliance, and disclosure frameworks aligned with public market standards.  | **Objectives and Description of the Project** <br>The Company's primary objective is to form a reporting U.S. company ("U.S. Co") filed with the SEC of the U.S., while also raising capital to support operations and the expansion plan ("Company Objectives").<br>The objective of this project is to drive a Corporate Development effort. For this purpose, the Company has engaged the Firm exclusively to provide financial advisory and strategic consulting services as outlined in this SO.<br>**Scope of Services**<br>This SO defines the services to be provided by the Firm in support of the Company's corporate development initiatives. These services intend to help the Company achieve its stated objectives of becoming a U.S. reporting company, raising capital, and executing its expansion plan.<br>The Firm will provide the following services to the Company on a best-efforts basis:<br>**1. Corporate Structuring & SEC Readiness**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Advise on the formation of a U.S. reporting company ("U.S. Co") and prepare for SEC registration and reporting requirements. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Assist in developing governance, compliance, and disclosure frameworks aligned with public market standards.  |

---

------© 2025 Fairbanks Group. All Rights Reserved. Private, Privilege and Confidential Page 5

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br> **2. Capital Raising Support**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Provide strategic guidance on capital raising initiatives, including equity, debt, and hybrid structures. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Assist in the preparation of investor presentations, offering memoranda, and related fundraising materials. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Support engagement with institutional investors, private equity, and strategic capital partners. <br>**3. Strategic Growth & Expansion Advisory**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Advise on acquisition opportunities, joint ventures, and strategic partnerships in non-bank lending and adjacent sectors. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Conduct financial and strategic assessments of potential targets. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Support integration planning under the Company's platform model. <br>**4. Financial & Valuation Advisory**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Assist in financial modeling, valuation analyses, and scenario planning. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Advise on capital allocation strategies to maximize shareholder value. <br>**5. Corporate Development Program Management**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Provide ongoing strategic consulting services to align execution with the Company's long-term objectives. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Monitor progress and provide recommendations to ensure alignment with the Company's IPO readiness and expansion roadmap. <br>**Note**: The Company understands and acknowledges that the Firm may, at its discretion, assign or subcontract portions of the work described herein to third parties.<br>**Payment Schedule** (All cash payments are in US Dollars unless specified in this SO) <br>In accordance with Section 3 and Section 4 of the Agreement, respectively, unless otherwise superseded herein:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.** **Retainer** (Section 4 of the Agreement). <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.The initial retainer shall be US$80,000. The Company shall pay the Firm the retainer in the following manner: US$40,000 due upon signing the Agreement and US$40,000 due on November 5, 2025. <br>

------© 2025 Fairbanks Group. All Rights Reserved. Private, Privilege and Confidential Page 6

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.** **Professional Service Fee** <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Company shall pay the Firm Fees for Services ("Service Fee") based on actual time spent using the Fee Schedule attached as ***Appendix C***. Payment of the Service Fee may be made in both cash and non-cash forms, as mutually agreed upon by the Company and the Firm. If any portion of the fee is paid in equity, the equity will be valued at the Company's current fair market valuation, with a 30% discount applied. This discount percentage may be adjusted by mutual agreement between the Company and the Firm. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any unpaid invoices that are past due for 45 days shall be paid through a promissory note with an annual interest rate of 9.5%, subject to mutual consent. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Unpaid invoices and any non-cash payment will incur a 15% additional handling fee for the amount. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.For clarity, Pre-Effective Services (as defined in Section 3 of the Agreement) performed by the Firm prior to September 3, 2025 are billable under this Service Order. <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.** **Consulting Success Compensation** <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.The Firm may earn consulting success-based compensation upon achieving mutually agreed business or strategic milestones, including (but not limited to) the execution of strategic partnerships, board-approved transactions, achievement of revenue or growth benchmarks, or other corporate development outcomes ("Consulting Success Compensation"). <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Consulting Success Compensation will be based on milestone phases documented and agreed upon in writing by both the Company and the Firm. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Payment is due upon completion of the agreed milestone, and may be made in cash, non-cash consideration, or equity, as mutually agreed by the parties. <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.For clarity, the Firm does not act as a broker-dealer, underwriter, or placement agent, and its compensation is tied to advisory and consulting services, not to the purchase or sale of securities. <br>**Note:** <br> All payments shall be made to the bank account designated by the Firm.<br> If payment is not received within five (5) business days, a daily interest rate of 0.05% will apply.<br>

IN WITNESS WHEREOF, this SO is effective as of the date of signing.

---

| | |
|:---|:---|
| &nbsp;&nbsp;For "**COMPANY"** | &nbsp;&nbsp;For "**FIRM"** |
| &nbsp;&nbsp; <br>By: */s/ Luis Carlos Ung* | &nbsp;&nbsp; <br>By: */s/ Nancy Wong* |
| &nbsp;&nbsp;Print Name: Luis Carlos Ung<br> Title: CEO <br> Date: September 23, 2025  | &nbsp;&nbsp;Print Name: Nancy Wong<br> Title: Managing Director<br> Date: September 23, 2025 |

---

------© 2025 Fairbanks Group. All Rights Reserved. Private, Privilege and Confidential Page 7

------

**Appendix B - Sample Status Report**

**Status Report**

---

| | |
|:---|:---|
| Name | Date |
| Project | Period Ending |
| Accomplishments Last Period  | Accomplishments Last Period  |
| Problems Encountered & Solutions | Problems Encountered & Solutions |
| Next Period's Tasks & Challenges | Next Period's Tasks & Challenges |
| Exceptions (This section deals with reporting unexpected changes) | Exceptions (This section deals with reporting unexpected changes) |
| <br> ☐ Cost ☐ Schedule ☐ Other: _____________________<br>Reason: Any unexpected, unplanned change in deadline time or cost needs to be immediately reported. | <br> ☐ Cost ☐ Schedule ☐ Other: _____________________<br>Reason: Any unexpected, unplanned change in deadline time or cost needs to be immediately reported. |

---

Signature

------© 2025 Fairbanks Group. All Rights Reserved. Private, Privilege and Confidential Page 8

------

**Appendix C - Fee Schedule**

(Effective Until June 30, 2026)

In accordance with Sections 3 and 4 of the Agreement and approved Service Orders, the following fees are established for compensation for Services under the Service Orders and Consulting Success-Based Compensation.

For clarity, the Firm is not a broker-dealer, underwriter, or placement agent, and does not engage in the sale of securities. Compensation described herein is for consulting and strategic advisory services only.

These Fees are subject to change, and the Firm will notify the Company of any updates to the Fee Schedule.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Professional Service Fee** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Administrative Associate - US$80/ Hour <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Associate Financial Analyst - US$155/ Hour <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Senior Financial Analyst - US$285/ Hour <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Director/Supervisor - US$450/ Hour <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Managing Director - US$625/ Hour <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Managing Partner - US$850/ Hour <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Senior Managing Partner - US$1,350/ Hour  |
| &nbsp;&nbsp;**Business Development Consulting Success Fee** | &nbsp;&nbsp;The fee is calculated using Lehman (2.0) as a consulting benchmark, payable upon the Firm's documented contribution to business development outcomes such as new client acquisition, partnerships, or revenue growth. |
| &nbsp;&nbsp;**Financial Introduction Support Fee** | &nbsp;&nbsp;The fee is calculated using Lehman (2.0) as a consulting benchmark, payable upon the Firm's documented provision of introductions and related advisory services that support the Company's financing efforts. Compensation is not contingent solely upon the sale of securities. |
| &nbsp;&nbsp;**M&A Consulting Success Fee** | &nbsp;&nbsp;The fee is calculated using Lehman (2.0) as a consulting benchmark, payable upon the Company's execution of an M&A or similar strategic transaction where the Firm has provided advisory support. The Firm's role is limited to consulting and advisory services. |
| &nbsp;&nbsp;**Performance Override Fee** | &nbsp;&nbsp;A 2% supplemental consulting fee payable when the Firm's efforts produce outcomes exceeding predefined business performance targets |

---

------© 2025 Fairbanks Group. All Rights Reserved. Private, Privilege and Confidential Page 9

## Exhibit 10.4

**TECHNICAL CONSULTING AGREEMENT**

**This Technical Consulting Agreement ("Agreement")** is entered into as of **September 25, 2025** ("Effective Date"), by and between:

**DentonX Inc**, a Wyoming corporation ("Client" or "DentonX"),

and

**LocusX Technologies Inc. (in formation)**, a Wyoming corporation currently being organized ("Consultant" or "LocusX").

Client and Consultant may each be referred to as a "Party" and collectively as the "Parties."

**1. SCOPE OF SERVICES**

**1.1 Services**

Consultant shall provide technical consulting, software automation, workflow engineering, systems architecture, API integrations, database engineering, and related development services required to design, build, test, and deploy the automation workflow described in **Exhibit A ("Proposal").**

**1.2 Deliverables**

Consultant shall produce the Deliverables listed in **Exhibit B (Milestones & Deliverables)**.

Deliverables include, without limitation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Automation Engines (Deposit/Leverage Engine, Lending Engine, Securitization Engine)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·API Integrations and Data Feed Setup

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Digital Record Architecture (Loans, Credit Lines, Securitized Pools)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·System Architecture Diagrams

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Technical Documentation

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Testing & QA Reports

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Status Reports

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Deployment Assistance

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Support across PoC, Pilot, and Rollout Phases

------

Private & Confidential 1

------

**1.3 Standard of Performance**

Consultant shall perform Services in a **professional, timely, and workmanlike manner** consistent with industry best practices for financial automation systems, including secure coding, documentation standards, and quality assurance methodologies.

**2. SOFTWARE DEVELOPMENT LIFECYCLE (SDLC)**

Consultant shall follow a structured SDLC process including:

1)Requirements Definition

2)Architecture and Design Review

3)Development & Implementation

4)Testing & Quality Assurance

5)User Acceptance Testing (UAT)

6)Deployment

7)Maintenance & Support

Each phase is subject to Deliverables and Acceptance Criteria as defined in **Exhibit B** and **Exhibit C**.

**3. STATUS REPORTING & COMMUNICATION**

Consultant shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Provide **weekly written status reports** summarizing progress, issues, risks, and next steps.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Hold **bi-weekly milestone review meetings** with DX.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Maintain an **issue tracking system** (Jira, Trello, ClickUp, or equivalent).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Document all changes using a **Change Request Form** approved by DX.

**4. ACCEPTANCE OF DELIVERABLES**

**4.1 Submission**

Consultant shall submit each Deliverable for review and acceptance upon completion.

------

Private & Confidential 2

------

**4.2 Acceptance Review**

Client shall have **10 business days** to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Accept the Deliverable, or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Reject it with written notice detailing deficiencies.

**4.3 Remediation**

If a Deliverable is rejected:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Consultant must correct deficiencies **within 10 business days** at no additional cost.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Deliverable will then be resubmitted for acceptance.

**4.4 No Payment Until Accepted**

Payments for each milestone are due **only after** formal acceptance by DX.

**5. TERM**

This Agreement remains in effect from the Effective Date until all Services are completed unless terminated earlier per Section 12.

**6. COMPENSATION**

**6.1 Fees**

**(a) Initial Payment**

Client shall make an initial payment of **US $50,000** to commence work ("Initial Payment").

**(b) Milestone Payments**

Milestone payments shall follow the pricing and structure detailed in **Exhibit B**.

**(c) Payment Condition**

No payment is owed until the corresponding Deliverables have been **accepted** by DX per **Section 4**.

------

Private & Confidential 3

------

**6.2 Expenses**

Client shall reimburse Consultant for **reasonable, pre-approved** out-of-pocket expenses.

**6.3 Payment Terms**

Invoices are due within **15 days** after acceptance. Late balances accrue interest at **1.5% per month** or the maximum allowed by law.

**7. INDEPENDENT CONTRACTOR**

Consultant is an independent contractor and not an employee, representative, or agent of Client.

**8. INTELLECTUAL PROPERTY**

**8.1 Ownership of Work Product**

All **Work Product** developed specifically for Client shall become the **sole and exclusive property of DentonX** upon payment of all amounts due.

**8.2 Consultant Tools**

Consultant retains ownership of any background technology not developed specifically for Client, but grants Client a **perpetual, royalty-free license** to use such tools as integrated into the Work Product.

**9. CONFIDENTIALITY**

Each Party shall protect the other's confidential information using commercially reasonable care. Confidentiality obligations survive **five (5) years** after termination.

**10. WARRANTIES**

Consultant warrants:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Services will be performed professionally and competently.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Deliverables will conform to the requirements and acceptance criteria in Exhibits A–C.

Except as stated above, Consultant disclaims all implied warranties.

------

Private & Confidential 4

------

**11. TESTING & QUALITY ASSURANCE**

Consultant shall provide:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Test Plans

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Test Scripts

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Unit Test Results

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Integration Test Results

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Performance & Load Testing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·User Acceptance Testing (UAT) Assistance

All testing documentation must be delivered prior to milestone acceptance.

**12. TERMINATION**

Either Party may terminate:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·With **30 days written notice**, or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Immediately for material breach not cured within **15 days**.

Upon termination:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Client shall pay for accepted Deliverables only.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Consultant must deliver all partially completed work and documentation.

**13. PERFORMANCE FAILURE**

If Consultant:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Misses a milestone by more than **15 days**,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Fails to meet acceptance criteria twice, or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Provides materially defective work,

Client may:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Withhold payments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Require remediation at no cost;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Replace Consultant and charge costs to Consultant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Terminate the Agreement for cause.

------

Private & Confidential 5

------

**14. LIMITATION OF LIABILITY**

Consultant's total liability is limited to the total fees paid by Client. Consultant shall not be liable for indirect or consequential damages.

**15. GOVERNING LAW**

This Agreement is governed by the laws of the State of **Wyoming**.

**16. MISCELLANEOUS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Assignment requires prior written consent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·This Agreement and its Exhibits constitute the entire agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Amendments must be in writing and signed by both Parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Electronic signatures are valid.

**SIGNATURES**

**DENTONX INC**

By: /s/____________________________________

Name:

Title:

**LOCUSX TECHNOLOGIES INC. (in formation)**

By: /s/____________________________________

Name:

Title:

------

Private & Confidential 6

------

**EXHIBIT A – PROPOSAL**

**Traditional Automation Workflow (No Virtual Currency Involvement)**

**Executive Summary**

Denton X (DX) currently operates a manual, labor-intensive lending ecosystem where investor fiat deposits trigger bank credit lines, fund loans to borrowers, and culminate in securitized loan sales to secondary markets. This process involves multiple intermediaries, paper-based documentation, and time-consuming transfers, leading to high operational costs and delays.

By leveraging traditional software automation tools (such as API integrations, cloud databases, and rules engines), DX can automate the entire workflow. This creates a centralized, transparent, and efficient system that reduces manual intervention by 80-90%, cuts costs, and enables 24/7 global access. The proposal outlines a phased implementation using secure cloud platforms (e.g., AWS or Azure), with fiat transfers handled via bank APIs.

**Current Process Pain Points**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Step** | &nbsp;&nbsp;**Description** | &nbsp;&nbsp;**Key Issues** |
| &nbsp;&nbsp;1. Investor Deposits | &nbsp;&nbsp;Fiat cash deposited in bank. | &nbsp;&nbsp;Manual verification; siloed banking systems. |
| &nbsp;&nbsp;2. Credit Line Issuance | &nbsp;&nbsp;Bank issues 4x leverage<br> ($1M → $4M credit). | &nbsp;&nbsp;Regulatory compliance checks; delayed approvals. |
| &nbsp;&nbsp;3. Loan Origination & Transfer | &nbsp;&nbsp;DX members lend via bank- to-bank transfers. | &nbsp;&nbsp;Error-prone manual approvals; slow settlements (days). |
| &nbsp;&nbsp;4. Securitization & Sale | &nbsp;&nbsp;Loans packaged as PDFs/ papers for secondary markets. | &nbsp;&nbsp;High admin costs; fraud risks; limited liquidity. |
| &nbsp;&nbsp;**Overall Challenges:** 70% of time spent on reconciliation, compliance, and paperwork; scalability limited by manual labor. | &nbsp;&nbsp;**Overall Challenges:** 70% of time spent on reconciliation, compliance, and paperwork; scalability limited by manual labor. | &nbsp;&nbsp;**Overall Challenges:** 70% of time spent on reconciliation, compliance, and paperwork; scalability limited by manual labor. |

---

**Proposed Solution: Software Automation Workflow**

Integrate automation software tools to handle triggers, conditions, and executions, while representing assets as digital records (e.g., database entries) for seamless transfers and trading. Key components:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Automation Rules Engine**: Handles escrow, leverage calculations, loan approvals, and securitization logic.

------

Private & Confidential 7

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Digital Asset Records**: Loans and credit lines represented as database entries (interchangeable for pools or individual loan records).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Data Feeds**: Third-party APIs (e.g., credit bureau interfaces) for fiat conversions, credit scores, and regulatory compliance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Fiat Bridge**: Partnerships with custodian banks for fiat transfers. The streamlined process reduces steps from 4 to 2, with end-to-end execution in minutes.

**Streamlined Process Flow**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.** **Investor Deposit & Credit Line Automation**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Current**: Manual bank deposit → Approval → Credit issuance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Proposed**: Investors deposit fiat via a regulated bank API. A Deposit Automation Engine escrows funds and triggers an API-verified 4x leverage calculation.

oExample Logic: If deposit ≥ $1M, generate $4M in "Credit Records" in the DX treasury database and assign to DX treasury.

oAutomation: No human approval needed post-KYC; system events notify stakeholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Time Savings**: From days to <1 hour.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.** **Loan Origination & Disbursement**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Current**: Manual loan approvals → Bank transfers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Proposed**: DX members (lenders) connect via a secure portal to a Lending Automation Engine. Borrowers submit applications online (integrated with credit APIs for automated scoring).

oUpon approval: Engine atomically transfers Credit Records (or partial fiat) from DX treasury to borrower's account, while generating a Loan Digital Record (embedding terms like interest rate, repayment schedule).

oTransfers: Instant via bank APIs; off-ramp to borrower's bank if needed.

oSecurity: Collateral (e.g., real estate records) auto-locks in escrow accounts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Time Savings**: From 3-5 days to seconds; reduces transfer errors by 100%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.** **Securitization & Secondary Market Sales (Combined with Step 4)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Current**: Manual packaging into PDFs → Broker sales.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Proposed**: A **Securitization Automation Engine** aggregates Loan Digital Records into a pooled digital asset (e.g., "Securitized Loan Pool" record).

------

Private & Confidential 8

------

oTriggers: When pool reaches threshold (e.g., $10M in loans), auto-generate digitized securities compliant with regs (via embedded KYC/AML metadata).

oSales: List on regulated secondary market platforms (e.g., broker systems) for fractional ownership. Buyers trade records directly; redemptions auto-distribute principal/interest.

oNo PDFs: All docs stored in secure cloud databases for auditability.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Time Savings**: From weeks to instant liquidity; enables global 24/7 trading.

**High-Level Architecture Diagram (Conceptual):**

Investor Fiat Deposit → Bank API (Escrow + 4x Leverage) → Credit Records Generated

↓

Lending Engine (Approval + Transfer) → Loan Digital Records Issued to Borrowers

↓

Securitization Engine (Pooling + Digitization) → Securitized Pool Records → Market Platform Trading/ Sale

**Implementation Roadmap**

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Phase** | &nbsp;&nbsp;**Timeline** | &nbsp;&nbsp;**Key Actions** | &nbsp;&nbsp;**Cost Estimate** |
| &nbsp;&nbsp;**1: Proof of Concept** | &nbsp;&nbsp;1-2 Months | &nbsp;&nbsp;Develop/test core engines in test environment; integrate APIs. | &nbsp;&nbsp;$50K-$100K (dev + audit) |
| &nbsp;&nbsp;**2: Pilot** | &nbsp;&nbsp;3-4 Months  | &nbsp;&nbsp;Onboard 5-10 DX members; handle $1M test volume.  | &nbsp;&nbsp;$150K (compliance + integration)  |
| &nbsp;&nbsp;**3: Full Rollout** | &nbsp;&nbsp;5-6 Months  | &nbsp;&nbsp;Scale to production; partner with banks for fiat bridges.  | &nbsp;&nbsp;$200K+ (marketing + scaling)  |
| &nbsp;&nbsp;**Ongoing** | &nbsp;&nbsp;Continuous  | &nbsp;&nbsp;Audits (e.g., third-party security reviews); regulatory filings (e.g., SEC for securities).  | &nbsp;&nbsp;Annual $50K  |

---

**Tech Stack:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Cloud Platform**: AWS/Azure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Engines**: Python/Java rules engines; secure libraries for protection.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Frontend**: Web portal with secure login (e.g., OAuth) for DX dashboard.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Compliance**: Embed digital identity verification for KYC proofs.

------

Private & Confidential 9

------

**Benefits**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Efficiency**: Automate 90% of manual tasks; end-to-end process in <1 day vs. weeks.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Cost Reduction**: Slash labor/admin costs by 70% (no paperwork/brokers); lower fees via

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·automation (e.g., $0.01/transaction).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Transparency & Security**: Immutable audit trail reduces fraud; automation engines enforce terms (e.g., auto-liquidate defaults).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Scalability & Liquidity**: Global access; fractional digital record trading boosts secondary market volume by 5x.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Revenue Upside**: DX earns protocol fees (e.g., 0.5% on securitizations) from automated activity.

**Potential Challenges & Mitigations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Regulatory Hurdles**: Securitization may classify as securities.

o*Mitigation*: Partner with legal experts (e.g., for Reg D compliance); start in U.S. jurisdictions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Adoption Barriers**: Users unfamiliar with digital portals.

o*Mitigation*: Hybrid UI (fiat-like interface); education via DX app.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Data Risks**: API feed failures.

o*Mitigation*: Use reliable third-parties; fallback manual overrides.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Volatility**: Fiat risks mitigated through bank monitoring.

**Conclusion** 

Adopting traditional software automation transforms DX from a mechanical operation into an efficient digital platform, positioning it as a leader in digitized lending. This not only streamlines the process but unlocks new revenue streams through programmable finance. We recommend initiating a PoC with a software development firm to validate feasibility

------

Private & Confidential 10

------

**EXHIBIT B – MILESTONES & DELIVERABLES**

**Phase 1: Proof of Concept (1–2 Months)**

**Cost: $50,000–$100,000**

Deliverables:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Requirements Specification

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Architecture Diagram

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.API Integration Plan

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.Prototype Engines (Deposit/Leverage, Lending)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.Digital Record Models

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.Test Reports

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.Weekly Status Reports

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.Demo + Acceptance

**Phase 2: Pilot (3–4 Months)**

**Cost: $150,000**

Deliverables:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Integration with 5–10 users

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.$1M test volume simulation

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Security Test Report

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.Updated Architecture

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.Pilot Report

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.Acceptance

**Phase 3: Full Rollout (5–6 Months)**

**Cost: $200,000+**

Deliverables:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Production system

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Bank API integration

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Stress Testing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.Compliance Logging

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.Deployment Documentation

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.Acceptance

------

Private & Confidential 11

------

**EXHIBIT C – ACCEPTANCE CRITERIA**

A Deliverable is accepted only if:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Meets documented requirements

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Passes all test cases

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Is free of critical bugs

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Includes all required documentation

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Receives written approval from DX

------

Private & Confidential 12

------

**EXHIBIT D – TESTING REQUIREMENTS**

Consultant shall provide:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Unit Tests (90% coverage target)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Integration Tests

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·End-to-End Workflow Tests

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Load/Performance Tests

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Security & Vulnerability Scan

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·User Acceptance Testing Support

------

Private & Confidential 13

## Exhibit 10.5

**LICENSE AGREEMENT**

**Private & Confidential**

This Non-Exclusive Licensing Agreement ("Agreement") is entered into on **September 25, 2025**, by and between:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.**LocusX Technologies Inc. (in formation)** ("Licensor" or "LocusX"), an entity in formation to be incorporated under the laws of the State of Wyoming. Until incorporation, all rights and obligations under this Agreement shall be held by the Founders in trust and automatically assigned to LocusX Technologies Inc. upon incorporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.**DentonX Inc** ("Licensee" or "DentonX"), a corporation duly organized and existing under the laws of the State of Wyoming, with its principal office at 1999 Harrison Street, Suite 1800, Oakland, CA 94612.

Licensor and Licensee may be collectively referred to as the "Parties" and individually as a "Party."

**1. GRANT OF LICENSE**

**1.1 License**

Licensor grants to Licensee and its affiliates-meaning any entity controlling, controlled by, or under common control with DentonX Inc-a non-exclusive, worldwide, non-transferable, and non-sublicensable license to use, operate, and integrate the Licensor's proprietary blockchain-based automation framework (the "Licensed Software") solely for enterprise workflow and data-management purposes within Licensee's internal systems.

Licensee may process data and workflows on behalf of its affiliates and related entities, provided that access to the Licensed Software remains administratively controlled by Licensee and is used solely within Licensee-managed infrastructure.

**1.2 Purpose and Scope**

The Licensed Software is a suite of programmable automation tools that allow Licensee to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)record, track, and reconcile operational data and transactions on a distributed-ledger network;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)automate business logic and event triggers (such as approval workflows, reconciliation, and settlement) through smart-contract modules; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)generate secure, immutable audit trails to improve transparency, efficiency, and accuracy in Licensee's business operations.

------

The Licensed Software is not designed or licensed for public trading, exchange, issuance, or sale of financial instruments, securities, or tokens to third parties. All use shall be confined to Licensee's internal business processes and enterprise data management**.**

**1.3 Exclusions.**

Without Licensor's prior written consent, Licensee shall not:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)use the Licensed Software to create or distribute publicly tradable tokens or digital assets representing financial value or ownership interests;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)offer any product or service that constitutes a "security," "swap," or "investment contract" as defined under applicable law; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)use the Licensed Software in connection with retail investment, consumer-lending, or other regulated financial activities.

**1.4 Updates and Enhancements.**

Licensor may provide updates, bug fixes, or enhancements to the Licensed Software that improve security, automation efficiency, or compatibility with evolving blockchain standards. Licensee's use of such updates shall remain subject to the same terms and restrictions set forth herein.

**Regulatory Compliance Disclaimer**

The Parties acknowledge and agree that the Licensed Software is intended solely for internal enterprise automation and data-management purposes.

Nothing in this Agreement shall be construed as the offer or sale of any "security" or "investment contract" as defined under U.S. federal or state securities laws.

The Licensed Software shall not be used to issue, trade, tokenize, or otherwise create financial instruments, digital assets, or securities for public or private offering.

DentonX Inc shall remain solely responsible for ensuring that its operations and use of the Licensed Software comply with all applicable securities regulations.

**2. LICENSE FEE AND CONSIDERATION**

**2.1 Initial Fee.**

The Licensee shall pay an initial licensing fee of Fifty Thousand Dollars ($50,000), which shall be paid through the issuance of 500,000 common shares of the Licensee.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Shares shall be issued within 180 days of the Effective Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The license fee shall be fully earned on the Effective Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Failure to issue the shares within 180 days after written notice shall entitle Licensor to terminate this Agreement after an additional 60-day cure period.

**2.2 Royalties.**

Licensee shall pay Licensor a royalty equal to 7% of net revenues derived from products or services utilizing the Technology in any given calendar year. No royalties shall be due for annual net revenues below USD 100,000 attributable to such products or services. For avoidance of doubt, 'net revenues' for purposes of royalty calculation shall exclude: (i) internal use of the Technology by Licensee; (ii) intercompany or intracompany transfers, allocations, billings, or re-billings; and (iii) any non-arm's-length or non-commercial internal transactions. Royalties shall be payable solely on revenues arising from genuine arm's-length transactions with third-party customers.

**2.3 Minimum Annual Fee.**

A minimum annual fee of Thirty Thousand Dollars ($30,000) shall be paid by the Licensee to maintain the rights granted under this Agreement.

**3. TERM AND TERMINATION**

**3.1 Term.**

This Agreement shall remain in force for **ten (10) years** from the Effective Date unless terminated earlier as provided herein.

**3.2 Termination.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Either Party may terminate for material breach not cured within ninety (90) days of written notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Licensor may terminate if Licensee fails to deliver equity consideration or royalties as required under Section 2.

**3.3 Effect of Termination.**

Upon termination, Licensee shall cease all use of the Technology and return or destroy all related materials within ninety (90) days. Sections 3–7 shall survive termination.

------

**4. INTELLECTUAL PROPERTY RIGHTS**

**4.1 Ownership.**

All intellectual property rights in and to the Technology, including smart contracts, source code, oracles, APIs, and design frameworks, remain the sole property of Licensor (or its Founders prior to incorporation).

**4.2 Joint Improvements.**

**4.3 Licensee Data.**

DentonX Inc retains full ownership of its operational data, loan and borrower information, investor data, and all tokenized loan and credit assets created through the Technology.

**5. CONFIDENTIALITY**

**5.1 Obligation.**

Each Party shall maintain the confidentiality of all non-public technical, business, or financial information disclosed by the other Party in connection with this Agreement.

**5.2 Exclusions.**

Confidential Information does not include information that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)is or becomes public through no fault of the recipient;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)was lawfully known prior to disclosure; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)is independently developed without use of the discloser's Confidential Information.

**5.3 Duration.**

The confidentiality obligations shall remain in effect for **three (3) years** after termination of this Agreement.

------

**6. WARRANTIES, INDEMNIFICATION, AND DISCLAIMER**

**6.1 Licensor's Warranties.**

Licensor represents that it owns or will own, upon incorporation, the rights necessary to grant this license and that, to its knowledge, the Technology does not infringe upon any third-party rights.

**6.2 Licensee's Warranties.**

Licensee represents that it will comply with all applicable regulations, including financial services, securities, and KYC/AML requirements, in connection with its use of the Technology.

**6.3 Indemnification.**

Each Party shall indemnify the other against claims, damages, or losses arising from its breach of this Agreement or willful misconduct.

**6.4 Disclaimer.**

The Technology is provided "AS IS" without warranty of merchantability or fitness for a particular purpose. The Parties acknowledge the experimental nature of blockchain technology and the inherent risks related to oracles, smart contract bugs, and regulatory interpretation.

**7. GOVERNING LAW AND DISPUTE RESOLUTION**

**7.1 Governing Law.**

This Agreement shall be governed by and construed in accordance with the laws of the State of Wyoming, without regard to conflict-of-law principles.

**7.2 Dispute Resolution.**

Disputes shall first be resolved through mediation in Wyoming. If unresolved, disputes shall be submitted to binding arbitration in Wyoming under the rules of the American Arbitration Association. The arbitrator's decision shall be final and binding.

------

**8. MISCELLANEOUS**

**8.1 Incorporation of Licensor.**

Upon incorporation of LocusX Technologies Inc., all rights and obligations under this Agreement shall automatically transfer to the incorporated entity.

**8.2 Amendments.**

No amendment or modification shall be valid unless in writing and signed by both Parties.

**8.3 Entire Agreement.**

This Agreement constitutes the entire understanding between the Parties regarding the Technology and supersedes all prior discussions or representations.

**8.4 Notices.**

All notices shall be in writing and sent to the Parties at their respective addresses above.

**IN WITNESS WHEREOF**, the Parties have executed this Agreement as of the date first written above.

---

| | |
|:---|:---|
| **LocusX Technologies Inc. (in formation)** | **DentonX Inc** |
| <br> By: */s/ Shaofeng Yang* | <br> By: */s/ Luis Carlos Ung* |
| Name: Shaofeng Yang | Name: Luis Carlos Ung |
| Title: Chairman | Title: CEO |

---

------

**Appendix A - Description of Licensed Technology**

The Licensed Software consists of a proprietary, modular automation system built on distributed-ledger technology, designed for secure enterprise process automation and digital record-keeping.

It includes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.**Workflow Smart-Contract Modules** – Configurable scripts enabling automatic execution of predefined business rules, such as data validation, task sequencing, and process completion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.**Digital-Asset Registry Layer** – A private or permissioned ledger component that assigns and tracks digital identifiers for operational assets (e.g., loans, receivables, inventory), strictly for internal reference-not for public trading or investment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.**Integration APIs and Oracles** – Interfaces that connect internal databases, compliance systems, and external data sources (e.g., credit or payment verification) for accurate, real-time process automation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.**Security and Audit Framework** – Cryptographic controls, identity-management features, and immutable logging tools that provide end-to-end data integrity and regulatory-grade auditability.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.**Compliance and Privacy Controls** – Built-in permissioning and encryption features supporting KYC/AML verification, data-access governance, and adherence to corporate information-security policies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.**Deployment Architecture** – Designed for permissioned enterprise environments (e.g., private Ethereum or Layer-2 networks) with configurable access layers, ensuring that all transactions remain within DentonX's controlled infrastructure.

**Intended Use:**

The Licensed Software is provided as an enterprise-grade automation platform. It does not create, list, or trade securities or financial products and is not intended to serve as a marketplace, exchange, or investment platform.

------

## Exhibit 10.6

![Picture 1](dtnxex106_1.jpg)

------

**EXCLUSIVE MANAGEMENT COOPERATION AGREEMENT**

**This Exclusive Management Cooperation Agreement ("Agreement")** is entered into as of November 11, 2025, by and between **DentonX Outstanding Investment Co.** ("Newco" or the "Company"), a Wyoming corporation to be formed and majority-owned by **DentonX Inc** ("DentonX") and **Outstanding Investment Co., Inc.** ("OIC" or the "Manager"), with offices at 2450 Washington Ave Ste 100, San Leandro, CA 94577.

**RECITALS**

**WHEREAS**, DentonX and OIC have engaged in discussions regarding a strategic partnership aimed at expanding OIC's lending and investment operations through DentonX's structuring, capital markets, and mergers and acquisitions capabilities;

**WHEREAS**, the parties have agreed in principle that such partnership will include, among other matters, (i) the formation of **DentonX Outstanding Investment Co.** ("Newco") as a majority-owned subsidiary of DentonX, (ii) the lease by Newco of OIC's certain business assets, and (iii) a purchase option for Newco to acquire such assets after an agreed period, based on a negotiated EBITDA multiple;

**WHEREAS**, OIC possesses operational expertise, client relationships, and intellectual property critical to the growth and success of Newco;

**WHEREAS**, DentonX will capitalize Newco and provide strategic oversight, capital markets guidance, and public company infrastructure to support Newco's growth and IPO pathway;

**WHEREAS,** upon its formation and as of the Closing Date, Newco will enter into this Exclusive Management Cooperation Agreement with OIC, as well as other definitive agreements, including the Lease Agreement, Share Grant Agreement and Investment Rights Agreement;

**WHEREAS**, the parties intend that the Lease Agreement applies only to the lending business, client base, and assets of OIC as they existed and were operated prior to the Closing Date ("Existing Business"), and that any new business, clients, contracts, or revenue streams developed by Newco after the Closing Date ("New Business") shall not be subject to the Lease Agreement but will be addressed under this Exclusive Management Cooperation Agreement;

**WHEREAS**, the parties now desire to enter into this definitive Exclusive Management Cooperation Agreement to set forth the terms and conditions under which OIC will provide management services to Newco and participate in performance-based earn-outs and incentives;

**WHEREAS**, concurrently herewith, the principals and management team of OIC have executed a *Key Person Undertaking Addendum* (the "Key Person Undertaking") in favor of Newco, confirming their personal obligations to comply with and perform the covenants set forth in this Agreement, including confidentiality, non-compete, and Management Committee directives.

------

Private & Confidential 1

------

![Picture 1](dtnxex106_1.jpg)

------

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements herein contained, the parties agree as follows:

**1. DEFINITIONS**

**"DentonX"** means DentonX Inc, a Wyoming corporation.

**"NewCo"** means means DentonX Outstanding Investment Co., a Wyoming corporation to be formed and initially majority owned by DentonX prior to the Closing Date.

**"OIC"** means Outstanding Investment Co., Inc. and its principals, led by Steven Guang Leung.

**"Existing Business"** means the lending business, client base, and assets of OIC as they existed and were operated prior to the Closing Date, as defined in the Lease Agreement.

**"New Business"** means any new business, clients, contracts, or revenue streams developed by Newco after the Closing Date, which are not derived from or directly related to the Existing Business.

**"Management Fee"** means the monthly fee payable to OIC for management services provided to Newco, as set forth in Section 3.

**"Management Committee Addendum"** means the addendum attached hereto as *Schedule A*, which establishes the Management Committee as the executive body through which Newco exercises management authority over OIC pursuant to this Agreement.

**"Earn-Out"** means additional equity or cash payments to be made to OIC based on achievement of specific performance milestones, as set forth in Section 4 and *Schedule B*.

**"Key Person Undertaking"** means the Key Person Undertaking Addendum executed by certain principal managers and shareholders of OIC in favor of Newco, substantially in the form attached hereto as *Schedule C*.

**"Lease Agreement"** means the Lease Agreement with Purchase Option between Newco and OIC, dated November 11, 2025.

**"Closing Date"** means the date on which (i) Newco is duly formed and organized as a majority-owned subsidiary of DentonX, and (ii) all parties have executed the definitive agreement(s).

**"Cause"** means:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Willful misconduct, gross negligence, or fraud by OIC or its principals in the performance of duties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Conviction of, or plea of guilty or no contest to, a felony or crime involving moral turpitude;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Material breach of this Agreement or any other definitive agreement, not cured within thirty (30) days after written notice;

------

Private & Confidential 2

------

![Picture 1](dtnxex106_1.jpg)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Willful or repeated refusal or failure to perform material duties under this Agreement after written notice;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Misappropriation or unauthorized disclosure of confidential information, trade secrets, or intellectual property of Newco or DentonX.

**"Good Leaver"** means termination of OIC's engagement due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Death or permanent disability of OIC's principal(s);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Termination by Newco without Cause;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Mutual agreement in writing between the parties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any other event agreed to in writing by the Board as constituting a Good Leaver event.

**2. CONDITIONS PRECEDENT**

This Agreement shall become effective only upon (i) the formation of Newco as a majority-owned subsidiary of DentonX, and (ii) execution by all parties as of the Closing Date. If Newco is not formed and the Closing Date does not occur, this Agreement shall be void and of no effect.

**3. APPOINTMENT AND SCOPE**

**3.1 Appointment**

OIC hereby engages Newco (or its designated affiliate) to provide strategic management and control over OIC's operations and financial decisions, including direction of OIC's lending and investment business.

All management rights and authorities of Newco under this Agreement shall be exercised through the **Management Committee** established pursuant to the Management Committee Addendum *(Schedule A)*. The Committee shall function as the formal mechanism for implementation of Newco's strategic and operational direction within OIC.

The Parties acknowledge that the Key Persons of OIC have each executed the Key Person Undertaking Addendum (*Schedule C*) to this Agreement, thereby agreeing personally to comply with the management directives of Newco and to observe the obligations set forth in this Agreement as though each were a direct party hereto with respect to confidentiality, exclusivity, and good-leaver/bad-leaver provisions.

**3.2 Scope of Services**

Newco shall have ultimate decision-making authority and strategic control over OIC's key operating, financial, and governance matters, including but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Strategic planning and execution, including growth through M&A

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Client acquisition and retention

------

Private & Confidential 3

------

![Picture 1](dtnxex106_1.jpg)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Business development, including launching and growing new businesses

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Oversight of consulting operations and personnel

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Implementation of business strategy and growth initiatives

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Financial management, oversight, and reporting

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Other duties as reasonably required for the effective operation of Newco

Newco may, at its discretion, provide or arrange financial support, working capital, technology resources, and operational resources as necessary to sustain OIC's operations.

**4. TERM**

**4.1 Initial Term**

This Agreement shall commence on the Closing Date and continue for three (3) years, unless earlier terminated pursuant to Section 10.

**4.2 Renewal**

The Agreement may be renewed for additional terms by mutual written consent.

**5. MANAGEMENT COMPENSATION**

**5.1 Management Fee**

OIC shall pay Newco a Monthly Management Fee of **[amount TBD]** for the strategic, operational, and financial management of OIC's entire business, including both the Existing Business and any New Business developed after the Effective Date.

The Management Fee shall be calculated as **5% of the Existing Business** and **10% of the New Business**.

The Lease Payments payable by Newco to OIC under Section 1.3 of the Lease Agreement and the Management Fee payable by OIC to Newco under this Section 5.1 are separate obligations. The difference between the two represents Newco's management spread and its compensation for assuming operational risk and exercising full management control.

**5.2 Variable Performance Participation**

For any New Business developed under Newco's management, OIC shall pay Newco a Performance Participation Fee equal to **[5%–20%]** of the net profits attributable to such New Business, calculated after statutory taxes and agreed reserves.

This fee reflects Newco's strategic, operational, and financial contributions to the creation and scaling of the New Business, and constitutes Newco's variable economic participation in those operations.

------

Private & Confidential 4

------

![Picture 1](dtnxex106_1.jpg)

------

**5.3 Scope of Compensation**

The Management Fee shall apply to the management of both the Existing Business and any New Business developed by Newco after the Closing Date.

For the avoidance of doubt, Lease Payments under the Lease Agreement apply only to the Existing Business and are separate from the Management Fee.

**5.4 Performance Bonus**

Newco shall be eligible for annual performance bonuses based on achievement of agreed financial and operational targets, as set forth in **Schedule B**.

**5.5 Access to Growth Capital**

Newco will have access to growth capital as approved by the Board, for business expansion and operational needs, with funding provided and/or arranged by DentonX.

**6. PERFORMANCE EARN-OUT**

**6.1 Earn-Out Structure**

Newco shall be entitled to additional equity or cash earn-outs upon achievement of the specific milestones set forth in **Schedule C**, which may include but are not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Revenue targets

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·EBITDA thresholds

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·New client acquisition

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Retention of key clients

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Expansion into new service areas

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Other mutually agreed KPIs

**6.2 Calculation and Payment**

Earn-out awards shall be calculated based on audited (or mutually agreed unaudited) financial statements. Cash earn-outs shall be paid within thirty (30) days of confirmation of milestone achievement. Equity earn-outs shall be issued within thirty (30) days of confirmation.

**6.3 Dispute Resolution**

Any disputes regarding earn-out calculations shall be resolved by an independent accounting firm mutually agreed upon by the parties.

------

Private & Confidential 5

------

![Picture 1](dtnxex106_1.jpg)

------

**7. COORDINATION WITH LEASE AGREEMENT**

The Lease Agreement governs the Existing Business only. The Management Fee compensates Newco for management of both the Existing Business and any New Business. OIC shall not retain any residual economic interest in New Business other than its 20% equity ownership in Newco.

**8. BOARD PARTICIPATION AND GOVERNANCE**

**8.1 Board Seat**

OIC shall have the right to appoint one (1) member to Newco's Board of Directors for so long as it holds at least 10% of Newco's issued and outstanding shares.

**8.2 Reserved Matters**

Certain key decisions, as outlined in the Shareholders Agreement, shall require approval of the OIC-appointed director.

The Management Committee, as described in *Schedule A*, shall constitute the primary executive and decision-making body of OIC for purposes of this Agreement. Decisions of the Committee shall be binding on OIC and deemed acts of Newco.

**8.3 Strategic Oversight**

DentonX shall provide strategic oversight, capital markets guidance, and Board-level governance to Newco, including support for IPO readiness and public company compliance.

**9. REPORTING AND COMPLIANCE**

**9.1 Financial Reporting**

OIC shall prepare and deliver to the Board:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Monthly financial statements within 15 days of month-end

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Quarterly financial reports within 30 days of quarter-end

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Annual financial statements within 60 days of year-end

**9.2 Operational Reporting**

OIC shall provide regular updates on operational performance, client acquisition, and strategic initiatives.

**9.3 Compliance**

OIC shall ensure Newco's operations comply with all applicable laws, regulations, and industry standards, and shall cooperate with DentonX's public company reporting and compliance requirements.

------

Private & Confidential 6

------

![Picture 1](dtnxex106_1.jpg)

------

**10. IPO PATHWAY AND EXIT**

**10.1 IPO Preparation**

Newco shall be part of a public company and may prepare its client companies for public listing, subject to qualification. With OIC's cooperation, Newco shall lead governance enhancements, audit readiness, and listing execution. OIC shall have the right to piggyback on the listing vehicle.

**10.2 Conversion or Buyout**

Upon any public listing or liquidity event of these clients of Newco, OIC's equity in any relevant listing vehicle may, at Newco's option, be converted into shares of such listing vehicle or bought out at fair market value.

**11. TERMINATION**

**11.1 Termination for Cause**

Newco may terminate this Agreement for Cause (as defined in Section 1) with immediate effect upon written notice to OIC.

**11.2 Termination without Cause**

Either party may terminate this Agreement without Cause by providing ninety (90) days' written notice.

**11.3 Voluntary Resignation**

OIC may terminate this Agreement by providing ninety (90) days' written notice to Newco.

**11.4 Good Leaver Events**

If OIC's engagement is terminated due to a Good Leaver Event, vesting of equity and other rights will be handled in accordance with Section 11.

**12. VESTING, CLAW BACK, AND FORFEITURE**

**12.1 Vesting**

OIC's equity in Newco and any DentonX share grants shall vest according to the Equity & Vesting Agreement and DentonX Share Grant Agreement.

The Equity Grant is intended to incentivize OIC's long-term participation in the management and cooperative structure of Newco and shall vest in accordance with Newco's performance milestones, governance compliance, and continued cooperation under this Agreement.

**12.2 Claw Back**

If this Agreement is terminated for Cause or by voluntary resignation before full vesting, all unvested shares shall be forfeited and redeemable by Newco at nominal value.

------

Private & Confidential 7

------

![Picture 1](dtnxex106_1.jpg)

------

**12.3 Good Leaver Acceleration**

If OIC is a Good Leaver, the Board may, at its discretion, accelerate vesting of some or all unvested shares.

**12.4 Earn-Out Impact**

Upon termination for any reason, OIC shall remain entitled to any earned but unpaid earn-outs for milestones achieved prior to termination.

**12.5 Equity Grant to Key Persons**

DentonX has issued, or will issue, equity-based incentive awards to certain Key Persons of OIC in the form of **Three Hundred Sixty** (360) Series B Preferred Shares of DentonX, as further described in the *DentonX Share Grant Agreement* (the "Share Grant Agreement").

The Grant Shares vest over a three-year period in twelve (12) equal quarterly installments, and all vesting is expressly conditioned upon each Key Person's (i) continued adherence to the directives of the Management Committee, (ii) full compliance with this Agreement, and (iii) ongoing fulfillment of his or her obligations under the Key Person Undertaking.

Failure by any Key Person to comply with these obligations shall result in the automatic forfeiture of all unvested Grant Shares held by such Key Person.

**13. CONFIDENTIALITY AND EXCLUSIVITY**

**13.1 Confidentiality**

Both parties shall maintain strict confidentiality regarding all non-public information related to Newco, DentonX, and their respective businesses, except as required by law.

**13.2 Exclusivity**

OIC agrees to a 90-day exclusivity period for due diligence and deal finalization from the date of the Agreement.

**14. MISCELLANEOUS**

**14.1 Governing Law**

This Agreement shall be governed by the laws of Wyoming.

**14.2 Entire Agreement**

This Agreement, together with all Schedules and Addenda, including the Management Committee Addendum (*Schedule A*) and the Key Person Undertaking Addendum (*Schedule C*), constitutes the entire agreement among the Parties regarding the subject matter herein.

------

Private & Confidential 8

------

![Picture 1](dtnxex106_1.jpg)

------

The Parties acknowledge that this Agreement forms part of the integrated cooperation structure among OIC, Newco, and DentonX, and that the Management Committee Addendum (*Schedule A*) sets out the mechanism through which Newco exercises contractual control over OIC.

**14.3 Amendments**

Any amendment must be in writing and signed by both parties.

**14.4 Counterparts**

This Agreement may be executed in counterparts.

**IN WITNESS WHEREOF**, the parties have executed this Exclusive Management Cooperation Agreement as of the Closing Date.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**DentonX Outstanding Investment Co. (Newco)**<br>| &nbsp;&nbsp;**Outstanding Investment Co., Inc.**<br>|
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* | &nbsp;&nbsp;By: */s/ Steven Guang Leung* |
| &nbsp;&nbsp;Name: Luis Carlos Ung | &nbsp;&nbsp;Name: Steven Guang Leung |
| &nbsp;&nbsp;Title: CEO | &nbsp;&nbsp;Title: CEO |
| &nbsp;&nbsp;Date: | &nbsp;&nbsp;Date: |

---

------

Private & Confidential 9

------

![Picture 1](dtnxex106_1.jpg)

------

**Schedule A: Management Committee Addendum**

**ADDENDUM TO MANAGEMENT & EARN-OUT AGREEMENT**

**(Management Committee Addendum)**

This Management Committee Addendum ("Addendum") is made as of the Effective Date of the *Exclusive Management Cooperation Agreement* (the "Agreement"), by and between DentonX Outstanding Investment Co. ("Newco") and Outstanding Investment Co., Inc. ("OIC"), and forms an integral part of the Agreement. Capitalized terms not defined herein shall have the meanings set forth in the Agreement.

**1. Establishment of the Management Committee**

**1.1 Creation.**

OIC hereby establishes a Management Committee (the "Committee") which shall serve as the governing and executive body of OIC for purposes of strategic, operational, and financial decision-making.

**1.2 Purpose.**

The Committee shall act as the formal mechanism through which Newco exercises its contractual management rights and oversight of OIC, and through which OIC's internal management participates in decision-making under the direction of Newco.

**1.3 Authority.**

The Committee shall have authority over all material decisions and activities of OIC, including but not limited to:

(a) Strategic planning and business expansion;<br>(b) Budgeting and financial management;<br>(c) Appointment and compensation of senior officers;<br>(d) Approval of lending policies, client relationships, and material contracts;<br>(e) Mergers, acquisitions, divestitures, or new service lines; and<br>(f) Any other matters deemed significant to OIC's operations or economic performance.

All such decisions shall be subject to Newco's approval or direction, as described below.

**2. Composition of the Management Committee**

**2.1 Members.**<br>The Committee shall consist of five (5) members, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Two (2) members appointed by Newco, representing Newco's management;

------

Private & Confidential 10

------

![Picture 1](dtnxex106_1.jpg)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Three (3) members appointed by OIC, selected from OIC's senior management team.

**2.2 Chairperson.**

The Chairperson of the Committee shall be designated by Newco and shall have the tie-breaking vote on all matters submitted to the Committee.

**2.3 Continuity of Roles.**

The individuals appointed by OIC to the Committee may concurrently hold management positions within OIC. Their participation on the Committee does not limit their duties within OIC but aligns such duties with Newco's strategic oversight.

**2.4 Replacement and Vacancies.**

Newco shall have the right to appoint or remove its designated Committee members at any time. OIC shall promptly fill any vacancy of its appointees.

**3. Operation and Decision-Making**

**3.1 Meetings.**

The Committee shall meet at least monthly and additionally as required by Newco or the Chairperson.

**3.2 Voting.**

Decisions of the Committee shall require a simple majority vote, except where otherwise specified. In the event of a tie, the Chairperson's vote shall prevail.

**3.3 Quorum.**

A quorum shall consist of at least three (3) members, including at least one (1) member appointed by Newco.

**3.4 Documentation.**

Minutes of all meetings shall be recorded and circulated to both Newco and OIC management within five (5) business days.

**4. Integration with Management Agreement**

**4.1 Delegation of Authority.**

The Committee shall function as the primary management body of OIC under the direction of Newco. The rights and obligations of Newco under the Agreement shall be exercised through the Committee.

------

Private & Confidential 11

------

![Picture 1](dtnxex106_1.jpg)

------

**4.2 Supremacy.**

In the event of any conflict between this Addendum and OIC's internal bylaws or resolutions, the provisions of this Addendum shall govern as between the parties.

**4.3 Economic Linkage.**

Decisions by the Committee regarding performance targets, budgets, or capital allocation shall be deemed to have been made under the authority of Newco for purposes of management fees, performance bonuses, and any earn-out determinations.

**5. Purpose for Financial Reporting**

The parties acknowledge that the formation of this Committee and the delegation of strategic decision-making authority to Newco are intended to establish Newco's contractual power to direct the activities of OIC that most significantly affect its economic performance, thereby satisfying the "power" criterion under ASC 810 (Variable Interest Entities) for consolidation purposes.

**6. Duration**

This Addendum shall remain in effect for so long as the *Exclusive Management Cooperation Agreement* remains in force or until replaced by mutual written agreement.

**Signatures**

---

| | |
|:---|:---|
| &nbsp;&nbsp;**DentonX Outstanding Investment Co. (Newco)**<br>| &nbsp;&nbsp;**Outstanding Investment Co., Inc.**<br>|
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* | &nbsp;&nbsp;By: */s/ Steven Guang Leung* |
| &nbsp;&nbsp;Name: Luis Carlos Ung | &nbsp;&nbsp;Name: Steven Guang Leung |
| &nbsp;&nbsp;Title: CEO | &nbsp;&nbsp;Title: CEO |
| &nbsp;&nbsp;Date: | &nbsp;&nbsp;Date: |

---

------

Private & Confidential 12

------

![Picture 1](dtnxex106_1.jpg)

------

**Schedule B: Performance Targets and Bonus Structure**

*(To be finalized and attached)*

---

| | | |
|:---|:---|:---|
| **Performance Metric** | **Target** | **Bonus Amount** |
| Annual Revenue | Each $1 million | TBD |
| EBITDA | More than $250,000 | TBD |
| Client Retention | More than 85% | TBD |
| New Client Acquisition | For every 5 new clients | TBD |

---

------

Private & Confidential 13

------

![Picture 1](dtnxex106_1.jpg)

------

**Schedule C: Key Person Undertaking Addendum**

**KEY PERSON UNDERTAKING ADDENDUM**

This Key Person Undertaking Addendum (this "Undertaking") is entered into as of November 11, 2025 by and among:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Outstanding Investment Co., Inc. ("OIC"), a [Jurisdiction] company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·DentonX Outstanding Investment Co. ("Newco"), a Wyoming / [or another state] company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·the undersigned individuals (each, a "Key Person," and collectively, the "Key Persons"), being the principal managers and shareholders of OIC.

**1. Purpose**

This Undertaking supplements the Exclusive Management Cooperation Agreement dated November 11, 2025 between OIC and Newco (the "Management Agreement") to confirm the personal obligations of the Key Persons who are responsible for the day-to-day management of OIC.

**2. Acknowledgment of Control and Governance**

Each Key Person acknowledges and agrees that:

(a) OIC's strategic, financial, and operational management is directed by Newco through the Management Committee established under the Management Agreement; and

(b) the Key Persons shall act, and shall cause OIC to act, in accordance with the directions, policies, and resolutions of such Committee.

**3. Performance and Compliance Obligations**

Each Key Person undertakes to:

(a) faithfully perform his or her management duties under the Management Agreement and any position held within OIC in accordance with Newco's oversight;

(b) observe all confidentiality, non-compete, and non-solicitation obligations applicable to OIC under the Management Agreement as though personally bound thereby;

(c) not, without Newco's prior written consent, engage in any competing or conflicting business activity; and

(d) cooperate fully in implementing any actions or directives approved by the Management Committee.

------

Private & Confidential 14

------

![Picture 1](dtnxex106_1.jpg)

------

**4. Good-Leaver / Bad-Leaver and Claw Back**

Each Key Person acknowledges that the "Good-Leaver," "Bad-Leaver," and "Claw Back" provisions set forth in the Management Agreement shall apply mutatis mutandis to such Key Person's direct and indirect interest in any incentive equity or earn-out payments thereunder.

**5. Remedies**

Each Key Person acknowledges that breach of this Undertaking would cause irreparable harm to Newco and OIC and agrees that Newco shall be entitled to specific performance, injunctive relief, and any other remedies available at law or in equity.

**6. No Employment Relationship**

Nothing in this Undertaking shall be construed as creating an employment relationship between any Key Person and Newco. All Key Persons remain employed or engaged by OIC.

**7. Counterparts**

This Undertaking may be executed in counterparts and shall form part of and be read together with the Management Agreement.

IN WITNESS WHEREOF, the Parties have executed this Undertaking as of the date first above written.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**DentonX Outstanding Investment Co. (Newco)**<br>| &nbsp;&nbsp;**Outstanding Investment Co., Inc.**<br>|
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* | &nbsp;&nbsp;By: */s/ Steven Guang Leung* |
| &nbsp;&nbsp;Name: Luis Carlos Ung | &nbsp;&nbsp;Name: Steven Guang Leung |
| &nbsp;&nbsp;Title: CEO | &nbsp;&nbsp;Title: CEO |
| &nbsp;&nbsp;Date: | &nbsp;&nbsp;Date: |

---

KEY PERSONS: (Sign each individually)

1. ________________________ Steven Guang Leung

2. ________________________ John Tam

3. ________________________ (Name)

------

Private & Confidential 15

------

![Picture 1](dtnxex106_1.jpg)

------

**Schedule D: Earn-Out Milestones**

*(To be finalized and attached)*

---

| | | |
|:---|:---|:---|
| **Milestone** | **Timing** | **Earn-Out Award** |
| Achieve $1 million in annual revenue | By the end of Year 1 | TBD |
| Achieve $250,000 in EBITDA | By the end of Year 2 | TBD |
| Secure 5 new enterprise clients | By the end of Year 1 | TBD |
| Expand into a new service area | By the end of Year 2 | TBD |
| Achieve a 15% profit margin | By the end of Year 3 | TBD |

---

------

Private & Confidential 16

## Exhibit 10.7

![Picture 1](dtnxex107_1.jpg)

------

**LEASE AGREEMENT WITH PURCHASE OPTION**

**This Lease Agreement with Purchase Option ("Agreement")** is entered into as of November 11, 2025, by and between **DentonX Outstanding Investment Co.** ("Newco" or the "Lessee"), a Wyoming corporation to be formed and majority-owned by DentonX Inc ("DentonX") and **Outstanding Investment Co., Inc.** ("OIC" or the "Lessor"), with offices at 2450 Washington Ave Ste 100, San Leandro, CA 94577.

**RECITALS**

**WHEREAS**, DentonX and OIC have engaged in discussions regarding a strategic partnership aimed at expanding OIC's lending and investment operations through DentonX's structuring, capital markets, and mergers and acquisitions capabilities;

**WHEREAS**, the parties have agreed in principle that such partnership will include, among other matters, (i) the formation of **DentonX Outstanding Investment Co.** ("Newco") as a majority-owned subsidiary of DentonX, (ii) the lease by Newco of OIC's certain business assets, and (iii) a purchase option for Newco to acquire such assets after an agreed period, based on a negotiated EBITDA multiple;

**WHEREAS**, the parties intend that this Lease Agreement applies only to the lending business, client base, and assets of OIC as they existed and were operated prior to the Closing Date ("Existing Business"), and that any new business, clients, contracts, or revenue streams developed by Newco after the Closing Date ("New Business") shall not be subject to this Lease Agreement but will be addressed under the Management & Earn-Out Agreement;

**WHEREAS**, the parties now desire to enter into this definitive Lease Agreement with Purchase Option to set forth the terms and conditions under which OIC will lease its lending business assets to Newco, with the intention that lease payments approximate the present profitability of the OIC lending business;

**WHEREAS**, the Parties acknowledge that, through this Lease Agreement and the related Management & Earn-Out Agreement, Newco shall have the power to direct the activities of OIC's lending business that most significantly affect its economic performance, and therefore the Leased Assets and related operations shall be treated as part of Newco's consolidated financial statements in accordance with applicable accounting standards.

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements herein contained, the parties agree as follows:

------

Private & Confidential 1

------

![Picture 1](dtnxex107_1.jpg)

------

**1. Lease of Assets**

**1.1 Scope of Leased Assets**

OIC hereby leases to Newco, and Newco hereby leases from OIC, the lending business assets described in Exhibit A (the "Leased Assets"), including but not limited to brand, systems, client base, know-how, and all related intellectual property, as they existed and were operated by OIC prior to the Closing Date (collectively, the "Existing Business").

**For the avoidance of doubt:**

Any new business, clients, contracts, or revenue streams developed by Newco after the Closing Date ("New Business"), which are not derived from or directly related to the Existing Business, shall not be subject to this Lease Agreement or included in the calculation of Lease Payments.

**1.2 Lease Term**

The lease term shall commence on the Closing Date and continue for three years, and shall be renewable for an additional three years, unless earlier terminated in accordance with this Agreement.

**1.3 Lease Payments**

(a) **Monthly Lease Payment**

Newco shall pay OIC a Monthly Lease Payment [amount TBD] for the lease of OIC's Existing Business assets, goodwill, and operating platform as of the Effective Date.

This Lease Payment represents contractual return to OIC approximating its historical profit from the Existing Business. All residual profit and risk shall belong exclusively to Newco.

(b) **Adjustment**

The Monthly Lease Payment shall be subject to an annual adjustment for inflation equal to the lesser of (i) 4% or (ii) the percentage change in the U.S. Consumer Price Index (CPI-U, All Items).

**2. Purchase Option**

**2.1 Option to Purchase**

Newco shall have the exclusive option to purchase the Leased Assets at any time after one (1) year from the Closing Date, subject to the terms and conditions herein.

For the avoidance of doubt, this option shall not include any equity interests held by OIC prior to the Closing Date in its client companies or affiliated entities, unless otherwise mutually agreed by the parties in writing.

------

Private & Confidential 2

------

![Picture 1](dtnxex107_1.jpg)

------

**2.2 Purchase Price**

The purchase price for the Leased Assets shall be calculated as eight (8) times the trailing twelve-month EBITDA of the Existing Business as of the date of exercise of the option, or such other formula as may be set forth in **Exhibit C**.

The calculation shall exclude any unrealized or realized gains from OIC's pre-Closing equity holdings, unless those holdings are separately offered and accepted as part of the transaction under mutually agreed terms.

**2.3 Closing of Purchase**

Upon exercise of the option and payment of the purchase price, OIC shall transfer all right, title, and interest in the Leased Assets to Newco, free and clear of all liens and encumbrances.

**3. Operations and Transition**

**3.1 Strategic and Financial Control**

During the Lease Term, Newco shall have exclusive authority to manage, operate, and direct all material aspects of the Leased Assets and the business activities arising therefrom, including but not limited to:

(i) strategic and business planning;

(ii) pricing, client selection, and contract approval;

(iii) appointment and removal of key management personnel; and

(iv) approval of budgets and financial reporting.

OIC shall not take any material action relating to the Leased Assets or the lending business without Newco's prior written consent.

**3.2 Transition Assistance**

OIC shall provide reasonable transition assistance to Newco as may be necessary to ensure a smooth transfer of operations and client relationships.

**3.3 Coordination with Management Committee**

All management rights of Newco under this Agreement shall be exercised through the Management Committee established under Schedule A of the Management Agreement, which serves as the executive body directing OIC's day-to-day and strategic operations. Decisions of the Management Committee concerning the Leased Assets shall be binding on OIC.

------

Private & Confidential 3

------

![Picture 1](dtnxex107_1.jpg)

------

**3.4 Reporting and Oversight**

OIC shall provide Newco (and DentonX, as applicable) full and timely access to all accounting records, financial statements, and operational data relating to the Leased Assets. Newco shall have the right to audit such records at any time and to integrate financial results of the Leased Assets into its consolidated financial statements

**3.5 Restrictions on OIC Actions**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Without Newco's prior written approval, OIC shall not:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)incur debt, pledge, or dispose of any Leased Assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)enter into, terminate, or amend any material contract relating to the Leased Assets; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)transfer or license any intellectual property or goodwill associated with the Leased Assets.

**3.6 Step-in Rights**

In the event of any failure by OIC to perform its obligations under this Agreement or to comply with the directives of Newco or the Management Committee, Newco shall have the right to step in and assume direct management and operation of the Leased Assets without further consent from OIC until such non-compliance is remedied.

**4. Representations and Warranties**

**4.1. By OIC (Lessor)**

OIC hereby represents and warrants to Newco as of the date of this Agreement and as of the Closing Date that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Authority:** OIC is duly organized, validly existing, and in good standing under the laws of its jurisdiction of formation, and has full power and authority to enter into and perform this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Title:** OIC is the sole legal and beneficial owner of the Leased Assets, free and clear of all liens, claims, encumbrances, and security interests, except as disclosed in Exhibit A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**No Conflicts:** The execution, delivery, and performance of this Agreement by OIC does not and will not (i) violate any provision of its organizational documents, (ii) violate any applicable law or regulation, or (iii) conflict with, result in a breach of, or constitute a default under any agreement or instrument to which OIC is a party or by which it is bound.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Consents:** No consent, approval, or authorization of, or filing with, any governmental authority or third party is required for the execution, delivery, and performance of this Agreement by OIC, except as already obtained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Litigation:** There is no pending or, to OIC's knowledge, threatened action, suit, or proceeding before any court or governmental authority that challenges or may have a

------

Private & Confidential 4

------

![Picture 1](dtnxex107_1.jpg)

------

material adverse effect on the Leased Assets or OIC's ability to perform its obligations under this Agreement.

**4.2. By Newco (Lessee)**

Newco hereby represents and warrants to OIC as of the date of this Agreement and as of the Closing Date that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Authority:** Newco is or will be duly organized, validly existing, and in good standing under the laws of its jurisdiction of formation, and has full power and authority to enter into and perform this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**No Conflicts:** The execution, delivery, and performance of this Agreement by Newco does not and will not (i) violate any provision of its organizational documents, (ii) violate any applicable law or regulation, or (iii) conflict with, result in a breach of, or constitute a default under any agreement or instrument to which Newco is a party or by which it is bound.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Consents:** No consent, approval, or authorization of, or filing with, any governmental authority or third party is required for the execution, delivery, and performance of this Agreement by Newco, except as already obtained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Litigation:** There is no pending or, to Newco's knowledge, threatened action, suit, or proceeding before any court or governmental authority that challenges or may have a material adverse effect on Newco's ability to perform its obligations under this Agreement.

**5. Indemnification**

**5.1. Indemnification by OIC**

OIC shall indemnify, defend, and hold harmless Newco and its affiliates, officers, directors, employees, and agents ("Newco Indemnitees") from and against any and all losses, damages, liabilities, claims, costs, and expenses (including reasonable attorneys' fees) ("Losses") arising out of or resulting from:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any breach of any representation, warranty, or covenant made by OIC in this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any claim by a third party relating to the ownership, use, or operation of the Leased Assets prior to the Closing Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any fraud, willful misconduct, or gross negligence by OIC.

------

Private & Confidential 5

------

![Picture 1](dtnxex107_1.jpg)

------

**5.2. Indemnification by Newco**

Newco shall indemnify, defend, and hold harmless OIC and its affiliates, officers, directors, employees, and agents ("OIC Indemnitees") from and against any and all Losses arising out of or resulting from:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any breach of any representation, warranty, or covenant made by Newco in this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any claim by a third party relating to the use or operation of the Leased Assets by Newco after the Closing Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any fraud, willful misconduct, or gross negligence by Newco.

**5.3. Indemnification Procedures**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The indemnified party shall promptly notify the indemnifying party in writing of any claim or action for which indemnification is sought.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The indemnifying party shall have the right to assume the defense of any such claim with counsel reasonably satisfactory to the indemnified party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The indemnified party shall cooperate fully in the defense of such claim and may participate in the defense at its own expense.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·No settlement of any claim shall be made without the prior written consent of the indemnified party, which shall not be unreasonably withheld.

**6. Miscellaneous**

**6.1. Governing Law**

This Agreement shall be governed by and construed in accordance with the laws of Wyoming State.

**6.2. Entire Agreement**

This Agreement constitutes the entire understanding and agreement among the parties with respect to the subject matter herein and supersedes all prior discussions, negotiations, or understandings, whether written or oral, relating to such subject matter.

The Parties acknowledge that this Agreement forms part of the integrated cooperation structure among OIC, Newco, and DentonX. For the avoidance of doubt, the Management Committee Addendum (Schedule A to the Management Agreement) establishes the management and decision-making mechanism through which Newco directs OIC's operations, including the business assets subject to this Lease Agreement.

This Agreement shall be interpreted in harmony with the other integrated agreements executed concurrently among the Parties.

------

Private & Confidential 6

------

![Picture 1](dtnxex107_1.jpg)

------

**6.3. Amendments**

Any amendment to this Agreement must be in writing and signed by both parties.

**6.4. Counterparts**

This Agreement may be executed in counterparts, each of which shall be deemed an original.

**IN WITNESS WHEREOF**, the parties have executed this Lease Agreement with Purchase Option as of the date first above written.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**DentonX Outstanding Investment Co. (Newco)**<br>| &nbsp;&nbsp;**Outstanding Investment Co., Inc.**<br>|
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* | &nbsp;&nbsp;By: */s/ Steven Guang Leung* |
| &nbsp;&nbsp;Name: Luis Carlos Ung | &nbsp;&nbsp;Name: Steven Guang Leung |
| &nbsp;&nbsp;Title: CEO | &nbsp;&nbsp;Title: CEO |
| &nbsp;&nbsp;Date: | &nbsp;&nbsp;Date: 12/9/2025 |

---

------

Private & Confidential 7

------

![Picture 1](dtnxex107_1.jpg)

------

**Exhibit A**

**Description of Leased Assets**

The Leased Assets subject to this Agreement include, but are not limited to, the following lending business assets owned by OIC:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·All tangible and intangible assets related to the lending business, including:

oClient contracts, client lists, and client relationships

oIntellectual property, including trademarks, copyrights, trade secrets, and know-how

oBusiness systems, processes, methodologies, and proprietary software

oBranding materials, marketing collateral, and goodwill associated with the business

oEquipment, furniture, and fixtures used exclusively in the lending business

oAll licenses, permits, and approvals necessary to operate the lending business

oAny other assets reasonably necessary for the operation of the lending business as of the Closing Date

A detailed inventory of tangible assets and copies of key contracts and intellectual property registrations shall be attached as schedules to this Exhibit A.

------

Private & Confidential 8

------

![Picture 1](dtnxex107_1.jpg)

------

**Exhibit B - Lease Payment Formula**

This Exhibit B is incorporated into and forms part of the Lease Agreement. It sets forth the detailed terms relating to Lease Payments referenced in Section 1.3 of the Agreement.

1. Base Amount. TBD

2. CPI Adjustment. Increase annually by ≤ 4 % or CPI-U change, whichever is lower.

3. Scope. Applies only to the Existing Business as of the Effective Date.

4. Purpose. Provides OIC a stable contractual return while allocating all operational control and risk to Newco.

------

Private & Confidential 9

------

![Picture 1](dtnxex107_1.jpg)

------

**Exhibit C**

**Purchase Price Formula**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.**Purchase Option Exercise:**

Newco may exercise the purchase option to acquire the Leased Assets at any time after One (1) year from the Closing Date, by providing written notice to OIC as specified in the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.**Purchase Price Calculation:**

The purchase price for the Leased Assets shall be calculated as follows:

Purchase Price = EBITDA × Multiple

Where:

o**EBITDA** = The trailing twelve-month Earnings Before Interest, Taxes, Depreciation, and Amortization of the lending business assets as reported in the audited financial statements most recently available prior to the exercise date.

o**Multiple** = A multiplier of 8

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.**Adjustments:**

The Purchase Price shall be adjusted for:

oAny outstanding liabilities related to the Leased Assets assumed by Newco;

oAny capital expenditures made by Newco on the Leased Assets during the lease term, if agreed by the parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.**Payment Terms:**

The Purchase Price shall be payable in cash or other mutually agreed consideration at the closing of the purchase.

------

Private & Confidential 10

## Exhibit 10.8

![Picture 1](dtnxex108_1.jpg)

------

**EQUITY & VESTING AGREEMENT**

**This Equity & Vesting Agreement ("Agreement")** is entered into as of November 11, 2025, by and between **DentonX Outstanding Investment Co.** ("Newco" or the "Company"), a Wyoming corporation to be formed and majority-owned by **DentonX Inc** ("DentonX") and **Outstanding Investment Co., Inc.** ("OIC" or the "Manager"), with offices at 2450 Washington Ave Ste 100, San Leandro, CA 94577.

**RECITALS**

**WHEREAS**, DentonX and OIC have engaged in discussions regarding a strategic partnership aimed at expanding OIC's lending and investment operations through DentonX's structuring, capital markets, and mergers and acquisitions capabilities;

**WHEREAS**, the parties have agreed in principle that such partnership will include, among other matters, (i) the formation of **DentonX Outstanding Investment Co.** ("Newco") as a majority-owned subsidiary of DentonX, (ii) the lease by Newco of OIC's certain business assets, and (iii) a purchase option for Newco to acquire such assets after an agreed period, based on a negotiated EBITDA multiple;

**WHEREAS**, the parties now desire to enter into this definitive Equity & Vesting Agreement to set forth the terms and conditions under which Newco shall issue to OIC and its principals 20% of the fully diluted equity of Newco, subject to vesting and claw back as further described herein;

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements herein contained, the parties agree as follows:

**1. Grant of Equity**

**1.1 Grant**

Upon the closing of the strategic transaction between DentonX, Newco, and OIC (the "Closing Date"), Newco shall issue to OIC and its principals equity representing 20% of the fully diluted share capital of Newco.

**1.2 Grant Date**

The equity is deemed granted as of the Closing Date.

------

Private & Confidential 1

------

![Picture 1](dtnxex108_1.jpg)

------

**2. Vesting**

**2.1 Vesting Schedule**

The equity grant to OIC shall vest over a period of thirty-six (36) months from the Grant Date, with vesting occurring in equal quarterly installments (i.e., 1/12th of the total grant every three months).

**2.2 Acceleration**

In the event of (a) a Change of Control of Newco or (b) an IPO or public listing of Newco or its successor, all unvested equity shall immediately vest.

**3. Claw Back and Forfeiture**

**3.1 Claw Back**

If the Management Agreement between Newco and OIC is terminated for cause, or if OIC voluntarily resigns before full vesting, all unvested shares as of the termination date shall be immediately forfeited and redeemable by Newco at nominal value.

**3.2 Good Leaver**

If OIC's termination is not for cause (e.g., due to death, disability, or mutual agreement), the Board may, at its discretion, accelerate vesting of some or all unvested shares.

**4. Transfer Restrictions and Right of First Refusal**

**4.1 Lock-Up**

OIC may not transfer, sell, assign, pledge, or otherwise dispose of any vested or unvested shares for the first twelve (12) months following the Grant Date, except with the prior written consent of the Board.

**4.2 Right of First Refusal**

After the lock-up period, if OIC wishes to transfer any vested shares, DentonX (or Newco, as designated by the Board) shall have a right of first refusal to purchase such shares on the same terms as offered to any third party.

**5. Miscellaneous**

**5.1 Governing Law**

This Agreement shall be governed by and construed in accordance with the laws of Wyoming State.

------

Private & Confidential 2

------

![Picture 1](dtnxex108_1.jpg)

------

**5.2 Entire Agreement**

This Agreement constitutes the entire understanding and agreement among the parties with respect to the subject matter herein and supersedes all prior discussions, negotiations, or understandings, whether written or oral, relating to such subject matter.

This Agreement forms part of an integrated cooperation structure among Outstanding Investment Co., Inc. ("OIC"), DentonX Outstanding Investment Co. ("Newco"), and DentonX Inc ("DentonX").

The Parties acknowledge that this Agreement, together with the Management & Earn-Out Agreement (including Schedule A – Management Committee Addendum) and the other definitive agreements executed concurrently herewith, collectively constitute the unified contractual framework through which Newco exercises strategic and operational control over OIC.

Capitalized terms used but not otherwise defined herein shall have the meanings given in the Management Agreement.

**5.3 Amendments**

Any amendment to this Agreement must be in writing and signed by both parties.

**5.4 Counterparts**

This Agreement may be executed in counterparts, each of which shall be deemed an original.

**IN WITNESS WHEREOF**, the parties have executed this Equity & Vesting Agreement as of the date first above written.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**DentonX Outstanding Investment Co. (Newco)**<br>| &nbsp;&nbsp;**Outstanding Investment Co., Inc.**<br>|
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* | &nbsp;&nbsp;By: */s/ Steven Guang Leung* |
| &nbsp;&nbsp;Name: Luis Carlos Ung | &nbsp;&nbsp;Name: Steven Guang Leung |
| &nbsp;&nbsp;Title: CEO | &nbsp;&nbsp;Title: CEO |
| &nbsp;&nbsp;Date: | &nbsp;&nbsp;Date: 1/10/2026 |

---

------

Private & Confidential 3

------

![Picture 1](dtnxex108_1.jpg)

------

**Exhibit A: Vesting Schedule Example**

---

| | | |
|:---|:---|:---|
| **Quarter** | **% Vested (Cumulative)** | **Shares Vested (Example)** |
| Q1 | 8.33% | [Number x 0.0833] |
| Q2 | 16.67% | [Number x 0.1667] |
| Q3 | 25.00% | [Number x 0.25] |
| ... | ... | ... |
| Q12 | 100% | [Number] |

---

**Notes:** 

"Number" refers to the total number of shares that will be issued to OIC and its principals pursuant to Section 1.1 of this Agreement, representing 20% of the fully diluted equity of Newco as of the Grant Date. The actual number of shares will be determined once Newco is formed and its total capitalization is finalized.

------

Private & Confidential 4

## Exhibit 10.9

![Picture 1](dtnxex109_1.jpg)

------

**DENTONX SHARE GRANT AGREEMENT**

**This DentonX Share Grant Agreement** ("Agreement") is made as of November 11, 2025, by and between **DentonX Inc**, a Wyoming corporation ("DentonX"), with offices at 1999 Harrison Street, Suite 1800, Oakland, CA 94612; and **Outstanding Investment Co., Inc. and** **its Key Person(s)** ("Key Person" has the meaning given in the Key Person Undertaking Addendum (*Schedule C*) to the Exclusive Management Cooperation Agreement between Newco and OIC), led by Steven Guang Leung ("OIC"), with offices at 2450 Washington Ave Ste 100, San Leandro, CA 94577.

**RECITALS**

**WHEREAS**, DentonX and OIC have engaged in discussions regarding a strategic partnership aimed at expanding OIC's lending and investment operations through DentonX's structuring, capital markets, and mergers and acquisitions capabilities;

**WHEREAS**, the parties have agreed in principle that such partnership will include, among other matters, (i) the formation of **DentonX Outstanding Investment Co.** ("Newco") as a majority-owned subsidiary of DentonX, (ii) the lease and potential acquisition of certain business assets owned by OIC through Newco, (iii) the issuance of equity in Newco to OIC, and (iv) a one-time equity grant in DentonX to certain Key Person(s) associated with OIC as a performance-based incentive;

**WHEREAS**, the parties now wish to enter into this definitive Share Grant Agreement to set forth the terms and conditions under which DentonX shall grant to OIC and its Key Person(s) a one-time strategic equity award in DentonX, subject to vesting and claw back provisions as further described herein;

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements herein contained, the parties agree as follows:

**1. Grant of Shares**

**1.1 Grant**

Upon the closing of the strategic transaction between DentonX, NewCo, and OIC (the "Closing Date"), DentonX hereby grants to the Key Person a one-time award of **Three Hundred Sixty** ("Number") **Series B Preferred Shares** (the "Grant Shares"), as a performance-based incentive and equity kicker in recognition of their contribution to Newco and DentonX's value creation.

**1.2 Recipient of Grant**

The Equity Grant is awarded solely to the individual Key Person, who are the individual(s) designated as Key Persons in the *Key Person Undertaking Addendum* (Schedule C) to the

------

Private & Confidential 1

------

![Picture 1](dtnxex109_1.jpg)

------

*Exclusive Management Cooperation Agreement* between Newco and OIC, each of whom has executed such Undertaking.

The Parties acknowledge and agree that no Equity Grant shall be issued to OIC as an entity, and no Equity Grant shall confer any voting, management, or shareholder rights to OIC.

**1.3 Grant Date**

The Grant Shares are deemed granted as of the Closing Date (the "Grant Date").

**2. Vesting**

**2.1 Vesting Schedule**

The Grant Shares shall vest over three (3) years in twelve (12) equal quarterly installments, with 1/12 of the Grant Shares vesting every three months, so that 100% of the Grant Shares shall be fully vested on the third anniversary of the Grant Date.

Vesting is dependent upon:

(i) the Key Person's continued service and cooperation under the Exclusive Management Cooperation Agreement ("EMCA");

(ii) compliance with Management Committee directives; and

(iii) adherence to all confidentiality, exclusivity, and non-compete obligations.

**2.2 Acceleration**

In the event of (a) a Change of Control of DentonX, or (b) an IPO or public listing of Newco or its successor, all unvested Grant Shares shall immediately vest.

**3. Claw Back and Forfeiture**

**3.1 Clawback**

If the Exclusive Management Cooperation Agreement between Newco and OIC is terminated for cause, or if OIC voluntarily resigns before full vesting, all unvested Grant Shares as of the termination date shall be immediately forfeited and returned to DentonX at nominal value.

Any violation by the Key Person or by OIC of the EMCA or the Key Person Undertaking shall result in the immediate forfeiture of all unvested shares.

**3.2 Good Leaver**

If OIC's termination is not for cause (e.g., due to death, disability, or mutual agreement), the DentonX Board may, at its discretion, accelerate vesting of some or all unvested Grant Shares.

------

Private & Confidential 2

------

![Picture 1](dtnxex109_1.jpg)

------

**4. Restrictions on Transfer**

**4.1 Lock-Up**

OIC may not transfer, sell, assign, pledge, or otherwise dispose of any vested or unvested Grant Shares for the first twelve (12) months following the Grant Date, except with the prior written consent of DentonX's Board.

**4.2 Compliance**

All transfers of Grant Shares are subject to compliance with applicable securities laws and DentonX's insider trading policy.

**5. Miscellaneous**

**5.1 No Rights as Shareholder Until Vesting**

OIC shall not have rights as a shareholder with respect to unvested Grant Shares until such shares have vested and been issued.

**5.2 Taxes**

OIC is solely responsible for any tax liabilities arising from the grant, vesting, or disposition of Grant Shares.

**5.3 Governing Law**

This Agreement shall be governed by and construed in accordance with the laws of the State of Wyoming.

**5.4 Entire Agreement**

This Agreement constitutes the entire understanding and agreement among the parties with respect to the subject matter herein and supersedes all prior discussions, negotiations, or understandings, whether written or oral, relating to such subject matter.

This Share Grant Agreement is entered into as part of the integrated cooperation structure among OIC, Newco, and DentonX, and it shall be interpreted together with the Exclusive Management Cooperation Agreement and the Key Person Undertaking Addendum referred to therein.

**5.5 Amendments**

Any amendment to this Agreement must be in writing and signed by both parties.

**5.6 Counterparts**

This Agreement may be executed in counterparts, each of which shall be deemed an original.

------

Private & Confidential 3

------

![Picture 1](dtnxex109_1.jpg)

------

**IN WITNESS WHEREOF**, the parties have executed this DentonX Share Grant Agreement as of the date first above written.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**DentonX Inc** | &nbsp;&nbsp;**Outstanding Investment Co., Inc. & its Key Person(s)** |
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* | &nbsp;&nbsp;By: */s/ Steven Guang Leung* |
| &nbsp;&nbsp;Name: Luis Carlos Ung | &nbsp;&nbsp;Name: Steven Guang Leung |
| &nbsp;&nbsp;Title: CEO | &nbsp;&nbsp;Title: CEO |
| &nbsp;&nbsp;Date: | &nbsp;&nbsp;Date: |

---

------

Private & Confidential 4

------

![Picture 1](dtnxex109_1.jpg)

------

**Exhibit A: Vesting Schedule Example**

---

| | | |
|:---|:---|:---|
| **Quarter** | **Vested (Cumulative)** | **Shares Vested (Example)** |
| Q1 | 1/12 | [Number x 1/12] |
| Q2 | 1/6 | [Number x 1/6] |
| Q3 | 1/4 | [Number x 1/4] |
| ... | ... | ... |
| Q12 | 1 | [Number] |

---

**Notes**

Refer to Section 1.1 for the definition of "Number".

------

Private & Confidential 5

## Exhibit 10.10

![Picture 1](dtnxex1010_1.jpg)

------

**INVESTMENT RIGHTS AGREEMENT**

*(Discounted Share Purchase Rights)*

**This Investment Rights Agreement ("Agreement")** is entered into as of November 11, 2025, by and between **Denton**X **Inc** ("Company" or "DentonX"), a Wyoming corporation with offices at 1999 Harrison Street, Suite 1800, Oakland, CA 94612, and **Outstanding Investment Co., Inc. and/or its principals** ("Investor"), with offices at 2450 Washington Ave Ste 100, San Leandro, CA 94577.

**RECITALS**

**WHEREAS**, DentonX and OIC have engaged in discussions regarding a strategic partnership aimed at expanding OIC's lending and investment operations through DentonX's structuring, capital markets, and mergers and acquisitions capabilities;

**WHEREAS**, the parties have agreed in principle that such partnership will include, among other matters, (i) the formation of **DentonX Outstanding Investment Co.** ("Newco") as a majority-owned subsidiary of DentonX, (ii) the lease and potential acquisition of certain business assets owned by OIC through Newco, (iii) the issuance of equity in Newco to OIC, and (iv) a one-time equity grant in DentonX to OIC and its principals as a performance-based incentive;

**WHEREAS**, the parties now wish to enter into this definitive Investment Rights Agreement to set forth the terms and conditions under which DentonX shall grant to OIC and its principals a one-time strategic equity award in DentonX, subject to vesting and claw back provisions as further described herein;

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements herein contained, the parties agree as follows:

**1. DEFINITIONS**

**"DentonX"** means DentonX Inc, a Wyoming corporation.

**"NewCo"** means DentonX Outstanding Investment Co., a Wyoming corporation to be formed and majority owned by DentonX, referenced for context only.

**"Discounted Share Purchase"** means the purchase of DentonX shares by Investor at a price discounted from the 30-day volume-weighted average price (VWAP), as set forth in this Agreement.

**"VWAP"** means the volume-weighted average price of DentonX's publicly traded shares for the 30 trading days immediately preceding the Exercise Date.

------

Private & Confidential 1

------

![Picture 1](dtnxex1010_1.jpg)

------

**"Exercise Date"** means the date on which Investor delivers written notice to DentonX of its intent to exercise the Discounted Share Purchase right.

**"Closing Date"** means the date on which the definitive agreement(s) are executed.

**2. DISCOUNTED SHARE PURCHASE RIGHT**

**2.1. Grant of Right**

DentonX hereby grants to Investor the right to purchase up to 10% of DentonX's total outstanding shares as of the Closing Date ("Purchase Shares") at a 15% discount to the 30-day VWAP, exercisable at any time within twelve (12) months following the Closing Date, subject to the terms herein.

**2.2. Exercise Procedure**

To exercise this right, Investor must deliver written notice to DentonX specifying the number of shares to be purchased (up to the maximum permitted), the intended Exercise Date, and evidence of funds availability.

**2.3. Purchase Price**

The purchase price per share shall be calculated as follows:

Purchase Price per Share = VWAP × (1-Discount Percentage)

Where the Discount Percentage is 15% as agreed and confirmed in writing prior to exercise.

**2.4. Payment and Closing**

Investor shall pay the aggregate purchase price in immediately available funds at closing, and DentonX shall deliver the Purchase Shares to Investor within five (5) business days of receipt of payment.

**2.5. Restrictions**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The right may be exercised in one or more tranches, provided the aggregate does not exceed 10% of DentonX's total outstanding shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·All purchases are subject to compliance with applicable securities laws, insider trading policies, and any trading window or volume restrictions as required by law or DentonX's policies.

------

Private & Confidential 2

------

![Picture 1](dtnxex1010_1.jpg)

------

**3. INVESTOR RIGHTS**

**3.1. Preemptive Rights**

If DentonX proposes to issue new equity securities (other than in connection with employee compensation or strategic acquisitions), Investor shall have the right to purchase its pro rata share of such new securities on the same terms as offered to other investors.

**3.2. Registration Rights**

If DentonX files a registration statement for a public offering of its shares, Investor shall have "piggyback" registration rights to include its shares in such offering, subject to customary underwriter cutbacks.

**3.3. Transfer Restrictions**

Investor may not transfer any Purchase Shares for six (6) months following the date of purchase, except with DentonX's prior written consent or as otherwise required by law.

**3.4. Right of First Refusal**

If Investor wishes to transfer Purchase Shares after the lock-up period, DentonX shall have a right of first refusal to purchase such shares on the same terms as offered to any third party.

**4. REPRESENTATIONS AND WARRANTIES**

**4.1. By DentonX**

DentonX represents and warrants to Investor that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·DentonX is duly organized, validly existing, and in good standing under the laws of Wyoming;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·DentonX has full power and authority to enter into and perform this Agreement and to issue and sell the Purchase Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The execution, delivery, and performance of this Agreement do not and will not violate any organizational documents, law, or contract binding on DentonX;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The Purchase Shares, when issued and delivered, will be duly authorized, validly issued, fully paid, and non-assessable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·No consent or approval of any governmental authority or third party is required for the execution and performance of this Agreement, except as already obtained.

**4.2. By Investor**

Investor represents and warrants to DentonX that:

------

Private & Confidential 3

------

![Picture 1](dtnxex1010_1.jpg)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Investor is duly organized, validly existing, and in good standing under the laws of its jurisdiction of formation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Investor has full power and authority to enter into and perform this Agreement and to purchase the Purchase Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The execution, delivery, and performance of this Agreement do not and will not violate any organizational documents, law, or contract binding on Investor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Investor is acquiring the Purchase Shares for its own account and not with a view to distribution in violation of applicable securities laws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Investor is an "accredited investor" as defined under applicable securities laws.

**5. INDEMNIFICATION**

**5.1. By DentonX**

DentonX shall indemnify and hold harmless Investor from and against any and all losses, claims, damages, or liabilities arising out of any breach of DentonX's representations, warranties, or covenants in this Agreement.

**5.2. By Investor**

Investor shall indemnify and hold harmless DentonX from and against any and all losses, claims, damages, or liabilities arising out of any breach of Investor's representations, warranties, or covenants in this Agreement.

**5.3. Procedures**

The indemnified party shall promptly notify the indemnifying party of any claim. The indemnifying party may assume the defense of any such claim with counsel reasonably satisfactory to the indemnified party.

**6. MISCELLANEOUS**

**6.1. Governing Law**

This Agreement shall be governed by and construed in accordance with the laws of the State of Wyoming.

**6.2. Entire Agreement**

This Agreement constitutes the entire understanding and agreement among the parties with respect to the subject matter herein and supersedes all prior discussions, negotiations, or understandings, whether written or oral, relating to such subject matter.

------

Private & Confidential 4

------

![Picture 1](dtnxex1010_1.jpg)

------

The Parties acknowledge that this Investment Rights Agreement forms part of the same integrated cooperation structure among OIC, Newco, and DentonX. Reference is made to the Management Committee Addendum (Schedule A to the Management Agreement), which establishes Newco's contractual control and management authority over OIC. The rights and obligations set forth herein shall be construed in a manner consistent with the integrated agreements executed concurrently among the Parties.

**6.3. Amendments**

Any amendment to this Agreement must be in writing and signed by both parties.

**6.4. Counterparts**

This Agreement may be executed in counterparts, each of which shall be deemed an original.

**6.5. Notices**

All notices shall be in writing and delivered by hand, courier, certified mail, or email to the addresses set forth above or to such other address as a party may designate in writing.

**6.6. Assignment**

This Agreement may not be assigned by any party without the prior written consent of the other party.

**6.7. Severability**

If any provision of this Agreement is held invalid or unenforceable, the remainder shall remain in full force and effect.

**IN WITNESS WHEREOF**, the parties have executed this Investor Rights Agreement as of the date first above written.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**DentonX Inc** | &nbsp;&nbsp;**Outstanding Investment Co., Inc. & Principals** |
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* | &nbsp;&nbsp;By: */s/ Steven Guang Leung* |
| &nbsp;&nbsp;Name: Luis Carlos Ung | &nbsp;&nbsp;Name: Steven Guang Leung |
| &nbsp;&nbsp;Title: CEO | &nbsp;&nbsp;Title: CEO |
| &nbsp;&nbsp;Date: | &nbsp;&nbsp;Date: 1/10/2026 |

---

------

Private & Confidential 5

------

![Picture 1](dtnxex1010_1.jpg)

------

**Key Terms Recap:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Shares:** Up to 10% of DentonX outstanding shares

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Discount:** 15% off 30-day VWAP

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Exercise Period:** 12 months post-closing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Volume/Trading Restrictions:** As per company policy and law

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Compliance:** Insider trading and securities law compliance required

------

Private & Confidential 6

## Exhibit 10.11

![Picture 1](dtnxex1011_1.jpg)

------

**SHAREHOLDERS AGREEMENT**

of DentonX Outstanding Investment Co. ("Newco")

**This Shareholders Agreement ("Agreement")** is entered into as of November 11, 2025, by and among:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**DentonX Inc** ("DentonX"), a Wyoming corporation with offices at 1999 Harrison Street, Suite 1800, Oakland, CA 94612;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Outstanding Investment Co., Inc. and its principals** ("OIC"), with offices at 2450 Washington Ave Ste 100, San Leandro, CA 94577.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**DentonX Outstanding Investment Co.** ("Newco" or the "Company"), a Wyoming corporation to be formed and majority-owned by DentonX Inc;

**RECITALS**

**WHEREAS**, DentonX and OIC have engaged in discussions regarding a strategic partnership aimed at expanding OIC's lending and investment operations through DentonX's structuring, capital markets, and mergers and acquisitions capabilities;

**WHEREAS**, the parties have agreed in principle that such partnership will include, among other matters, (i) the formation of **DentonX Outstanding Investment Co.** ("Newco") as a majority-owned subsidiary of DentonX, (ii) the lease and potential acquisition of certain business assets owned by OIC through Newco, (iii) the issuance of equity in Newco to OIC, subject to vesting and claw back, and (iv) a management and earn-out structure to align the interests of the parties;

**WHEREAS**, the parties now wish to enter into this definitive Shareholders Agreement to set forth the terms and conditions governing the ownership, management, and operation of NewCo, including the issuance of equity to OIC and the rights and obligations of the shareholders;

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements herein contained, the parties agree as follows:

**1. Definitions**

**"DentonX"** means DentonX Inc, a Wyoming corporation.

**"Board"** means the Board of Directors of NewCo.

**"Cause"** means:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Willful misconduct, gross negligence, or fraud by OIC or its principals in the performance of duties;

------

Private & Confidential 1

------

![Picture 1](dtnxex1011_1.jpg)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Conviction of, or plea of guilty or no contest to, a felony or crime involving moral turpitude;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Material breach of this Agreement or any other definitive agreement, not cured within thirty (30) days after written notice;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Willful or repeated refusal or failure to perform material duties under the Management Agreement after written notice;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Misappropriation or unauthorized disclosure of confidential information, trade secrets, or intellectual property of NewCo or DentonX.

**"Change of Control"** means (i) any person or entity becoming the beneficial owner of more than 50% of the voting power of NewCo; (ii) a merger, consolidation, or similar transaction after which the shareholders of NewCo immediately prior to such transaction do not own at least 50% of the voting power of the surviving entity; or (iii) a sale of all or substantially all of NewCo's assets.

**"Closing Date"** means the date on which (i) NewCo is duly formed and organized as a majority-owned subsidiary of DentonX, and (ii) all parties have executed the definitive agreement(s).

**"Good Leaver"** means termination of OIC's engagement due to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Death or permanent disability of OIC's principal(s);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Termination by NewCo without Cause;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Mutual agreement in writing between the parties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any other event agreed to in writing by the Board as constituting a Good Leaver event.

**"OIC"** means Outstanding Investment Co., Inc. and its principals, led by Steven Guang Leung.

**"NewCo"** means DentonX Outstanding Investment Co., a Wyoming corporation to be formed and initially majority owned by DentonX prior to the Closing Date.

**"Shares"** means the issued and outstanding shares of capital stock of NewCo.

**2. Formation and Capital Structure**

**2.1. Formation of NewCo**

DentonX shall form NewCo as a majority-owned subsidiary prior to the Closing Date.

**2.2. Initial Capitalization**

Upon formation, NewCo shall be initially capitalized by DentonX in an amount sufficient to commence operations.

------

Private & Confidential 2

------

![Picture 1](dtnxex1011_1.jpg)

------

**2.3. Share Issuance to OIC**

Upon the Closing Date, DentonX shall cause NewCo to issue to OIC shares representing 20% of the fully diluted equity of NewCo, subject to vesting as set forth in the Equity & Vesting Agreement. The remaining 80% of NewCo's equity shall be held by DentonX.

**2.4. Future Capital Contributions**

Any future capital contributions shall be made on terms approved by the Board, with DentonX having a right of first offer to provide such capital.

**3. Board of Directors**

**3.1. Board Composition**

The Board shall initially consist of three (3) directors, with two (2) directors appointed by DentonX and one (1) director appointed by OIC.

**3.2. OIC's Board Seat**

OIC shall have the right to appoint one (1) member to the Board for so long as it holds at least 10% of NewCo's issued and outstanding shares.

**3.3. Board Meetings**

The Board shall meet at least quarterly. Notice of meetings shall be provided at least five (5) business days in advance, unless waived by all directors.

**3.4. Quorum and Voting**

A quorum for Board meetings shall require the presence of a majority of directors. Except for Reserved Matters, Board decisions shall be made by simple majority vote.

**4. Reserved Matters**

**4.1. Matters Requiring Special Approval**

The following actions shall require approval by both the OIC-appointed director and a majority of the Board:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Amendments to Certificate of Incorporation or Bylaws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Issuance of new shares or securities (including options, warrants, or convertible instruments);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Sale, lease, transfer, or disposition of all or substantially all of Newco's assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Mergers, consolidations, or dissolution of Newco;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Approval of annual budget or business plan;

------

Private & Confidential 3

------

![Picture 1](dtnxex1011_1.jpg)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Entry into, amendment, or termination of any material contract outside the ordinary course of business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Incurrence of indebtedness above an amount to be determined from time to time by the Board of Directors, or granting of any security interest over company assets without prior Board approval;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Related party transactions involving shareholders or their affiliates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any change to the rights or privileges of OIC's equity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Any other matter mutually agreed by the parties in writing.

**5. Transfer Restrictions**

**5.1. Lock-Up Period**

Neither DentonX nor OIC may transfer any Shares for a period of twelve (12) months following the Closing Date without the prior written consent of the other party.

**5.2. Right of First Refusal**

After the lock-up period, if either shareholder (the "Offering Shareholder") receives a bona fide offer from a third party to purchase any or all of its Shares and wishes to accept such offer, the Offering Shareholder must first offer to sell such Shares to the other shareholder on the same terms.

**5.3. Tag-Along Rights**

If DentonX proposes to sell Shares representing more than 50% of the total issued and outstanding Shares to a third party, OIC shall have the right to participate in such sale on a pro rata basis and the same terms and conditions.

**5.4. Drag-Along Rights**

If DentonX proposes to sell all of its Shares to a third party, DentonX may require OIC to sell all of its Shares to such third party on the same terms and conditions, provided that (i) such sale values Newco at a minimum of $15 million, and (ii) OIC receives the same per-share consideration as DentonX.

**6. IPO Pathway and Exit**

**6.1. IPO Preparation**

NewCo shall be part of a public company and may prepare its client companies for public listing, subject to qualification. With OIC's cooperation, NewCo shall lead governance enhancements, audit readiness, and listing execution. OIC shall have the right to piggyback on the listing vehicle.

------

Private & Confidential 4

------

![Picture 1](dtnxex1011_1.jpg)

------

**6.2. Conversion or Buyout**

Upon any public listing or liquidity event of these clients of Newco, OIC's equity in any relevant listing vehicle may, at Newco's option, be converted into shares of such listing vehicle or bought out at fair market value.

**6.3. Registration Rights**

In the event of an IPO, OIC shall have customary piggyback registration rights with respect to its Shares or any DentonX shares received in exchange for its Newco equity.

**7. Dividends and Distributions**

**7.1. Dividend Policy**

The Board shall determine the dividend policy of Newco, taking into account working capital needs, growth plans, and other relevant factors.

**7.2. Pro Rata Distributions**

All dividends and distributions shall be made pro rata to all shareholders based on their respective ownership percentages.

**8. Information Rights**

Each shareholder shall have reasonable access to Newco's books and records during normal business hours upon reasonable notice, subject to any limitations or procedures established by the Board of Directors or set forth in its bylaws.

**9. Non-Competition and Non-Solicitation**

**9.1. Non-Competition**

During the term of the Management Agreement and for a period of months thereafter, OIC and its principals shall not, directly or indirectly, engage in any business that competes with Newco.

**9.2. Non-Solicitation**

During the term of the Management Agreement and for a period of months thereafter, neither party shall solicit or attempt to solicit employees, contractors, or clients of Newco.

**10. Confidentiality**

**10.1. Confidential Information**

Each party shall maintain the confidentiality of all non-public information relating to Newco, its business, operations, and clients.

------

Private & Confidential 5

------

![Picture 1](dtnxex1011_1.jpg)

------

**10.2. Exceptions**

The confidentiality obligations shall not apply to information that (i) is or becomes publicly available through no fault of the receiving party, (ii) is required to be disclosed by law or court order, or (iii) is disclosed with the prior written consent of the other party.

**11. Dispute Resolution**

**11.1. Negotiation**

The parties shall attempt in good faith to resolve any dispute arising out of or relating to this Agreement through negotiation between executives with the authority to settle the dispute.

**11.2. Mediation**

If the dispute cannot be resolved through negotiation within 30 days, the parties shall submit the dispute to mediation under the rules of the American Arbitration Association (AAA).

**11.3. Arbitration**

If the dispute cannot be resolved through mediation within 60 days, the dispute shall be finally resolved by arbitration under the rules of the American Arbitration Association (AAA).

**12. Miscellaneous**

**12.1. Governing Law**

This Agreement shall be governed by and construed in accordance with the laws of Wyoming State.

**12.2. Entire Agreement**

This Agreement constitutes the entire understanding and agreement among the parties with respect to the subject matter herein and supersedes all prior discussions, negotiations, or understandings, whether written or oral, relating to such subject matter.

This Agreement is one component of the integrated cooperation structure among OIC, Newco, and DentonX. The Parties confirm that the Management Committee Addendum (Schedule A to the Management Agreement) defines the governance and control structure applicable to OIC and its management, and that this Shareholders Agreement shall be interpreted consistently with such framework and the other definitive agreements executed concurrently herewith.

**12.3. Amendments**

Any amendment to this Agreement must be in writing and signed by all parties.

**12.4. Counterparts**

This Agreement may be executed in counterparts, each of which shall be deemed an original.

**12.5. Notices**

------

Private & Confidential 6

------

![Picture 1](dtnxex1011_1.jpg)

------

All notices shall be in writing and delivered by hand, courier, certified mail, or email to the addresses set forth in the preamble or to such other address as a party may designate in writing.

**12.6. Assignment**

This Agreement may not be assigned by any party without the prior written consent of the other parties.

**12.7. Severability**

If any provision of this Agreement is held invalid or unenforceable, the remainder of the Agreement shall remain in full force and effect.

**IN WITNESS WHEREOF**, the parties have executed this Shareholders Agreement as of the date first above written.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**DentonX Inc** | &nbsp;&nbsp;**Outstanding Investment Co., Inc. & Principals** |
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* | &nbsp;&nbsp;By: */s/ Steven Guang Leung* |
| &nbsp;&nbsp;Name: Luis Carlos Ung | &nbsp;&nbsp;Name: Steven Guang Leung |
| &nbsp;&nbsp;Title: CEO | &nbsp;&nbsp;Title: CEO |
| &nbsp;&nbsp;Date: | &nbsp;&nbsp;Date: |
| &nbsp;&nbsp;**DentonX Outstanding Investment Co.**  |  |
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* |  |
| &nbsp;&nbsp;Name: |  |
| &nbsp;&nbsp;Title: |  |
| &nbsp;&nbsp;Date: |  |

---

------

Private & Confidential 7

------

![Picture 1](dtnxex1011_1.jpg)

------

**Attachments:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Schedule 1: Cap Table

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Schedule 2: Vesting Schedule

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Schedule 3: Reserved Matters

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Schedule 4: Management Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Schedule 5: Lease Agreement with Purchase Option

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Schedule 6: Earn-Out Terms

------

Private & Confidential 8

------

![Picture 1](dtnxex1011_1.jpg)

------

**Schedule 1: Cap Table (Initial Share Capitalization Table)**

---

| | | | |
|:---|:---|:---|:---|
| **Shareholder** | **Number of Shares** | **% Ownership (Fully Diluted)** | **Vesting Status** |
| DentonX Inc (DentonX) | [X] | 80% | Fully Vested |
| Outstanding Investment Co., Inc. / Principals | [Y] | 20% | Subject to 36-month vesting (see Schedule 2) |

---

**Notes:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·"X" refers to the total number of shares that will be issued to DentonX, representing 80% of the fully diluted equity of Newco upon the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·"Y" refers to the total number of shares that will be issued to OIC and its principals, representing 20% of the fully diluted equity of Newco upon the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·The actual number of shares representing 100% of the fully diluted equity of Newco as of the Closing Date will be determined once Newco is formed and its total capitalization is finalized.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·OIC's 20% is subject to vesting and claw back as described in Schedules 2 and 3.

------

Private & Confidential 9

------

![Picture 1](dtnxex1011_1.jpg)

------

**Schedule 2: Vesting Schedule (OIC Equity in Newco)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Total Equity Subject to Vesting:** 20% of fully diluted equity in Newco.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Vesting Period:** 36 months from the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Vesting Frequency:** Quarterly (every 3 months).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Vesting Cliff:** Quarterly (i.e., 1/12th of total equity vests each quarter).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Vesting Table Example:**

---

| | | |
|:---|:---|:---|
| **Month** | **% Vested Cumulative** | **Shares Vested (Example)** |
| 0 | 0% | 0 |
| 3 | 8.33% | [Number x 0.0833] |
| 6 | 16.67% | [Number x 0.1667] |
| 9 | 25.00% | [Number x 0.25] |
| ... | ... | ... |
| 36 | 100% | [Number] |

---

**Notes:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·"Number" refers to the total number of shares that will be issued to OIC and its principals, representing 20% of the fully diluted equity of Newco upon the Closing Date. The actual number of shares will be determined once Newco is formed and its total capitalization is finalized.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·**Claw Back:** Unvested shares are forfeited and redeemable at nominal value if the Management Agreement is terminated for cause or if OIC resigns before full vesting.

------

Private & Confidential 10

------

![Picture 1](dtnxex1011_1.jpg)

------

**Schedule 3: Reserved Matters (Requiring Special Approval)**

The following actions by Newco require approval by the Newco Board of Directors, including both the OIC-appointed director and a majority of the Board, and the majority votes of the Newco Shareholders:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Amendments to Certificate of Incorporation or Bylaws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Issuance of new shares or securities (including options, warrants, or convertible instruments).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Sale, lease, transfer, or disposition of all or substantially all of Newco's assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.Mergers, consolidations, or dissolution of Newco.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.Approval of annual budget or business plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.Entry into, amendment, or termination of any material contract outside the ordinary course of business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.Incurrence of indebtedness above an amount to be determined from time to time by the Board of Directors, or granting of any security interest over company assets without prior Board approval;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.Related party transactions involving shareholders or their affiliates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.Any change to the rights or privileges of OIC's equity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.Any other matter mutually agreed by the parties in writing.

------

Private & Confidential 11

------

![Picture 1](dtnxex1011_1.jpg)

------

**Schedule 4: Management Agreement**

------

Private & Confidential 12

------

![Picture 1](dtnxex1011_1.jpg)

------

**Schedule 5: Lease Agreement with Purchase Option**

------

Private & Confidential 13

------

![Picture 1](dtnxex1011_1.jpg)

------

**Schedule 6: Earn-Out Terms (Performance-Based Incentives)**

**1. Purpose:**

To incentivize OIC for achieving key milestones that drive growth and value creation for Newco.

**2. Milestones and Triggers:**

Earn-out awards (equity or cash) will be granted upon achievement of the following, to be finalized in the Management & Earn-Out Agreement:

---

| | | |
|:---|:---|:---|
| **Milestone** | **Timing** | **Earn-Out Award** |
| Achieve $1 million in annual revenue | By the end of Year 1 | TBD |
| Achieve $250,000 in EBITDA | By the end of Year 2 | TBD |
| Secure 5 new enterprise clients | By the end of Year 1 | TBD |
| Expand into a new service area | By the end of Year 2 | TBD |
| Achieve a 15% profit margin | By the end of Year 3 | TBD |

---

**3. Calculation and Payment:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Awards are calculated based on audited (or mutually agreed unaudited) financials.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Earn-out equity is subject to the same vesting and claw back provisions as initial equity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Earn-out cash is payable within days of milestone confirmation.

**4. Board Approval:**

All earn-out awards require Board approval (not to be unreasonably withheld if milestones are met).

------

Private & Confidential 14

## Exhibit 10.12

**MASTER SERVICE AGREEMENT FOR:**

**CONSULTING AND CORPORATE DEVELOPMENT SERVICES**

**\*\* Alphega Global Partners Corp. \*\***

This Master Services Agreement ("MSA") is entered into as of November 26, 2025 ("Effective Date"), by and between:

- DentonX Inc., hereinafter referred to as the "Client".

- Alphega Global Partners Corp., hereinafter referred to as the "Consultant".

WHEREAS, the Client desires to engage the Consultant to provide corporate development and financial consulting services, and the Consultant agrees to provide such services under the terms and conditions set forth herein.

NOW, THEREFORE, the parties agree as follows:

**SECTION 1: THE ENGAGEMENT**

1.1. Scope of Services. The Consultant will perform the services as detailed in specific Statements of Work ("SOW"). Each SOW will be issued by the Client, mutually agreed upon in writing, and will be incorporated into this MSA. The standard format for an SOW is attached as \*\*Appendix A\*\*. Any modification to an existing SOW must be documented in a new, signed SOW that expressly supersedes the prior version.

1.2. Client Responsibilities. The Client shall provide its full and timely cooperation to ensure the successful performance of the services. This includes, but is not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- Promptly responding to inquiries and requests for information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- Providing access to all necessary documentation and relevant data.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- Ensuring fluid communication and review of deliverables.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- Timely payment of all fees and expenses as outlined in Section 2.

The Client acknowledges that any delay or failure in these responsibilities may negatively impact the project's outcome and timeline.

**SECTION 2: FINANCIAL TERMS**

2.1. Fees and Compensation. In consideration for the services, the Client shall compensate the Consultant according to the fee structure defined in the applicable SOW. The detailed Payment Schedule, including professional service fees and success-based compensation, is outlined in the SOW (\*\*Appendix A\*\*) and its corresponding Fee Schedule (\*\*Appendix C\*\*). All payments are to be made in cash unless otherwise agreed in writing. Any services rendered by the Consultant prior to the Effective Date are billable under these terms.

2.2. Retainer. Upon execution of this MSA, the Client will provide a retainer as specified in the SOW. This retainer will be maintained at its full amount throughout the engagement. Upon termination, the retainer will be applied against any final outstanding invoices, and any remaining surplus will be refunded to the Client. The retainer is not an estimate of total costs.

------© 2025 Alphega Global Partners Corp. All rights reserved. Private and Confidential. 1

------

2.3. Objections to Invoices. The Client must provide written notice of any objection to a billed fee or cost within seven (7) days of receiving the invoice. Failure to do so will be considered a waiver of any claim regarding the disputed charges.

2.4. Cost Estimates. Any estimates of fees or timelines provided by the Consultant are for guidance purposes only and are not binding. Should the actual work be projected to significantly exceed an estimate, the Consultant will notify the Client, who may then decide whether to proceed.

**SECTION 3: TERM AND TERMINATION**

3.1. Termination. This Agreement may be terminated by either party with sixty (60) days' written notice (the "Termination Period"). The Consultant may also terminate this Agreement if the Client fails to meet its obligations and does not remedy such failure within ten (10) days of receiving written notice.

3.2. Effect of Termination. In the event of termination, the Client remains responsible for the payment of all services and costs incurred up to and including the final day of the Termination Period.

3.3. Return and Destruction of Records. Upon termination, the Consultant may offer to return the Client's records. The Client will have thirty (30) days to provide a delivery address. If no address is provided within this period, the Consultant reserves the right to destroy said records, and the Client waives all claims related to their destruction.

**SECTION 4: COVENANTS AND PROTECTIONS**

4.1. Confidentiality. The Client agrees not to disclose the contents of this MSA, its SOWs, or related agreements to any third party. Both parties will continue to honor any pre-existing non-disclosure agreements.

4.2. Non-Solicitation and Non-Circumvention. The Client acknowledges the Consultant's reliance on its resources and network. Therefore, during the term of this MSA and for twenty-four (24) months following its termination, the Client agrees not to, directly or indirectly, solicit, circumvent, hire, or employ any employee, contractor, supplier, investor, or contact introduced by the Consultant without the Consultant's express written consent.

4.3. Right of First Refusal. If, within two (2) years of this MSA's date, the Client is part of a merger, acquisition, or similar transaction and seeks management or incubation services, the Client shall promptly notify the Consultant in writing. The Consultant will have a 60-day right of first refusal to provide such services on terms no less favorable than those offered by any third party.

**SECTION 5: DISCLAIMERS AND LIABILITY**

5.1. Disclaimer of Warranties. The Consultant will perform all services with professional diligence. However, the Consultant makes no warranties, express or implied, including but not limited to the merchantability or fitness for a particular purpose of the work performed.

5.2. Limitation of Liability. In no event shall the Consultant be liable to the Client or any third party for any incidental, indirect, special, or consequential damages (including, without limitation, lost profits or loss of data) arising from this MSA.

5.3. Acknowledgment of Role. The Client acknowledges that the Consultant is not a law firm, broker-dealer, or underwriter and provides no services related to the offering or sale of securities.

------© 2025 Alphega Global Partners Corp. All rights reserved. Private and Confidential. 2

------

5.4. Potential Conflicts of Interest. The Client acknowledges that the Consultant serves other clients, including those in the same industry. Subject to its confidentiality obligations, nothing in this MSA shall restrict the Consultant from engaging in other business activities.

**SECTION 6: GOVERNING LAW AND DISPUTE RESOLUTION**

6.1. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the jurisdiction where the Consultant's principal place of business is located.

6.2. Dispute Resolution & Legal Costs. In the event of a dispute, the parties agree to resolve it through binding arbitration. The prevailing party shall be entitled to the reimbursement of its reasonable costs and attorneys' fees.

**SECTION 7: GENERAL PROVISIONS**

7.1. Force Majeure. Neither party shall be liable for failures in performance resulting from causes beyond its reasonable control, such as fires, strikes, government regulations, or other "acts of God."

7.2. Entire Agreement. This MSA, together with its Appendices (\*\*Appendix A, Appendix B, and Appendix C\*\*) and all executed SOWs, constitutes the entire agreement between the parties and supersedes all prior oral or written agreements.

7.3. Amendments. Any modification to this MSA must be made in a written instrument signed by authorized representatives of both parties.

7.4. Severability. If any provision of this MSA is found to be unenforceable, the remaining provisions shall continue in full force and effect.

7.5. Effectiveness and Authority. This MSA becomes effective when signed by the Client and accepted by the Consultant. The signatory for the Client confirms they have the full authority to bind their organization to these terms.

IN WITNESS WHEREOF, the parties have executed this Master Services Agreement as of the Effective Date.

---

| | |
|:---|:---|
| &nbsp;&nbsp;For "CLIENT" (DentonX Inc.) | &nbsp;&nbsp;For "CONSULTANT" (Alphega Global Partners Corp.) |
| &nbsp;&nbsp;Sign: */s/ Luis Carlos Ung* | &nbsp;&nbsp;Sign: */s/ Yanilen Bertel* |
| &nbsp;&nbsp;Print Name: Luis Carlos Ung | &nbsp;&nbsp;Print Name: Yanilen Bertel |
| &nbsp;&nbsp;Title: President | &nbsp;&nbsp;Title: Managing Partner |
| &nbsp;&nbsp;Date: _________________________ | &nbsp;&nbsp;Date: _________________________ |

---

------© 2025 Alphega Global Partners Corp. All rights reserved. Private and Confidential. 3

------

**Appendix A - Service Order Form**

---

| | |
|:---|:---|
| **Company:** | **Consultant:** |
| DentonX Inc.<br> 1999 Harrison Street, Suite 1800<br> Oakland, CA 94612 | Alphega Global Partners Corp |
| **Project Name:** | **Project Name:** |
| Business Operations, Marketing, Compliance & Corporate Development Support | Business Operations, Marketing, Compliance & Corporate Development Support |
| **Project Status:** | **Project Status:** |
| New Contract | New Contract |
| **Objectives and Description of the Project** | **Objectives and Description of the Project** |
| This engagement is designed to actively provide DentonX with **business operations support, marketing and communications assistance, government services coordination, and strategic corporate development support** to enhance the Company's readiness for growth, compliance, and capital market initiatives. Consultant will support the Company's internal teams, external advisors, and executives by providing structured administrative, operational, and strategic coordination in furtherance of the Company's business objectives. | This engagement is designed to actively provide DentonX with **business operations support, marketing and communications assistance, government services coordination, and strategic corporate development support** to enhance the Company's readiness for growth, compliance, and capital market initiatives. Consultant will support the Company's internal teams, external advisors, and executives by providing structured administrative, operational, and strategic coordination in furtherance of the Company's business objectives. |

---

**Scope of Services**

Pursuant to this Service Order ("SO"), the Consultant agrees to provide support to the Company, applying **diligent** and **best efforts**. The specific areas of engagement are defined as follows:

**A. Corporate Development & Strategic Advisory Support**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Assist with evaluating strategic initiatives, operational plans, and business opportunities, including market analysis and the preparation of support materials.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Support preparation for transactional processes (e.g., capital raising, M&A) by coordinating information and drafting business summaries, in a strictly non-brokerage and non-legal capacity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Provide support for business development activities and strategic relationship management, coordinating communications with external advisors, potential partners, and existing investors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Business Development Activities: like Investor Relations, Partner Relations, etc.

**B. Government Services & Compliance Coordination (Administrative Support Only)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Assist with the preparation, organization, and non-legal drafting of documents for compliance processes and government filings, as directed by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Coordinate the flow of information with external advisors (legal, auditors, etc.) and track key deadlines to ensure the timely delivery of documentation.

**Consultant does not:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Provide legal advice;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Draft legal or securities-law content;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Act as a broker-dealer or underwriter;

------© 2025 Alphega Global Partners Corp. All rights reserved. Private and Confidential. 4

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Prepare audited or unaudited financial statements.

**C. Marketing, Branding & Communications Support**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Support the development and oversight of brand strategy, positioning, and corporate narrative.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Assist with the general coordination of marketing, content creation, and digital communications activities to support business objectives.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Communications, PR & Leadership Visibility

**D. Operations, Administration & Project Management**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Provide project management support by coordinating tasks, timelines, and deliverables to ensure initiatives move forward.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Assist with creating operational documentation, designing workflows, and preparing internal communications and executive summaries for management.

**E. Technical Coordination & Support (Non-Engineering Functions)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Coordinate communication and tasks with third-party technology vendors and developers engaged by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Support the configuration of third-party software tools and execute basic, no-code updates on the Company's digital platforms.

**F. Technology & Digital**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Query design and/or market data web scraping for M&A pipeline data obtention.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;·Data science analysis workflow for screening analysis for M&A pipeline or similar.

**G. Additional Services**

The scope of this engagement may be expanded to include other reasonable services as requested by the Company, such as support in administration, coordination, project management, business operations, or marketing. Any such additional services require a formal written agreement executed by both parties before commencement.7

The Firm is obligated to furnish the Company with periodic status reports, which will adhere to the template provided in **Appendix B**. These reports will detail the progress made within the defined Scope of Services and proactively identify any emerging issues or risks that could impact the achievement of the Company's objectives.

------© 2025 Alphega Global Partners Corp. All rights reserved. Private and Confidential. 5

------

**Payment Schedule** (All cash payments are in US Dollars unless specified in this SO)

Subject to the terms of Sections 3 and 4 of the Agreement, respectively, unless specifically overridden by this document.:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.** **Retainer** (Section 4 of the Agreement).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.The initial retainer shall be US$30,000. The Company shall pay the Firm the retainer in the following manner: US$30,000 due upon signing the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.** **Professional Service Fee**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Company shall pay the Firm Fees for Services ("**Service Fee**") based on actual time spent using the Fee Schedule attached as ***Appendix C***. Payment of the Service Fee may be made in both cash and non-cash forms, as mutually agreed upon by the Company and the Firm. If any portion of the fee is paid in equity, the equity will be valued at the Company's current fair market valuation, with a 30% discount applied. These percentages may be changed by mutual agreement between the Company and the Firm.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any unpaid invoices that are past due for 45 days shall be paid through a convertible promissory note with an annual interest rate of 9.5%, subject to mutual consent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Unpaid invoices and any non-cash payment will incur a 15% additional handling fee for the amount.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.** **Success-Based Compensation**

The Firm earns success-based compensation upon achieving milestones, including M&A, finance and banking, and other transactions ("**Success-Based Compensation**"), as assigned by the Company and accepted by the Firm or mutually agreed upon from time to time. Refer to the details in ***Appendix C*** for Success-Based Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Success-based compensation will be based on the completion of milestone phases mutually agreed upon by the Company and the Firm.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Payment is due upon the successful transaction, with options for cash, non-cash, or equity, as determined by the Firm.

**Note:** 

&nbsp;&nbsp;&nbsp;&nbsp;All payments shall be made to the bank account designated by the Firm.

If payment is not received within five (5) business days, a daily interest rate of 0.05% will apply.

IN WITNESS WHEREOF, this SO is effective as of the signing date:

---

| | |
|:---|:---|
| <br> For "**COMPANY"**  | &nbsp;&nbsp;&nbsp;&nbsp; <br> For "**FIRM**" |
| <br>Sign: */s/ Luis Carlos Ung* | <br>Sign: */s/ Yanilen Bertel* |
| <br> Title: President | <br> Title: Managing Member |
| Date: | Date: |

---

------© 2025 Alphega Global Partners Corp. All rights reserved. Private and Confidential. 6

------

**Appendix B - Sample Status Report**

------© 2025 Alphega Global Partners Corp. All rights reserved. Private and Confidential. 7

------

**Appendix C - Fee Schedule**

(Effective till December 31, 2026)

Compensation for Services and Success-Based outcomes is established as follows.

**Professional Service Fee:**

• Administrative Associate - US$65/ Hour

• Associate Financial Analyst - US$155/ Hour

• Senior Financial Analyst - US$285/ Hour

• Director/Supervisor - US$450/ Hour

• Managing Director - US$625/ Hour

• Managing Partner - US$850/ Hour

• Senior Managing Partner - US$1,350/ Hour

**Success-Based Compensation:**

• **Business Development Consulting Success Fee:** Calculated using Lehman (2.0) as a benchmark, payable upon the Consultant's documented contribution to outcomes like new client acquisition or revenue growth.

• **Financial Introduction Support Fee:** Calculated using Lehman (2.0) as a benchmark, payable upon the Consultant's provision of introductions and advisory services supporting financing efforts. Compensation is not contingent solely upon the sale of securities.

• **M&A Consulting Success Fee:** Calculated using Lehman (2.0) as a benchmark, payable upon execution of an M&A transaction where the Consultant provided advisory support.

• **Performance Override Fee:** A 2% supplemental consulting fee payable when the Consultant's efforts produce outcomes exceeding predefined business performance targets.

**Note on Lehman Formula:**

Lehman (N) is the Nth multiplier of the standard Lehman formula. Lehman (2.0) equals 2 times the standard rate, resulting in:

- 10% on the first $1 million of the transaction.

- 8% on the second $1 million.

- 6% on the third $1 million.

- 4% on the fourth $1 million.

- 2% on the value above $4 million.

------© 2025 Alphega Global Partners Corp. All rights reserved. Private and Confidential. 8

## Exhibit 10.13

**PRIVATE AND CONFIDENTIAL**

**STRATEGIC BUSINESS CONSULTING AGREEMENT**

**BETWEEN**

**DENTON X INC. AND FAR SUN GLOBAL GROUP LLC**

**THIS STRATEGIC BUSINESS CONSULTING AGREEMENT** ("Agreement") is made and enter into on the date next to the signatures of the parties below in this Agreement ("Effective Date") by and between DentonX Inc., a Wyoming corporation ("Company") and Far Sun Global Group LLC, a Wyoming limited liability company ("Consultant") with respect to the following facts:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **Scope of Services**. The Consultant shall provide the services as detailed in the Service Order(s) from time to time submitted by the Company and accepted in writing by both the Company and the Consultant (the "Service Order(s)"). Each Service Order shall be in a form similar to the one attached as Exhibit A. Any accepted Service Order may be amended or superseded by any new Service Order only in writing executed by both parties, that expressly provided that it amends or superseded a prior Service Order. Each and all accepted Service Order including the Service Order in Exhibit A constitutes a part of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **Duties of the Company**. The Company shall cooperate with the Consultant in whatever way is reasonably necessary for the Consultant to provide the services contemplated hereunder and shall participate with the Consultant in handling the Company's matter. Without limiting the foregoing, the Company agrees to respond with reasonable promptness to telephone calls and other inquiries by the Consultant, review documents and correspondence, and regularly communicate with the Consultant about the matter in general, including but not limited to any suggestions, questions, or concerns that the Company has, and to promptly pay the charges for services rendered and expenses incurred hereunder. The Company further covenants to provide all relevant information and documentation requested by the Consultant necessary for the Consultant to handle the matter, and the Company acknowledges that failure to provide the information in a timely manner may affect the outcome and intended objective of the Service Order.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **Compensation**. The Company shall pay the Consultant a fee for services performed for the Company as specified in the Service Order(s). The Company shall pay the Consultant for invoiced services in cash or other such means as the parties agree upon in writing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **Retainer**. The Company shall pay the Consultant a retainer amount detailed in the Service Order at the time of the signing of this Agreement. The retainer is an advanced payment to secure Consultant's availability for future work, and ensures Consultant's availability and commitment, but it does not guarantee a specific outcome or final product. The retainer amount is not meant to be an estimate of the total fees that may be incurred, but rather an initial payment for the purposes of establishing the relationship. The retainer amount may increase if the nature of the services is changed. The Company will be informed of changes to the retainer amount.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. **Estimates of Costs**. While an estimate or indication of the amount of fees and time that will likely be incurred in any particular project may be provided from time to time, such estimates are not guaranteed amounts but rather are meant to serve as guidelines only.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;DentonX I Far Sun | &nbsp;&nbsp;**1** of **2** |

---

------

Numerous factors on any project may affect those estimates and require that they be revised. If at any time an estimate for a particular project has been given to the Company and it becomes apparent that the actual hours required for the project will significantly exceed the estimate, the Company will be informed of that fact, and the Company may elect to discontinue further action. The Company may, at any time, request a written estimate of projected fees and time associated with particular requirements or actions to be undertaken by the Service Provider.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. **Termination**. Either party shall have the right to terminate this Agreement with sixty (60) days written notice to the other party. Termination and withdrawal from further engagement may occur if the Company has failed or refused to comply with its obligations hereunder and if the Company does not cure the same within ten (10) days after receiving written notice thereof. In the event a termination notice is issued, the Company shall be responsible for payment of all services and costs incurred by Consultant up to and including the date the Termination takes effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. **Return of the Company Records**. Upon termination, the Consultant may give the Company notice that the Consultant wishes to deliver the Company's records in its possession to the Company. Within thirty (30) days, the Company shall notify the Consultant as to the address to which such records shall be delivered. If the Company does not respond within said thirty (30) day period, the Consultant shall be entitled to destroy such records, and the Company shall waive any and all claims relating to such destruction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. **Billing Disputes and Charges**. Consultant endeavors to ensures that clients are satisfied with its services and the reasonableness of the fees and disbursements charged for those services. Therefore, if Company have any questions about or objection to a billing statement or the basis for Consultant's fees, then Company should raise it promptly for discussion. Such inquiry shall be timely only if made in writing within 10 days after the date of the invoice. The Company's failure to timely set forth any such disagreement or objection to any fee for services rendered or costs incurred shall be considered to be a waiver of any such objections. In the event Company fail to pay any invoice within 30 days of the statement date, Consultant shall be entitled to charge interest at the maximum rate allowed by law, on the unpaid principal balance (consisting of fees, costs and expenses) from the date of the invoice until paid in full. Any waiver of such right shall not be deemed a waiver of any future interest. If Company object only to a portion of a statement, Consultant ask that Company pay the remainder, which will not constitute a waver of Company's objections.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. **Collection Fees**. In the event of any dispute between the parties, the prevailing party shall be entitled to reasonable costs incurred, including attorneys' fees.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. **Limitations on Liability**. The Consultant endeavors to perform the services contemplated in Exhibit A with reasonable care and professional skill. The Consultant does not warrant nor provide warranties of any kind, expressed or implied, including but not limited to the merchantability or fitness for use or purpose of the work performed or non-infringement. In no event shall the Consultant be liable to the Company or any third party for incidental, indirect, special, or consequential damages (including, without limitation, lost profits, loss of data, loss of use or claims of third parties) as a result of implementing this Agreement. The Company further acknowledges that Consultant does not provide legal advice and is not a broker-dealer or underwriter and does not provide services directly or indirectly related to the offering, issuance or sale of securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. **Confidentiality**. Non-Solicitation. and Non-Circumvention. The Company agrees not to disclose the content of this Agreement, Service Orders, or subordinate Agreements to this Agreement to third parties and non-parties of this Agreement in any form,

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;DentonX I Far Sun | &nbsp;&nbsp;**2** of **2** |

---

------

orally, electronically, or otherwise. Both parties agree to adhere to any executed Non-disclosure provisions of the Company and/or Consultant. Furthermore, the Company understands that the Consultant's business depends on its resources, which include but are not limited to human resources, knowledge, technology, intellectual property, partnerships, and contacts. The Company agrees, during the term of this Agreement and for a period of twenty-four (24) months after the termination of this Agreement, not to, directly or indirectly, solicit or circumvent, offer employment, hire, contract, or employ in any form for payor otherwise, any of the Consultant's resources including, but not limited to, employees, contractors, suppliers, investors, brokers, bankers, manufacturers, consultants, companies, introduced by Consultant to the Company, its directors, employees, agents, and affiliates during the performance of this Agreement without Consultant's expressed written approval. The Company shall inform in writing within seven (7) days from the Effective Date of any prior direct relationship that may affect the Consultant's contribution to the Agreement, especially as described in this section.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. **Force Majeure**. Neither party hereto shall be liable for any breach of its obligation hereunder resulting from causes beyond its reasonable control, including but not limited to fire, strikes (excluding their own employees), insurrection or riots, embargoes, wrecks, or delays in transportation, inability to obtain supplies and raw materials, or regulation of any civil or military authority. Each of the parties hereto agrees to give notice forthwith to the other upon becoming aware of an event of Force Majeure, such notice to contain details of the circumstances giving rise to the Force Majeure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. **Governing Law; Binding Arbitration**. This Agreement is governed by the laws of the state of Wyoming. In the event of any disagreement as to the billing statements, both parties have the right to arbitration. Any dispute arising out of or relating to this Agreement or the services provided hereof, including but not limited to any disagreement and/or appeal remaining after the arbitration referred to in the previous sentence, shall be resolved through binding arbitration by an arbitrator under the place of the registration of the Consultant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. **Potential Conflicts of Interest**. The Company acknowledges that the Consultant has been, and may in the future be, engaged to provide services as a consultant to other companies in the industry in which the Company is involved. Subject to the confidentiality provisions of the Consultant contained in Section 11 hereof, the Company acknowledges and agrees that nothing contained in this Agreement shall limit or restrict the right of the Consultant or of any member, manager, officer, employee, agent, or representative of the Consultant, to be a member, manager, partner, officer, director, employee, agent, or representative of, investor in, or to engage in, any other business, whether or not of a similar nature to the Company's business, nor to limit or restrict the right of the Consultant to render services of any kind to any other corporation, firm, individual or association; provided that the Consultant and any of its member, manager, officer, employee, agent, or representative shall not use the Information to the detriment of the Company. The Consultant may, but shall not be required to, present opportunities to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. **Severability**. In the event any of the provisions of this Agreement is held by a court or other tribunal of competent jurisdiction to be unenforceable, the other provisions of this Agreement will remain in full force and effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. **Amendments**. This Agreement shall not be amended or modified except in writing signed or otherwise confirmed by the parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. **Entire Agreement**. This Agreement, together with its Service Order(s), and appendices, constitutes the entire agreement between the parties and supersedes any prior understanding or representation of any kind preceding the date of this Agreement. There are no

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;DentonX I Far Sun | &nbsp;&nbsp;**3** of **2** |

---

------

other promises, conditions, understandings, or other agreements, whether oral or written, relating to the subject matter of this Agreement. This Agreement may be modified in writing and must be signed by both the Company and the Service Provider.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. **Effective Date**. The effective date of this Agreement will be the date on which all parties have executed this Agreement and a fully-executed copy thereof is received by Consultant. Notwithstanding the foregoing, this Agreement will govern all legal services commencing with the date Consultant first performed services. This Agreement will not take effect, and Consultant shall have no obligation to provide services, until Company pays the retainer set forth in Section 4 above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. **Right of First Refusal**. The Company agrees that if it is a party to any merger, acquisition, or any other business combination within two years of this Agreement, and it decides to engage in incubation and management services on a fee basis in connection therewith, the Company shall give prompt written notice of such an event to the Consultant, and the Consultant shall be entitled to a 60-day right of first refusal, beginning on the day the Consultant receives such written notice from the Company of such event, to provide services to the Company. If such right of first refusal is exercised by the Consultant, the terms of any such engagement of the Consultant will be separately agreed upon between the Company and the Consultant and will be no less favorable to the Company than the engagement the Company negotiated with the other party. Nothing contained herein to the contrary shall preclude the Company from continuing to raise capital on its own behalf.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20. **Consent To Electronic Communication**. In order to maximize efficiency, Consultant intend to use common electronic communications technology, including email, cellular telephones, video-conferencing, text-messaging and file-sharing systems such as DropBox. The current state of the art is such that using the aforesaid technology may place confidential or privileged information at risk of inadvertent disclosure. Company agree and acknowledge that the convenience and usefulness of such technology outweighs the associated risk. Accordingly, Company hereby consent to the use of such technology and assume the risks associated therewith.

21 . **This Agreement May Be Signed In Counterpart**. Facsimile signatures of the Company and Consultant shall be effective as original signatures.

[SIGNATURES ON NEXT PAGE]

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;DentonX I Far Sun | &nbsp;&nbsp;**4** of **2** |

---

------

[SIGNATURE PAGE OF AGREEMENT]

IN WITNESS WHEREOF, the parties to this Agreement have duly executed effective on the day

and year first above written.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**DentonX Inc.** | &nbsp;&nbsp;**Far Sun Global Group LLC** |
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* | &nbsp;&nbsp;By: */s/ Irene Chung* |
| &nbsp;&nbsp;Luis Carlos Ung | &nbsp;&nbsp;Irene Chung |
| &nbsp;&nbsp;Title: CEO | &nbsp;&nbsp;Title: Managing Director |
| &nbsp;&nbsp;Date: September 27, 2025 | &nbsp;&nbsp;Date |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;DentonX I Far Sun | &nbsp;&nbsp;**5** of **2** |

---

------

**EXHIBIT A**

Service Order Form

---

| | |
|:---|:---|
| &nbsp;&nbsp;Company: | &nbsp;&nbsp;DentonX Inc |
| &nbsp;&nbsp;Address: | &nbsp;&nbsp;1999 Harrison Street, Suite 1800, |
|  | &nbsp;&nbsp;Oakland, CA 94612 |
| &nbsp;&nbsp;Project Name: | &nbsp;&nbsp;Strategic Business Consulting |
| &nbsp;&nbsp;Project Status: | &nbsp;&nbsp;New contract |

---

Consultant is a service provider under the Company's Corporate Development and Financial Consulting Agreement with Fairbanks Global Partners II LLC dated September 23, 2025. The Company acknowledges Consultant's involvement as a subcontractor in the Project described below by executing Consultant's Strategic Business Consulting Agreement .

Upon acceptance of this Service Order ("SO") by the Company, the Consultant is hereby authorized to provide the services described below according to the Strategic Business Consulting Agreement ("Agreement") between the parties hereto.

**Objective and Description of the Project**

• To form a publicly reporting company with the U.S. Securities Exchange Commission ("SEC") under the securities laws of the United States of America;

• To provide assistance in support of the Company's capital raising for its operations and expansion plans;

• To drive the Project's Strategic Business Development efforts;

• To provide financial advisory and strategiC consulting services outlined in the SO.

**Scope of Services**

This SO defines the services to be provided by Consultant in furtherance of the Company's strategic business development plan to become a publicly reporting company in the United States with the ability to raise capital and to execute its expansion plans.

Consultant shall provide its services on a best-effort basis:

**1. Corporate structuring and SEC reporting readiness**

• Advise on the formation of a U.S. reporting company; SEC filing requirements; reporting requirements; the application process; and assist with the application process.

• Assist in developing corporate governance policy, corporate compliance and disclosure frameworks to align with the public market standards.

**2. Capital Raising Support**

• Provide strategic guidance on capital raising initiatives, including equity, debt, and hybrid structures.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Exhibit B – Fee Schedule | &nbsp;&nbsp;**1** of **1** |

---

------

• Assist in the preparation of investor presentations, offering memoranda, and related fundraising materials.

• Support engagement with institutional investors, private equity, and strategic capital partners.

**3. Strategic Growth & Expansion Advisory**

• Advise on acquisition opportunities, joint ventures, and strategic partnerships in non-bank lending and adjacent sectors

• Conduct financial and strategic assessments of potential targets.

• Support integration planning under the Company's platform model.

**4. Financial & Valuation Advisory**

• Assist in financial modeling, valuation analyses, and scenario planning.

• Advise on capital allocation strategies to maximize shareholder value.

**5. Corporate Development Program Management**

• Provide ongoing strategic consulting services to align execution with the Company's long-term objectives.

• Monitor progress and provide recommendations to ensure alignment with the Company's IPO readiness and expansion roadmap.

**Payment Schedule** (All cash payments are denominated in US Dollars unless specified in this SO).

**1. Retainer**. As a material consideration for Consultant agreeing to the initial partial payment of its retainer fee, the parties hereto agree that the initial retainer referenced in Section 4 of the Agreement shall be paid to Consultant in two payments as follows: U.S.$40,000 shall be paid upon execution of the Agreement, and the balance of $40,000 on or before November 5, 2025.

**2. Professional Service Fee**

a. Company shall pay the Consultant Fees for Services ("Service Fee") based on actual time spent using the Fee Schedule attached as Exhibit B. Payment of the Service Fee may be made in both cash and non-cash forms, as mutually agreed upon by the Company and the Consultant. If any portion of the fee is paid in equity, the equity will be valued at the Company's current fair market valuation, with a 30% discount applied. This discount percentage may be adjusted by mutual agreement between the Company and the Consultant.

b. Any unpaid invoices that are past due for 45 days shall be paid through a promissory note with an annual interest rate of 9.5%, subject to mutual consent.

c. Unpaid invoices and any non-cash payment will incur a 15% additional handling fee for the amount.

d. For clarity, Pre-Effective Services (as defined in Section 3 of the Agreement) performed by the Consultant prior to September 3, 2025 are billable under this Service Order.

**3. Consulting Success Compensation**

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Exhibit B – Fee Schedule | &nbsp;&nbsp;**2** of **1** |

---

------

a. The Consultant may earn consulting success-based compensation upon achieving mutually agreed business or strategic milestones, including (but not limited to) the execution of strategic partnerships, board-approved transactions, achievement of revenue or growth benchmarks, or other corporate development outcomes ("Consulting Success Compensation").

b. Consulting Success Compensation will be based on milestone phases documented and agreed upon in writing by both the Company and the Consultant.

c. Payment is due upon completion of the agreed milestone, and may be made in cash, non-cash consideration, or equity, as mutually agreed by the parties.

d. For clarity, the Consultant does not act as a broker-dealer, underwriter, or placement agent, and its compensation is tied to advisory and consulting services, not to the purchase or sale of securities.

IN WITNESS WHEREOF, this SERVICE ORDER FORM is effective as of the date of the signing.

---

| | |
|:---|:---|
| &nbsp;&nbsp;For Company: | &nbsp;&nbsp;For Consultant: |
| &nbsp;&nbsp;**DentonX Inc.** | &nbsp;&nbsp;**Far Sun Global Group LLC** |
| &nbsp;&nbsp;By: */s/ Luis Carlos Ung* | &nbsp;&nbsp;By: */s/ Irene Chung* |
| &nbsp;&nbsp;Luis Carlos Ung | &nbsp;&nbsp;Irene Chung |
| &nbsp;&nbsp;Title: CEO | &nbsp;&nbsp;Title: Managing Director |
| &nbsp;&nbsp;Date: September 27, 2025 | &nbsp;&nbsp;Date |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Exhibit B – Fee Schedule | &nbsp;&nbsp;**3** of **1** |

---

------

**Exhibit B - Fee Schedule**

In accordance with Sections 3 and 4 of the Agreement and approved Service Orders, the following fees are established for compensation for Services under the Service Orders and Success-Based Compensation. These Fees are subject to change, and the Consultant will notify the Company of any updates to the Fee Schedule.

The Professional Service Fee pertains to the time and effort spent on behalf of the Company. If the Company qualifies as an Incubation company, the Incubation rate may be applicable.

Success-Based Compensation is contingent on the successful completion of transactions. The Company and the Consultant should discuss the applicable Success-Based Compensation for each transaction before its completion.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Professional Service**<br> **Fee** | &nbsp;&nbsp;• Administrative Associate - US$80/ Hour<br> • Associate Financial Analyst - US$155/ Hour<br> • Senior Financial Analyst - US$285/ Hour<br> • Director/Supervisor - US$450/ Hour<br> • Managing Director - US$625/ Hour<br> • Managing Partner - US$850/ Hour<br> • Senior Managing Partner - US$1,350/ Hour |
| &nbsp;&nbsp;**Success-Based**<br> **Compensation** | &nbsp;&nbsp;• Business Development Success Feel - Lehman (2.0)2<br> • Financial Introduction Success Fee3 - Lehman (2.0)<br> • M&A Service Fee4 - Lehman (2.0)<br> • Performance Override Fee for Success5 - 2% |

---

**Note:**

**1. Business Development Success Fee**: This fee is typically charged when the Consultant contributes to the successful development of the Company's business, including securing new clients, expanding market share, forming strategic partnerships, or achieving predefined revenue targets.

**2. Lehman (N)** is defined as the Lehman formula at the Nth multiplier of the rate of the standard Lehman formula rate. For example, Lehman (2.0) equals 2 times Lehman, resulting in a 2 x 5% (10%) fee on the first $1 million of the transaction, 2 x 4% (8%) on the second $1 million, 2 x 3% (6%) on the third $1 million, 2 x 2% (4%) on the fourth $1 million, and 2 x 1 % (2%) on everything above $4 million of the total transactional value. Similarly, Lehman (2 .5) would represent 2.5 times the Lehman formula.

**3. Financial Introduction Success Fee**: This fee is associated with the successful introduction of financial entities by the Firm, and is paid upon a successful transaction.

**4. M&A Service Fee**: This fee is charged in the context of successfully facilitating a merger or acquisition, with payment occurring upon the signing of the closing document.

**5. Performance Override Fee for Success**: An override fee refers to supplemental compensation or an additional payment typically provided for achieving specific outcomes or exceeding predefined performance metrics. This fee is utilized in various business contexts, such as financial transactions, where the achievement of exceptional results or surpassing established targets warrants additional compensation beyond the standard or base fee.

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;Exhibit B – Fee Schedule | &nbsp;&nbsp;**1** of **1** |

---

## Exhibit 23.1

**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

We consent to the inclusion in this Registration Statement of DentonX Inc. of our report dated March 20, 2026, with respect to our audit of DentonX Inc.'s, (the "Company") financial statements as of September 30, 2025, and for the period from September 3, 2025 (inception) to September 30, 2025. Our report includes an explanatory paragraph as to the Company's ability to continue as a going concern,

We consent to the use of our name as it appears under the caption "Experts".

Very truly yours,

*/s/ RBSM LLP*

RBSM LLP

Larkspur, CA

March 20, 2026

## Exhibit 99.1

**Exhibit 99.1**

**SUBSCRIPTION AGREEMENT**

**DENTONX INC.**

The undersigned (the "Subscriber") desires to become a holder of shares of common stock, $0.0001 par value per share (the "Shares") of DentonX, a corporation organized under the laws of the State of Wyoming (the "Company"); the Subscriber hereby agrees as follows:

1. Subscription.

1.1The Subscriber hereby irrevocably subscribes for and agrees to purchase the number of Shares set forth on the signature page hereto at the $5.00 per share ("Per Share Purchase Price"), upon the terms and conditions set forth herein. The aggregate purchase price for the Shares with respect to each Subscriber (the "Purchase Price") is payable in the manner provided below.

1.2Subscriber understands that the Shares are being offered pursuant to the Registration Statement on Form S-1 deemed effective on____________ (the "Registration Statement") providing for the sale of up to 5,000,000 shares of Common Stock at the Per Share Purchase Price (the "Offering"). Subscriber hereby acknowledges and confirms that Subscriber has received a copy of the final prospectus dated ____________ (the "Prospectus"), which forms a part of the effective Registration Statement, has carefully read and understands the Prospectus (including all Risk Factors), and is purchasing the Shares solely in reliance on the information contained in the Prospectus and not on any other information, representations, or warranties (oral or written) from the Company or any of its officers, directors, employees, or agents.

1.3The closing of the Subscription of Shares hereunder (the "Closing") shall occur immediately upon: (i) receipt and acceptance by the Company of a properly executed Signature Page to this Agreement; and (ii) receipt of all funds for the subscription of the Shares hereunder. The Company may, in its sole discretion, accept or reject this subscription in whole or in part, and no subscription shall be binding on the Company until accepted in writing by an authorized officer.

1.4The terms of this Subscription Agreement shall be binding upon Subscriber and its permitted transferees, heirs, successors and assigns (collectively, the "Transferees"); provided, however, that for any such transfer to be deemed effective, the Transferee shall have executed and delivered to the Company in advance an instrument in form acceptable to the Company in its sole discretion, pursuant to which the proposed Transferee shall acknowledge and agree to be bound by the representations and warranties of Subscriber and the terms of this Subscription Agreement. No transfer of this Agreement may be made without the consent of the Company, which may be withheld in its sole and absolute discretion. Notwithstanding the foregoing, the Shares, once issued, shall be freely tradable without restriction or legend under the Securities Act of 1933, as amended (the "Securities Act"), subject to compliance with applicable securities laws (including, if applicable, Rule 144 or other exemptions). Subscriber acknowledges that any resale of the Shares may be subject to prospectus delivery requirements or other restrictions under federal or state securities laws.

2. Purchase Procedure. The Subscriber acknowledges that, to subscribe to Shares, Subscriber must, and Subscriber does hereby, deliver to the Company:

2.1One (1) executed counterpart of the Signature Page attached to this Agreement; and

2.2A check or a wire transfer payment in the amount set forth on the Signature Page attached to this Agreement, representing payment in full for the Shares desired to be purchased hereunder, pursuant to the wire instructions set forth on the signature page.

3. Representations of Subscriber. By executing this Agreement, the Subscriber makes the following representations, declarations, and warranties to the Company, with the intent and understanding that the Company will rely thereon:

------

3.1Such Subscriber acknowledges the public availability of the Company's current prospectus. This prospectus is made available in the Company's most recent Registration Statement. The terms and conditions of the Offering and the risks associated therewith are set forth in the prospectus included as part of the Registration Statement.

3.2 All information herein concerning the Subscriber is correct and complete as of the date hereof and as of the date of Closing.

3.3If the Subscriber is purchasing the Shares in a fiduciary capacity for another person or entity, including, without limitation, a corporation, partnership, trust, or any other entity, the Subscriber has been duly authorized and empowered to execute this Subscription agreement and all other subscription documents.

3.4Upon request of the Company, the Subscriber will provide true, complete, and current copies of all relevant documents of the Subscriber, authorizing its investment in the Company and/or evidencing the satisfaction of the foregoing.

3.5 Subscriber represents and warrants that: (a) Subscriber has such knowledge and experience in financial and business matters that Subscriber is capable of evaluating the merits and risks of an investment in the Shares; (b) Subscriber's investment in the Shares is not disproportionate to Subscriber's net worth; (c) Subscriber can bear the economic risk of loss of Subscriber's entire investment; (d) Subscriber is not acquiring the Shares with a view to or for resale in connection with any distribution thereof within the meaning of the Securities Act, and Subscriber is not an "underwriter" (as defined in Section 2(a)(11) of the Securities Act) with respect to the Shares; (e) Subscriber is not relying on the Company or any affiliate for any investment advice or recommendation; and (f) Subscriber has consulted Subscriber's own legal, tax, and financial advisors to the extent Subscriber deems necessary.

3.6 Subscriber represents that Subscriber is not a "bad actor" as described in Rule 506(d) of Regulation D under the Securities Act (even though not applicable here, for general compliance).

3.7 Subscriber acknowledges that the Shares are penny stock securities under applicable SEC rules, involve a high degree of risk (as detailed in the Prospectus), and may be difficult to sell or value due to limited market, quotation, or liquidity.

4. Applicable Law. This Agreement shall be construed in accordance with and governed by the laws applicable to contracts made and wholly performed in the State of Wyoming. The parties irrevocably submit to the exclusive jurisdiction of the state and federal courts located in Sheridan County, Wyoming, for any dispute arising hereunder, and waive any objection to venue or inconvenience of forum. EACH PARTY HEREBY WAIVES ANY RIGHT TO A JURY TRIAL IN ANY ACTION ARISING OUT OF THIS AGREEMENT.

5. Indemnity. The representations, warranties and covenants made by Subscriber herein shall survive the closing of this Subscription Agreement. Subscriber agrees to indemnify and hold harmless the Company and its respective officers, directors and affiliates, and each other person, if any, who controls the Company against any loss, liability, claim, damage and expense whatsoever (including, but not limited to, any reasonable attorneys' fees, including attorneys' fees on appeal) and expenses reasonably incurred in investigating, preparing or defending against any false representation or warranty or breach of failure by Subscriber to comply with any covenant or agreement made by Subscriber herein or in any other document furnished by Subscriber to any of the foregoing in connection with this transaction.

6. Execution in Counterparts. This Subscription Agreement may be executed in one or more counterparts. This Agreement may be executed and delivered by facsimile, PDF, or electronic signature (including DocuSign or similar), which shall be deemed an original.

7. Persons Bound. This Subscription Agreement shall, except as otherwise provided herein, inure to the benefit of and be binding on the Company and its successors and assigns and on each Subscriber and his respective heirs, executors, administrators, successors and assigns.

------

8. Notices. Any notice or other communication required or permitted hereunder shall be in writing. It shall be delivered personally, telegraphed, telexed, sent by facsimile transmission, or sent by certified, registered, or express mail, postage prepaid, to the address of each party set forth herein. Any such notice shall be deemed given when delivered personally, telegraphed, telexed, or sent by facsimile transmission.

9. Certification. The Subscriber certifies that he has read this entire subscription agreement and that every statement made by the subscriber herein is accurate and complete.

**[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]**

------

**SUBSCRIBER SIGNATURE**

The undersigned, desiring to subscribe for the number of shares of the Company as set forth below, acknowledges that the undersigned has received and understands the terms and conditions of the Subscription Agreement attached hereto and that the undersigned does hereby agree to all the terms and conditions contained therein.

IN WITNESS WHEREOF, the undersigned has hereby executed this Subscription Agreement as of the date set forth below.

Total Amount of Subscription: _________________________

Number of Shares:_________________________ ($5.00 Per Share Purchase Price)

Exact Name of Subscriber: _________________________

Address of Subscriber: _________________________

_________________________

_________________________

Email of Subscriber: _________________________

Signature of Subscriber: _________________________

Name/Title (if an entity):_________________________

Tax ID:_________________________

Date: _________________________

The Company hereby accepts the foregoing subscription this ___ day of ________, 2026.

Authorized signature of DentonX Inc.:

By: _____________________________

Name: Lionel Pinuer

Title: Chief Executive Officer and Chief Financial Officer

WIRE INSTRUCTIONS:

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Calculation of Filing Fee Tables**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **S-1**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **DentonX Inc**  |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Security Type**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Security Class Title**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Calculation or Carry Forward Rule**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount Registered**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Proposed Maximum Offering Price Per Unit**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Maximum Aggregate Offering Price**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Rate**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount of Registration Fee**  |
| **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** |
| Fees to be Paid | 1 | Equity | Common | 457(o) | 3000000 | $5.00 | $15000000.00 | 0.0001381 | $2071.50 |
| Fees Previously Paid |  |  |  |  |  |  |  |  |  |
| **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** | **Carry Forward Securities** |
| Carry Forward Securities |  |  |  |  |  |  |  |  |  |
|  |  |  | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $15000000.00  |  | $2071.50  |
|  |  |  | Total Fees Previously Paid:  | Total Fees Previously Paid:  | Total Fees Previously Paid:  |  |  |  | $0.00  |
|  |  |  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $0.00  |
|  |  |  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $2071.50  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Offering Note** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>1</sup> The offering price has been arbitrarily determined by the Company and bears no relationship to assets, earnings, or any other valuation criteria. No assurance can be given that the shares offered hereby will have a market value or that they may be sold at this, or at any price.

---

| |
|:---|
| |
| **Rules 457(b) and 0-11(a)(2)** |
| Fee Offset Claims |
| Fee Offset Sources |
| **Rule 457(p)** |
| Fee Offset Claims |
| Fee Offset Sources |

---